
<html lang="en"     class="pb-page"  data-request-id="bd9bada7-9537-452a-a367-8e993680c44c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2015.58.issue-7;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.5b00115"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride" /></meta><meta name="dc.Creator" content="Christophe  Rochais" /></meta><meta name="dc.Creator" content="Cédric  Lecoutey" /></meta><meta name="dc.Creator" content="Florence  Gaven" /></meta><meta name="dc.Creator" content="Patrizia  Giannoni" /></meta><meta name="dc.Creator" content="Katia  Hamidouche" /></meta><meta name="dc.Creator" content="Damien  Hedou" /></meta><meta name="dc.Creator" content="Emmanuelle  Dubost" /></meta><meta name="dc.Creator" content="David  Genest" /></meta><meta name="dc.Creator" content="Samir  Yahiaoui" /></meta><meta name="dc.Creator" content="Thomas  Freret" /></meta><meta name="dc.Creator" content="Valentine  Bouet" /></meta><meta name="dc.Creator" content="François  Dauphin" /></meta><meta name="dc.Creator" content="Jana  Sopkova de Oliveira Santos" /></meta><meta name="dc.Creator" content="Céline  Ballandonne" /></meta><meta name="dc.Creator" content="Sophie  Corvaisier" /></meta><meta name="dc.Creator" content="Aurélie  Malzert-Fréon" /></meta><meta name="dc.Creator" content="Remi  Legay" /></meta><meta name="dc.Creator" content="Michel  Boulouard" /></meta><meta name="dc.Creator" content="Sylvie  Claeysen" /></meta><meta name="dc.Creator" content="Patrick  Dallemagne" /></meta><meta name="dc.Description" content="In this work, we describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhib..." /></meta><meta name="Description" content="In this work, we describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhib..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 31, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00115" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00115" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00115" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00115" /></link>
        
    
    

<title>Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00115" /></meta><meta property="og:title" content="Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0016.jpeg" /></meta><meta property="og:description" content="In this work, we describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhibitory effects and partial 5-HT4R agonist activity, among which donecopride was selected for further in vivo evaluations in mice. The latter displayed procognitive and antiamnesic effects and enhanced sAPPα release, accounting for a potential symptomatic and disease-modifying therapeutic benefit in the treatment of Alzheimer’s disease." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00115"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00115">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00115&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00115&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00115&amp;href=/doi/10.1021/acs.jmedchem.5b00115" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3172-3187</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00050" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00136" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT<sub>4</sub>R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Rochais">Christophe Rochais</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9dric++Lecoutey">Cédric Lecoutey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florence++Gaven">Florence Gaven</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrizia++Giannoni">Patrizia Giannoni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katia++Hamidouche">Katia Hamidouche</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Damien++Hedou">Damien Hedou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emmanuelle++Dubost">Emmanuelle Dubost</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Genest">David Genest</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samir++Yahiaoui">Samir Yahiaoui</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Freret">Thomas Freret</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valentine++Bouet">Valentine Bouet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fran%C3%A7ois++Dauphin">François Dauphin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jana++Sopkova+de+Oliveira+Santos">Jana Sopkova de Oliveira Santos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9line++Ballandonne">Céline Ballandonne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sophie++Corvaisier">Sophie Corvaisier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aur%C3%A9lie++Malzert-Fr%C3%A9on">Aurélie Malzert-Fréon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Remi++Legay">Remi Legay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Boulouard">Michel Boulouard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvie++Claeysen">Sylvie Claeysen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Dallemagne">Patrick Dallemagne</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie), F-14032 Caen, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">CNRS, UMR-5203, Institut de Génomique Fonctionnelle, F-34000 Montpellier, France</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Inserm, U1191, F-34000 Montpellier, France</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Université de Montpellier, UMR-5203, F-34000 Montpellier, France</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">UNICAEN, GMPc5 (Groupe Mémoire et Plasticité comportementale), F-14032 Caen, France</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#02616a706b71766d726a672c706d616a636b7142776c6b6163676c2c6470"><span class="__cf_email__" data-cfemail="aac9c2d8c3d9dec5dac2cf84d8c5c9c2cbc3d9eadfc4c3c9cbcfc484ccd8">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#413120353328222a6f25202d2d242c20262f2401342f282220242f6f2733"><span class="__cf_email__" data-cfemail="c8b8a9bcbaa1aba3e6aca9a4a4ada5a9afa6ad88bda6a1aba9ada6e6aeba">[email protected]</span></a>. Tel.: +33-2-31-56-68-13. Fax +33-2-31-56-68-03.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00115&amp;href=/doi/10.1021%2Facs.jmedchem.5b00115" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3172–3187</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 20, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 January 2015</li><li><span class="item_label"><b>Published</b> online</span>31 March 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 April 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00115" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00115</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3172%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristophe%2BRochais%252C%2BC%25C3%25A9dric%2BLecoutey%252C%2BFlorence%2BGaven%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D7%26contentID%3Dacs.jmedchem.5b00115%26title%3DNovel%2BMultitarget-Directed%2BLigands%2B%2528MTDLs%2529%2Bwith%2BAcetylcholinesterase%2B%2528AChE%2529%2BInhibitory%2Band%2BSerotonergic%2BSubtype%2B4%2BReceptor%2B%25285-HT4R%2529%2BAgonist%2BActivities%2BAs%2BPotential%2BAgents%2Bagainst%2BAlzheimer%25E2%2580%2599s%2BDisease%253A%2BThe%2BDesign%2Bof%2BDonecopride%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3187%26publicationDate%3DApril%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00115"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2503</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">75</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00115" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Rochais&quot;},{&quot;first_name&quot;:&quot;Cédric&quot;,&quot;last_name&quot;:&quot;Lecoutey&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;Gaven&quot;},{&quot;first_name&quot;:&quot;Patrizia&quot;,&quot;last_name&quot;:&quot;Giannoni&quot;},{&quot;first_name&quot;:&quot;Katia&quot;,&quot;last_name&quot;:&quot;Hamidouche&quot;},{&quot;first_name&quot;:&quot;Damien&quot;,&quot;last_name&quot;:&quot;Hedou&quot;},{&quot;first_name&quot;:&quot;Emmanuelle&quot;,&quot;last_name&quot;:&quot;Dubost&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Genest&quot;},{&quot;first_name&quot;:&quot;Samir&quot;,&quot;last_name&quot;:&quot;Yahiaoui&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Freret&quot;},{&quot;first_name&quot;:&quot;Valentine&quot;,&quot;last_name&quot;:&quot;Bouet&quot;},{&quot;first_name&quot;:&quot;François&quot;,&quot;last_name&quot;:&quot;Dauphin&quot;},{&quot;first_name&quot;:&quot;Jana&quot;,&quot;last_name&quot;:&quot;Sopkova de Oliveira Santos&quot;},{&quot;first_name&quot;:&quot;Céline&quot;,&quot;last_name&quot;:&quot;Ballandonne&quot;},{&quot;first_name&quot;:&quot;Sophie&quot;,&quot;last_name&quot;:&quot;Corvaisier&quot;},{&quot;first_name&quot;:&quot;Aurélie&quot;,&quot;last_name&quot;:&quot;Malzert-Fréon&quot;},{&quot;first_name&quot;:&quot;Remi&quot;,&quot;last_name&quot;:&quot;Legay&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Boulouard&quot;},{&quot;first_name&quot;:&quot;Sylvie&quot;,&quot;last_name&quot;:&quot;Claeysen&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Dallemagne&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;3172-3187&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00115&quot;},&quot;abstract&quot;:&quot;In this work, we describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhibitory effects and partial 5-HT4R agonist activity, among which donecopride was selected for further in vivo evaluations in mice. The latter displayed procognitive and antiamnesic effects and enhanced sAPPα release, accounting for a potential symptomatic and disease-modifying therapeutic benefit in the treatment of Alzheimer’s disease.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00115&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00115" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00115&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00115" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00115&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00115" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00115&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00115&amp;href=/doi/10.1021/acs.jmedchem.5b00115" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00115" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00115" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00115%26sid%3Dliteratum%253Aachs%26pmid%3D25793650%26genre%3Darticle%26aulast%3DRochais%26date%3D2015%26atitle%3DNovel%2BMultitarget-Directed%2BLigands%2B%2528MTDLs%2529%2Bwith%2BAcetylcholinesterase%2B%2528AChE%2529%2BInhibitory%2Band%2BSerotonergic%2BSubtype%2B4%2BReceptor%2B%25285-HT4R%2529%2BAgonist%2BActivities%2BAs%2BPotential%2BAgents%2Bagainst%2BAlzheimer%25E2%2580%2599s%2BDisease%253A%2BThe%2BDesign%2Bof%2BDonecopride%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D7%26spage%3D3172%26epage%3D3187%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/jmcmar.2015.58.issue-7/20150409/jmcmar.2015.58.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In this work, we describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhibitory effects and partial 5-HT<sub>4</sub>R agonist activity, among which donecopride was selected for further in vivo evaluations in mice. The latter displayed procognitive and antiamnesic effects and enhanced sAPPα release, accounting for a potential symptomatic and disease-modifying therapeutic benefit in the treatment of Alzheimer’s disease.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD), the most common form of dementia among the elderly, is a chronic, progressive and degenerative disorder of the brain featuring impairments in cognitive functions, especially memory processes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> As of 2013, there were an estimated 44.4 million people with dementia worldwide.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> By 2050, it is projected that this figure will have increased to over 115 million. Not only are there numerous reasons for concern, but AD and dementia have an enormous impact on societies.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The total estimated worldwide costs of dementia were U.S. $604 billion in 2010. Given that the pathogenesis of AD is complex and related to the abnormality and dysfunction of multisystems, the prevention and treatment of AD have remained elusive to date. Most of the current treatments produce only symptomatic benefits through the catalytic inhibition of acetylcholinesterase (AChE).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> So far, investigational new drugs that have reached clinical trials have been targeting amyloid aggregation or neurofibrillary tangle production linked to the abnormality of protein τ phosphorylation. Nevertheless, many of these trials recently failed, and some of these failures have been attributed to the extreme selectivity of the tested drugs against a single target, disregarding the fact that neurodegenerative syndromes involve multiple pathogenic factors.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Consequently, efficient treatments should associate several drugs whose actions are oriented toward several targets involved in the pathogenesis. These drugs could be combined in a cocktail (multiple-medication therapy) or in a single formulation (multiple-compounded medication). However, these approaches might be disadvantageous for patients with respect to compliance difficulties, drug–drug interactions, problems of bioavailability, and metabolism.</div><div class="NLM_p">These issues are difficult to solve when the drugs present different pharmacokinetic profiles.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Today, a new concept is emerging; also called “hybride molecules”, “designed multiple ligands”, or “multitarget-directed ligands” (MTDLs), it describes those compounds that are effective in treating complex diseases because of their ability to interact with the multiple targets thought to be responsible for the disease pathogenesis.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22">(9-22)</a> Besides reducing the pharmacokinetic and interaction problems linked to multiple-medication therapy, MTDLs generally show a synergistic effect. They could be particularly useful in the treatment of neurodegenerative diseases like AD.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34">(23-34)</a> Recently, hybrid agents with a dual mode of action against AD have been described. One of the most widely adopted approaches in the field has been to modify the molecular structure of an AChE inhibitor (AChEI) in order to complement it with additional biological activities that are useful for treating AD, like M2 receptor antagonism,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> direct inhibition of amyloid beta peptide (Aβ) aggregation,<a onclick="showRef(event, 'ref36 ref37 ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39 ref40 ref41">(36-41)</a> AChE-dependent amyloid aggregation inhibition (dual-binding site [DBS] inhibitors),<a onclick="showRef(event, 'ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref45 ref46">(42-46)</a> or providing it with antioxidant properties<a onclick="showRef(event, 'ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50">(47-50)</a> linked to MAO-B inhibition,<a onclick="showRef(event, 'ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53 ref54">(51-54)</a> calcium channel blockage,<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> or control oxidative damage properties.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Within this scope, we very recently described the design of <b>1</b> (donecopride), a novel drug candidate exhibiting, for the first time, both in vitro DBS AChE inhibitory activity and a serotonergic subtype 4 receptor (5-HT<sub>4</sub>R) partial agonist effect, promoting the secretion of the neurotrophic protein sAPPα in an in vitro cellular model and finally leading to an in vivo procognitive effect in mice.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Donecopride was conceived as a structural compromise between donepezil (DPZ), an AChEI drug, and <b>2</b> (RS67333),<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> a 5-HT<sub>4</sub>R agonist (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of donecopride, DPZ, and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This MTDL profile seems to confer to donecopride the ability to display both improvements in cholinergic neurotransmission (through the catalytic inhibition of AChE and the 5-HT<sub>4</sub>R-dependent release of ACh) and in the inhibition of Aβ accumulation and aggregation. This second effect would be possible through the nonamyloidogenic 5-HT<sub>4</sub>R-dependent cleavage of the precursor of Aβ and the consequent promotion of the neurotrophic protein, sAPPα, as well as through the interaction of donecopride with the peripheral anionic site (PAS) of AChE, which is able to counteract the chaperone role played by the latter in Aβ aggregation. Finally, these complementary activities could exert both symptomatic and disease-modifying effects for AD treatment (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pleiotropic interest of DBS AChEI/5-HT<sub>4</sub>R agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The present article aims to describe the discovery of donecopride in the context of the chemical series from which it was selected in order to establish some structure–activity relationships (SARs) as well as to describe additional in vivo experiments useful for precisely determining its pharmacological profile.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Donecopride was obtained according to a previously reported multistep sequence<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> starting from 4-amino-5-chloro-2-methoxybenzoic acid (<b>3</b>) (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The sequence starts with the synthesis of a β-ketoester (<b>4</b>) with a 62% yield, which took place after the carbonyldiimidazole (CDI) activation of the carboxylic acid group of <b>3</b>. The methylpiperidine moiety was then installed through a nucleophilic substitution using <i>N</i>-Boc 4-(iodomethyl)piperidine carboxylate at room temperature to avoid the risk of a double substitution, immediately followed by a saponification–decarboxylation sequence with hydroalcoholic potassium hydroxide which gave <b>5</b> in an 86% yield. <b>1</b> was finally obtained in 44% yield through the TFA-N-deprotection of <b>5</b>, immediately followed by another nucleophilic substitution with bromomethylcyclohexane. Starting from <b>5</b> and using various alkyl- and arylmethyl bromides according to these experimental conditions, numerous other N-substituted derivatives (<b>6</b>–<b>15</b>) were obtained. Finally, the oxime (<b>16</b>) and methyloxime (<b>17</b>) of donecopride were selectively obtained in excellent yield under their <i>E</i> form (according to their X-ray structure) under treatment using hydroxylamine and methoxylamine, respectively. The reduction of its carbonyl group, using sodium borohydride, afforded the hydroxyl derivative (<b>18</b>) in an 62% yield.</div><div class="NLM_p">The anisamide <b>19</b>, an analog of donecopride, was issued from a peptidic coupling between <b>3</b> and <i>N</i>-Boc aminomethylpiperidine and affording <b>20</b> which was then N-deprotected and substituted with a methylcyclohexyl group under treatment with bromomethylcyclohexane. Finally the ester <b>21</b> was synthesized in 31% yield through the esterification of <b>3</b> using the commercially available <i>N</i>-methylcyclohexyl-4-hydroxymethylpiperidine.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic pathways for access to compounds <b>1</b> and <b>6</b>–<b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions and reagents: (a) CDI, THF; (b) KO<sub>2</sub>CCH<sub>2</sub>CO<sub>2</sub>Et, MgCl<sub>2</sub>, THF; (c) <i>N</i>-Boc 4-iodomethylpiperidine, K<sub>2</sub>CO<sub>3</sub>, DMF; (d) KOH, EtOH/H<sub>2</sub>O; (e) TFA, DCM; (f) RBr, K<sub>2</sub>CO<sub>3</sub>, DMF; (g) HCl/EtOH; (h) H<sub>2</sub>NOR’, HCl, pyridine; (i) NaBH<sub>4</sub>, MeOH; (j) TEA, DMF; (k) HOBT, EDCI·HCl, <i>N</i>-Boc 4-aminomethylpiperidine, DMF; (l) CyHexCH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF; (m) <i>N</i>-CyHexCH<sub>2</sub>-4-hydroxymethylpiperidine, NaH, THF.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> In Vitro Results</h3><div class="NLM_p">All the synthesized compounds were evaluated as potential inhibitors of human AChE and equine BuChE as well as potential ligands for guinea pig 5-HT<sub>4</sub>R (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In these tests, DPZ was used as an AChEI control and <b>2</b> as both a 5-HT<sub>4</sub>R ligand and an AChEI control since we recently reported its MTDL pharmacological profile.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. (<i>h</i>)AChE Inhibitory Activity and Selectivity versus (<i>eq</i>)BuChE and (<i>gp</i>)5-HT<sub>4</sub>R Affinity for DPZ, <b>2</b>, and compounds <b>1</b> and <b>6</b>–<b>21</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0014.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Results reported from Lecoutey et al.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></p></div></div><div></div></div><div class="NLM_p">The results of these in vitro evaluations are reported in a double-entry table where we also reported the results concerning <b>2</b> and DPZ (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Among the 16 tested compounds, two of them (compounds <b>17</b>, <b>18</b>) were found to be almost inactive against the two designed targets. One of them (compound <b>16</b>) is highly inhibitor of AChE, but it is almost devoid of affinity for 5-HT<sub>4</sub>R, as is the case for DPZ. Conversely, four compounds (<b>6</b>, <b>7</b>, <b>19</b>, <b>21</b>) appear to be good ligands for 5-HT<sub>4</sub>R, but they do not show any AChE inhibitory effects. Finally, nine compounds (<b>1</b>, <b>8</b>–<b>10</b>, <b>11</b>–<b>15</b>) could be considered as MTDL since they exhibit both a <i>K</i><sub>i</sub><sub>(5-HT4R)</sub> ≤ 20 nM and an IC<sub>50(AChE)</sub> ≤ 400 nM, as was found with <b>2</b>. These compounds further showed a good selectivity toward AChE versus BuChE.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <sup>2</sup>D Representation of (<i>gp</i>)5-HT<sub>4</sub>R Affinity and (<i>h</i>)AChE Inhibitory Activity for Compounds <b>1</b>, <b>6</b>–<b>21</b>, DPZ, and <b>2</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0015.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">The most potent compounds (<b>1</b>, <b>8</b>–<b>10</b>, <b>13</b>) were further evaluated to establish their affinity and their pharmacological profile with regard to their potential agonist effects toward human 5-HT<sub>4</sub>R and their capacity to bind to the PAS of electric eel AChE using the propidium iodide displacement test (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. (<i>h</i>)5-HT<sub>4e</sub>R Binding Assay (Displacement of 1-(2-Methylsulfonylaminoethyl-4-piperidinyl)methyl-1-methyl-1<i>H</i>-indole-3-carboxylate (<b>22</b>) [<sup>3</sup>[H]GR113808]<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a>), (<i>h</i>)5-HT<sub>4e</sub>R Agonist Activity, And Propidium Iodide Competition Assay for Compounds <b>1</b>, <b>8</b>–<b>10</b>, <b>13</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">(<i>h</i>)5-HT<sub>4e</sub>R</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">control ligand displacement</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">% inhibition at 10<sup>–6</sup> M</th><th class="colsep0 rowsep0" align="center">% inhibition at 10<sup>–8</sup> M</th><th class="colsep0 rowsep0" align="center">% control agonist response</th><th class="colsep0 rowsep0" align="center">propidium iodide displacement from (<i>ee</i>)AChE PAS % inhibition at 10<sup>–5</sup> M</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">DPZ</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">21.5 ± 1.5 <i>n</i> = 2<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">73</td><td class="colsep0 rowsep0" align="center">48.3 ± 0.9 <i>n</i> = 3<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">24 ± 2 <i>n</i> = 2<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>2</b></td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">48.7 ± 5.2 <i>n</i> = 3<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>8</b></td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">58</td><td class="colsep0 rowsep0" align="center">48</td><td class="colsep0 rowsep0" align="center">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>9</b></td><td class="colsep0 rowsep0" align="center">99</td><td class="colsep0 rowsep0" align="center">46</td><td class="colsep0 rowsep0" align="center">58</td><td class="colsep0 rowsep0" align="center">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>10</b></td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">69</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>13</b></td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">41</td><td class="colsep0 rowsep0" align="center">65</td><td class="colsep0 rowsep0" align="center">13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Results reported from Lecoutey et al.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></p></div></div></div><div class="NLM_p last">By virtue of its in vitro activities and selectivity toward AChE and 5-HT<sub>4</sub>R as well as its good druggability parameters (water solubility, blood-brain barrier [BBB] cross-membrane penetration, P-gp inhibition, mutagenicity, cytotoxicity, hERG affinity and so on),<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> compound <b>1</b> was selected for in silico and in vivo studies aiming to evaluate its potential in AD treatment. We named it donecopride.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Silico Results</h3><div class="NLM_p">Ahead of the in silico study of donecopride, its three-dimensional structure was identified via the X-ray diffraction technique. The analysis carried out on the donecopride crystal showed that two molecules are present in the asymmetric unit, which differs principally in the position of the cyclohexane ring. As the crystal space group is a centrosymmetric one, another conformer, related to the asymmetric unit by a symmetric center, is present in the crystal for both molecules of the asymmetric unit (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Interestingly, the carbonyl group and the methoxy substituent of the benzene ring point in opposite directions in all solved structures. The four conformers observed in the crystal were used for the docking studies, and the opposite mutual orientation of the carbonyl and methoxy groups was used as a criterion for the selection of docking poses.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ORTEP diagram of donecopride (A) and superposition of its four conformations in the crystal (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Docking studies of donecopride were then performed in a human AChE structure (PDB ED: 4EY7)<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> as well as in a human 5-HT<sub>4</sub>R model, as previously reported by us.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">First, the four conformers of donecopride from the crystal structure (protonated on the piperidine ring) were docked separately into the (<i>h</i>)5-HT<sub>4</sub>R homology model that was built using the β<sub>2</sub>-adrenergic receptor crystal structure as a template (PDB ED: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RH1">2RH1</a>).<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a> In the selected pose (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A, mean ChemPLP fit = 78.61), the basic piperidine nitrogen interacts with Asp<sub>100</sub> (consistent with the constraint used during docking), and an additional polar interaction could be engaged through this basic nitrogen and the Tyr<sub>302</sub> hydroxyl group. The benzene ring is oriented toward the transmembrane helix 5 (TM5) (in yellow in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A), and the amino substituent on the benzene ring forms a hydrogen bond with the Ser<sub>197</sub> hydroxyl group. In this position the benzene ring is surrounded by several aromatic residues, oriented perpendicularly to it.</div><div class="NLM_p">During the docking of donecopride conformers into (<i>h</i>)AChE, a water molecule interacting with the protonated piperidine ring of DPZ was conserved (residue number 931). In the selected scoring pose (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B, mean ChemPLP Score = 109.59), the donecopride orientation was closed to DPZ and reproduced its interactions: (1) the charged nitrogen of the piperidine ring was oriented in a position that was suitable for interaction with the water molecule in the proximity of Tyr<sub>337</sub> and Tyr<sub>341</sub>; (2) the donecopride carbonyl formed a hydrogen bond with NH of the Phe<sub>295</sub> backbone; (3) the benzene ring was positioned in a parallel manner to the Trp<sub>286</sub> indole ring of the PAS at a 3.5 Å distance to favor a π-stacking interaction (which is in accordance with the result of the propidium displacement test results); and (4) the cyclohexane ring occupied the DPZ benzyl ring space (in the neighboring area of Trp<sub>86</sub>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Donecopride positioned in the (<i>h</i>)5-HT<sub>4</sub>R (A) and (<i>h</i>)AChE (B) binding sites from docking studies. The compound and the side chains of the binding site residues are represented by the stick-like shapes, and the protein is represented in ribbon. This figure was made with PYMOL (DeLano Scientific, 2002, San Carlo, U.S.A.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vivo Results</h3><div class="NLM_p">The data concerning the preliminary toxicological and pharmacological screening of donecopride (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) showed no symptoms at subtoxic doses (around 7-fold less than the approximative LD<sub>50</sub>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacological and Toxicological Properties of Donecopride</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">symptoms</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">doses (mg/kg)</th><th class="colsep0 rowsep0" align="center">LD<sub>50</sub> (mg/kg)</th><th class="colsep0 rowsep0" align="center"> subtoxic doses</th><th class="colsep0 rowsep0" align="center">toxic doses</th></tr></thead><tbody><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left" valign="middle">donecopride</td><td class="colsep0 rowsep0" align="center" valign="top">1–10</td><td class="colsep0 rowsep0" align="center" valign="top"> </td><td class="colsep0 rowsep0" align="left" valign="top">no symptoms</td><td class="colsep0 rowsep0" rowspan="2" align="center" valign="middle">convulsions</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">75</td><td class="colsep0 rowsep0" align="left">hypoactivity passivity</td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" align="left" valign="top">amphetamine</td><td class="colsep0 rowsep0" align="center" valign="top">2</td><td class="colsep0 rowsep0" align="center" valign="top"> </td><td class="colsep0 rowsep0" align="left" valign="top">hyperactivity exophtalmy irritability</td><td class="colsep0 rowsep0" align="center" valign="middle"> </td></tr><tr valign="middle" class="colsep0"><td class="colsep0 rowsep0" align="left" valign="top">chlorpromazine</td><td class="colsep0 rowsep0" align="center" valign="top">10</td><td class="colsep0 rowsep0" align="center" valign="top"> </td><td class="colsep0 rowsep0" align="left" valign="top">hypoactivity ataxia sleep</td><td class="colsep0 rowsep0" align="center" valign="middle"> </td></tr></tbody></table></div></div><div class="NLM_p">Thus, subsequent behavioral studies were realized at the maximum dose of 10 mg/kg. At the tested doses, donecopride demonstrated no effect on spontaneous locomotor activity (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of donecopride on spontaneous locomotor activity. Data are expressed as the mean ± standard deviation (<i>n</i> = 9–10). Drugs were administered intraperitoneally (IP) 30 min before placing mice in the actimeter, except for DPZ which was administered subcutaneously (SC) 20 min before the test. Donecopride: 0.1–1–10 mg/kg; AMP: amphetamine 2 mg/kg; CPZ: chlorpromazine 10 mg/kg; RS + DPZ: <b>2</b> 0.1 mg/kg + DPZ 0.3 mg/kg (*<i>p</i> < 0.05 NaCl, SNK test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We already showed that donecopride exhibited a procognitive effect with an improvement in memory performances, which was observed at 0.3 and 1 mg/kg on the object recognition test.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Moreover, in regards to scopolamine-induced spontaneous alternation deficit, an antiamnesic effect was observed at doses starting from 0.3 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Interestingly, a comparable effect has been obtained with the association of <b>2</b> to DPZ and with DPZ alone (1 mg/kg).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of donecopride on scopolamine-induced impairment during the spontaneous alternation test. Data are expressed as the mean ± standard deviation (<i>n</i> = 10–12). Drugs were administered IP 30 min before the test, except for DPZ, and scopolamine was administered SC 30 and 20 min, respectively. DC (donecopride): 0.1, 0.3, 3, and 10 mg/kg; DPZ: 1 mg/kg; RS + DPZ: <b>2</b> 0.1 mg/kg + DPZ 0.3 mg/kg; scopolamine: 0.5 mg/kg (*<i>p</i> < 0.05 versus 50%; univariate <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, a decreased time of immobility was observed during the forced swimming test for the 0.3 mg/kg dose of donecopride, suggesting a slight antidepressant-like effect (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of donecopride on time immobility during the forced swimming test. Data are expressed as the mean ± standard deviation (<i>n</i> = 10–12). Drugs were administered IP 30 min before the test. Donecopride: 0.3, 3 mg/kg; imipramine (IMI) 16 mg/kg (* <i>p</i> < 0.05 NaCl, Student–Newman–Keuls [SNK] test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the other hand, we have previously demonstrated that donecopride is able to increase sAPPα release in vitro in COS-7 cells transiently expressing 5-HT<sub>4</sub>R (EC<sub>50</sub> = 11.3 nM, <i>E</i><sub>max</sub> = 22.5% of the maximum 5-HT response over the basal response).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> In the present work, we administered one dose of donecopride (1 mg/kg) IP to C57BL/6 mice and collected cerebrospinal fluid (CSF) 90 min after the injection. Quantification of sAPPα in the samples showed a slight increase in the neuroprotective APP fragment which is nonsignificant in these conditions (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Further experiments taking into account the biodistribution of donecopride are necessary to adjust the time point of CSF collection and to unequivocally conclude that donecopride promotes in vivo sAPPα secretion.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Acute in vivo treatment with donecopride shows a tendency to increase sAPPα release in the CSF of 2-month-old C57BL/6 mice. sAPPα was quantified via enzyme-linked immunosorbent assay (ELISA). Each dot represents an individual mouse; the horizontal lines show the means of each group. The <i>p</i> value is indicated (unpaired Student’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">If we first try to establish some SAR from these results, we can point out that replacing the <i>n</i>-butyl group of <b>2</b> (<i>K</i><sub>i</sub><sub>[5-HT4R]</sub> = 9.33 nM and IC<sub>50[AChE]</sub> = 403 nM) with a methyl-cyclopropyl group results in a dramatic decrease in AChE inhibition (see compound <b>6</b> IC<sub>50[AChE]</sub> = 937 nM), while its 5-HT<sub>4</sub>R affinity is almost maintained (<i>K</i><sub>i</sub><sub>[5-HT4R]</sub> = 14.30 nM). Substituting the piperidine moiety by a methylcyclobutyl group (compound <b>7</b>) allows us to recover the 5-HT<sub>4</sub>R affinity of <b>2</b>, but it does not totally restore its AChE inhibitory effect (IC<sub>50[AChE]</sub> = 577 nM). A larger methylcycloalkyl group, however, highly increases the activities of compounds <b>8</b>, <b>1</b>, and <b>9</b> toward the two targets (IC<sub>50[AChE]</sub> < 100 nM; <i>K</i><sub>i</sub><sub>[5-HT4R]</sub> < 10 nM), thus rendering them as excellent MTDLs according to our criteria. The apparent degrees of freedom allowed for the nature of these alkyl groups are however quickly exceeded since replacing them by either an ethylcyclohexyl group (compound <b>11</b>) or a methyl <i>ortho</i>-methylcyclohexyl group (compound <b>12</b>) results in an important decrease in the AChE inhibitory activity, while the 5-HT<sub>4</sub>R affinity is maintained.</div><div class="NLM_p">On the other hand, substituting the <i>n</i>-butyl group of <b>2</b> by a benzyl group, similar to those of DPZ, results in a dramatic increase in the AChE inhibition exerted by compound <b>13</b> (IC<sub>50[AChE]</sub> = 8.5 nM), while its 5-HT<sub>4</sub>R affinity is slightly decreased (<i>K</i><sub>i</sub><sub>[5-HT4R]</sub> = 14.30 nM). This compound also appears to be as good an MTDL against the considered targets. Replacing its phenyl group by a <i>meta</i> (compound <b>14</b>) or <i>para</i> (compound <b>15</b>) pyridine group, however, leads to a decrease in 5-HT<sub>4</sub>R affinity (<i>K</i><sub>i</sub><sub>[5-HT4R]</sub> > 20 nM) which appears to be particularly linked to the basic nature of the intracyclic nitrogen, since the methylpiperidine substituent in compound <b>9</b> dramatically restores it (<i>K</i><sub>i</sub><sub>[5-HT4R]</sub> = 2.50 nM).</div><div class="NLM_p">We can also point out the apparent importance of the carbonyl group in these structures for 5-HT<sub>4</sub>R affinity since compounds <b>16</b>–<b>18</b> do not bind to this target. However, the oxime <b>16</b> remains an excellent AChEI, almost as potent as DPZ. Conversely, the benzamide (<b>19</b>) and the benzoate (<b>21</b>) exhibit excellent 5-HT<sub>4</sub>R affinities in a low nanomolar range while they are both almost devoid of the AChE inhibitory effect. The structure of <b>19</b> has been docked into the active site of (<i>h</i>)AChE. While, its conformation appeared to be similar to donecopride, the rigidity of <b>19</b> appears to be strengthened by the mesomeric effect due to its carboxamide group. Consequently, <b>19</b>, contrary to donecopride, seems not able to bind in the same time through its carbonyl group and its piperidine nitrogen atom with Phe<sub>295</sub> and Water<sub>931</sub> of (<i>h</i>)AChE, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). This might also explain the inactivity of <b>21</b> against AChE.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Two representative docking poses of compound <b>19</b> into (<i>h</i>)AChE. The compounds and the side chains of the binding site residues are in stick and the protein in ribbon representation. This figure was made with PYMOL (DeLano Scientific, 2002, San Carlo, U.S.A.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In summary, in the structural system derived from <b>2</b> as an MTDL hit, 5-HT<sub>4</sub>R affinity seems to be linked to the presence, on the nitrogen atom of the piperidine ring, of a not-too-hindering methylcycloalkyl group, eventually bearing an intracyclic nitrogen. On the other hand, the catalytic AChE inhibition appears to require such a methylcycloalkyl group, but can also be displayed by a benzyl, a methylpyridine, or a methylpiperidine substituent. It is on the basis of these results and considering our objective that we selected compounds <b>1</b>, <b>8</b>–<b>10</b>, and <b>13</b> for additional evaluations.</div><div class="NLM_p">All the tested compounds displayed also high human 5-HT<sub>4</sub>R affinities at 10<sup>–8</sup> M (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) confirming the relevance of the use (<i>gp</i>)5-HT<sub>4</sub>R to select potential (<i>h</i>)5-HT<sub>4</sub>R ligands.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">Concerning their pharmacological profile, while compounds <b>1</b>, <b>8</b>, <b>9</b>, and <b>13</b> were found to be 5-HT<sub>4</sub>R partial agonists (in a similar manner as <b>2</b>), compound <b>10</b> acted as a very partial agonist. This profile is in accordance with our objective, because prolonged exposure of G protein-coupled receptors to an agonist can result in receptor desensitization, which is often dependent on the degree of intrinsic activity.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> An opposite relationship seems to have been established between these results and the <i>K</i><sub>i</sub><sub>(5-HT4R)</sub> values of the tested compounds, since it appears that the higher their affinity, the more partial their agonist effect. This result appears to be concordant with that reported in the literature.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_p">At last, concerning the capacity of the tested compound to displace propidium iodide from the PAS of AChE, compounds <b>1</b>, <b>8</b>, and <b>9</b> acted in a similar manner as DPZ (20%–24%), while <b>13</b> displaced propidium less (13%) and <b>10</b> displaced it slightly more (30%). The results displayed by <b>13</b> and <b>10</b> could be correlated in an opposite relation with their IC<sub>50(AChE)</sub> values since the most potent AChEI in the series (<b>13</b>) weakly interacted with the PAS, while the less potent inhibitor (<b>10</b>) interacted more strongly. The weak AChE catalytic inhibitory effect displayed by the latter compound might appear to be inconsistent with its docking in the enzyme-active site. Indeed, the cationic nitrogen atom of the middle piperidine ring of <b>10</b> (protonated at physiologic pH as well as the nitrogen atom of the terminal piperidine) appears able to bind to the same water molecule as donecopride (mean ChemPLP Score fit = 104.02). At the same time, the second nitrogen atom on the terminal piperidine ring is located near Glu<sub>202</sub>, which unusually appeared protonated using the ProPKA software (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>A).<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> However, in these conditions, a second pose was also generated by the docking study in which it was the terminal piperidine that interacted with the water molecule (mean ChemPLP Score fit = 87.61; see Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>B). According to this hypothesis, the phenyl ring of compound <b>10</b> covers more Trp<sub>286</sub> whereas its interaction with Trp<sub>86</sub> would be weaker. Despite the lower score, the second pose seems to be in better agreement with experimental results, as it features the worst binding affinity and the greatest propidium displacement for compound <b>10</b> with respect to donecopride.</div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Two representative docking poses of compound <b>10</b> into (<i>h</i>)AChE. The compounds and the side chains of the binding site residues are represented by the stick-like shapes and the protein is represented by ribbon. This figure was made with PYMOL (DeLano Scientific, 2002, San Carlo, U.S.A.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Concerning in vivo investigations, we have shown that donecopride has an antiamnesiant effect in a scopolamine-induced deficit model of working memory. Together with our previous results showing the positive effect of donecopride in recognition memory performance in mice<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> (testing recognition memory), this result confirms the high therapeutic potential of this molecule in the treatment of the cognitive disorders associated with AD. Of note, with respect to the dose (0.3 mg/kg) that revealed a beneficial effect on the two memory and behavioral tests (antiamnesiant and promnesiant effects), an interesting additional antidepressant-like effect was demonstrated. Furthermore, these behavioral effects were associated with an increased release of the neuroprotective sAPPα fragment. Such observations are in agreement with data from the literature, showing, for instance, better memory performance in transgenic mice that overexpress MMP9, which consequently display an increased secretion of sAPPα.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Herein, we were only able to highlight a tendency of an increased release of the nonamyloidogenic APP fragment in the CSF 90 min following a systemic injection. However, that sAPPα increased upon 5-HT<sub>4</sub>R activation is transient,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> and it is consequently highly difficult to catch the peak of sAPPα in CSF. Kinetics studies using different collection times or intracerebral microdialysis would be necessary to precisely determine the acute action of donecopride in living animals. Moreover, it should be interesting to monitor ACh levels, sAPPα, and Aβ in the CSF or in the brain tissue at the same time. Chronic administration of 5-HT<sub>4</sub>R agonists reduces amyloid pathology and prevents cognitive deficits in AD mouse models.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71, 72)</a> Further experiments exploring chronic treatments of AD transgenic mice with donecopride, in comparison with DPZ and pure 5-HT<sub>4</sub>R agonists, would produce valuable insights regarding the potential of donecopride to exert a disease-modifying effect.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, we have developed a novel series of MTDL that displayed both DBS AChE inhibitory effects and partial 5-HT<sub>4</sub>R agonist activity in vitro in nanomolar ranges. Donecopride, which appears to be the lead of this family, further exhibited in vivo procognitive and antiamnesic effects in NMRI mice, and it also appeared able to promote the release of sAPPα in C57BL/6 mice in vivo. These results, which appear to gather in a single compound both the activities of DPZ and <b>2</b>, seem likely to confer a symptomatic and disease-modifying effect to donecopride, thus designing it as a potentially promising drug candidate in AD.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Material and Methods</h4><div class="NLM_p last">All chemical reagents and solvents were purchased from commercial sources and used without further purification. Melting points were determined on a Kofler melting point apparatus. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a BRUKER AVANCE III 400 MHz with chemical shifts expressed in parts per million (in chloroform-<i>d</i>, methanol-<i>d</i><sub>4</sub>, or DMSO-<i>d</i><sub>6</sub>) downfield from TMS as an internal standard and coupling in Hertz. IR spectra were recorded on a PerkinElmer BX FT-IR apparatus using KBr pellets. High-resolution mass spectra (HRMS) were obtained by impact electronic on a Jeol JMS GCMate spectrometer (compound <b>1</b>) or by electrospray on a Bruker maXis (compounds <b>4</b>, <b>7</b>, <b>8</b>, <b>13</b>–<b>19</b>) or on a Q-Tof micro Waters (compounds <b>6</b>, <b>9</b>–<b>12</b>, <b>21</b>). The purities of all tested compounds were analyzed by LC–MS, with the purity all being higher than 95%. Analyses were performed using a Waters Alliance 2695 as separating module (column XBridge C18 2.5 μM/4.6 × 50 mM) using the following gradients: A (95%)/B (5%) to A (5%)/B (95%) in 4.00 min. This ratio was hold for 1.50 min before returning to initial conditions in 0.50 min. Initial conditions were then maintained for 2.00 min (A = H<sub>2</sub>O, B = CH<sub>3</sub>CN; each containing HCOOH: 0.1%). MS were obtained on a SQ detector by positive ESI.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Procedure for the Deprotection and N-Alkylation of <i>tert</i>-Butyl 4-[3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxo-propyl]piperidine-1-carboxylate (5) (<b>1</b>; <b>6</b>–<b>9</b>; <b>11</b>–<b>15</b>; <b>17</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl 4-[3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxo-propyl]piperidine-1-carboxylate <b>5</b> was dissolved in DCM/TFA (1/1). The mixture was then stirred 15 min at rt. After concentration under reduced pressure, the resulting intermediate was dissolved in DMF or 1,4-dioxane (for compounds <b>13</b>-<b>15</b>). K<sub>2</sub>CO<sub>3</sub> (10 equiv) and halogenoalkyle (1.3 equiv) were added, and the mixture was warmed to 110 °C for 4 h. After cooling, DCM was added, and the mixture was washed 4 times with brine. The organic layer was then dried over MgSO<sub>4</sub>, filtered, and evaporated under reduced pressure. The crude residue was purified on deactivated silica gel (gradient of elution: DCM to DCM/MeOH (98/2)).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-one (<b>1</b>)<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></h4><div class="NLM_p last">Pale yellow powder (44%): mp 153–155 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.79 (s, 1H), 6.48 (s, 1H), 4.44 (br s, 2H), 3.85 (s, 3H), 2.89 (m, 2H), 2.84 (m, 2H), 2.08 (d, <i>J</i> = 6.8 Hz, 2H), 1.68 (m, 11H), 1.47 (m, 1H), 1.20 (m, 6H), 0.85 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 199.3, 159.5, 147.7, 132.2, 119.0, 111.2, 97.6, 66.3, 55.6, 54.5 (2C), 41.0, 35.8, 35.3, 32.3 (2C), 32.2 (2C), 31.4, 26.8, 26.2 (2C); LC-MS: [M + H]<sup>+</sup> = 393.58–395.59; IR (KBr): ν cm<sup>–1</sup> 3485, 3330, 2921, 2850, 1641, 1623, 1575, 1452, 1421, 1214, 1177; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>22</sub>H<sub>33</sub>ClN<sub>2</sub>O<sub>2</sub> [M]<sup>+</sup> 392.22303, found 392.22399.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Ethyl 3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxopropanoate (<b>4</b>)</h4><div class="NLM_p last">To a suspension of 4-amino-5-chloro-2-methoxybenzoic acid (603 mg, 2.99 mmol) in dry THF (30 mL) was added portion-wise CDI (533 mg, 3.29 mmol). The mixture was stirred at rt for 6 h and, then, potassium 3-ethoxy-3-oxopropanoate (611 mg, 3.59 mmol) and MgCl<sub>2</sub> (342 mg, 3.59 mmol) were added portion-wise. The mixture was stirred at 40 °C for 2 days. After evaporation of the solvent, the residue was diluted with DCM, washed successively with water, saturated aqueous NaHCO<sub>3</sub> and brine, dried over MgSO<sub>4</sub>, and evaporated in vacuo. The residue was then purified on silica gel (gradient of elution: CH/AcOEt 8/2 to 7/3) to afford 603 mg of product. White powder (62%): mp 124 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.92 (s, 1H), 6.23 (s, 1H), 4.56 (br s, 2H), 4.17 (qd, <i>J</i> = 7.3 Hz, 2H), 3.87 (s, 2H), 3.82 (s, 3H), 1.24 (t, <i>J</i> = 7.3 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 189.6, 168.6, 159.9, 148.7, 132.5, 117.3, 111.6, 97.0, 60.8, 55.4, 50.5, 14.2; LC-MS: [M + H]<sup>+</sup> = 272.43–274.43; IR (KBr): ν cm<sup>–1</sup> 3463, 3362, 3323, 2983, 1725, 1648, 1622, 1573, 1469, 1423, 1326, 1262, 1221, 1155; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>12</sub>H<sub>15</sub>ClNO<sub>4</sub> [M + H]<sup>+</sup> 272.068412, found 272.068374.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>tert</i>-Butyl 4-(3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxopropyl)piperidine-1-carboxylate (<b>5</b>)<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></h4><div class="NLM_p last">To a solution of compound <b>3</b> (2.3 g, 8.5 mmol) in DMF (20 mL) were added <i>tert</i>-butyl 4-(iodomethyl)piperidine-1-carboxylate (3.05 g, 9.5 mmol) and K<sub>2</sub>CO<sub>3</sub> (2.3 g, 17.1 mmol). The mixture was stirred at rt for 48 h. The reaction mixture was diluted with water, and the product was extracted with AcOEt. Combined organic layer was washed with water and brine and then dried over MgSO<sub>4</sub>. Evaporation of the solvent gave a crude mixture (4.8 g, 10.3 mmol), which was directly dissolved in EtOH (500 mL). H<sub>2</sub>O (100 mL) and KOH (2.65 g, 47.3 mmol) were added to the solution. The reaction mixture was refluxed for 3 h. EtOH was then evaporated, and the resulting residue was diluted with H<sub>2</sub>O and extracted with AcOEt. The organic layer was washed with H<sub>2</sub>O and brine. Evaporation of the solvent provided a crude product, which was purified by column on silica (gradient of elution: DCM to DCM/AcOEt 6/4) to provide compound <b>2</b> (2.9 g). White powder (86%): mp 135–137 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.71 (s, 1H), 6.23 (s, 1H), 4.63 (br s, 2H), 4.01 (m, 2H), 3.76 (s, 3H), 2.84 (t, <i>J</i> = 7.5 Hz, 2H), 2.61 (m, 2H), 1.61 (m, 2H), 1.53 (m, 2H), 1.39 (s, 9H), 1.35 (m, 1H), 1.03 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 198.7, 159.5, 154.8, 148.0, 131.9, 118.3, 111.0, 97.3, 79.1, 55.5, 43.8 (2C), 40.5, 35.6, 31.9 (2C), 31.0, 28.3 (3C); LC-MS: [M + H]<sup>+</sup> = 397.60–399.60; IR (KBr): ν cm<sup>–1</sup> 3470, 3353, 2975, 2930, 2851, 1673, 1624, 1588, 1421, 1366, 1311, 1250, 1216.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclopropylmethyl)-4-piperidyl]propan-1-one (<b>6</b>)</h4><div class="NLM_p last">Pale yellow powder (38%): mp 161–163 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.75 (s, 1H), 6.23 (s, 1H), 4.46 (s, 2H), 3.81 (s, 3H), 3.03 (m, 2H), 2.87 (m, 2H), 2.19 (d, <i>J</i> = 6.8 Hz, 2H), 1.88 (m, 2H), 1.67 (m, 2H), 1.56 (m, 2H), 1.32 (m, 1H), 1.27 (m, 2H), 0.83 (m, 1H), 0.47 (m, 2H), 0.06 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 199.2, 159.5, 147.7, 132.2, 118.9, 111.2, 97.5, 64.2, 55.6, 54.0 (2C), 40.9, 35.6, 32.2 (2C), 31.4, 8.5, 4.0 (2C); LC-MS: [M + H]<sup>+</sup> = 351.49–353.45; IR (KBr): ν cm<sup>–1</sup> 3466, 3350, 2924, 2849 1644, 1621, 1586, 1465, 1420, 1215, 1178; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>19</sub>H<sub>28</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 351.1839, found 351.1841.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclobutylmethyl)-4-piperidyl]propan-1-one (<b>7</b>)</h4><div class="NLM_p last">Yellow powder (45%): mp 142–144 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.77 (s, 1H), 6.25 (s, 1H), 4.41 (br s, 2H), 3.84 (s, 3H), 2.88 (t, <i>J</i> = 8.0 Hz, 2H), 2.81 (m, 2H), 2.54 (m, 1H), 2.37 (d, <i>J</i> = 6.6 Hz, 2H), 2.06 (m, 2H), 1.78 (m, 8H), 1.57 (m, 2H), 1.25 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 199.1, 159.4, 147.6, 132.2, 118.9, 111.2, 97.5, 65.9, 55.6, 54.0 (2C), 40.9, 35.4, 34.2, 32.2 (2C), 31.3, 28.3 (2C), 18.8; LC-MS: [M + H]<sup>+</sup> = 365.53–367.54; IR (KBr): ν cm<sup>–1</sup> 3485, 3327, 2923, 2852, 1642, 1624, 1575, 1453, 1421, 1214, 1175; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>20</sub>H<sub>30</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 365.199032, found 365.198665.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclopentylmethyl)-4-piperidyl]propan-1-one (<b>8</b>)</h4><div class="NLM_p last">Yellow powder (35%): mp 141–143 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.79 (s, 1H), 6.26 (s, 1H), 4.44 (br s, 2H), 3.85 (s, 3H), 2.90 (m, 4H), 2.24 (d, <i>J</i> = 7.1 Hz, 2H), 2.05 (m, 1H), 1.86 (m, 2H), 1.76 (m, 2H), 1.60 (m, 6H), 1.50 (m, 2H), 1.21 (m, 5H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 199.2, 159.4, 147.5, 132.2, 119.0, 111.2, 97.5, 65.2, 55.6, 54.3 (2C), 40.9, 37.5, 35.7, 32.2 (2C), 31.8 (2C), 31.3, 25.2 (2C); LC-MS: [M + H]<sup>+</sup> = 379.57–381.56; IR (KBr): ν cm<sup>–1</sup> 3486, 3332, 2924, 2860, 1644, 1623, 1574, 1453, 1422, 1214, 1175; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>32</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 379.214682, found 379.214484.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cycloheptylmethyl)-4-piperidylpropan-1-one (<b>9</b>)</h4><div class="NLM_p last">Yellow powder (42%): mp 147–149 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.78 (s, 1H), 6.27 (s, 1H), 4.49 (br s, 2H), 3.85 (s, 3H), 2.87 (m, 2H), 2.81 (m, 2H), 2.02 (d, <i>J</i> = 7.3 Hz, 2H), 1.57 (m, 17H), 1.22 (m, 3H), 1.08 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 198.2, 158.5, 146.7, 131.2, 117.8, 110.2, 96.5, 65.3, 54.6, 53.3 (2C), 39.9, 35.4, 34.6, 31.9 (2C), 31.0 (2C), 30.3, 27.5 (2C), 25.5 (2C); LC-MS: [M + H]<sup>+</sup> = 407.53–409.52; IR (KBr): ν cm<sup>–1</sup> 3481, 3247, 2920, 2850, 1638, 1622, 1582, 1454, 1419, 1214, 1176; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>23</sub>H<sub>36</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 407.2465, found 407.2461.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(4-piperidylmethyl)-4-piperidyl]propan-1-one dihydrochloride (<b>10</b>)</h4><div class="NLM_p last">Following the previous general procedure, the intermediate <i>tert</i>-butyl 4-[[4-[3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxo-propyl]-1-piperidyl]methyl] piperidine-1-carboxyl ate is obtained. Pale yellow powder (24%): mp 78–80 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.76 (s, 1H), 6.23 (s, 1H), 4.44 (br s, 2H), 4.03 (m, 2H), 3.82 (s, 3H), 2.87 (t, <i>J</i> = 7.8 Hz, 2H), 2.80 (m, 2H), 2.65 (m, 2H), 2.10 (d, <i>J</i> = 6.8 Hz, 2H), 1.83 (m, 2H), 1.58 (m, 7H), 1.41 (s, 9H), 1.23 (m, 3H), 1.03 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 199.1, 159.5, 155.0, 147.6, 132.3, 119.0, 111.3, 97.6, 79.2, 65.1, 55.7, 54.6 (2C), 43.8 (2C), 40.9, 35.7, 33.8, 32.3 (2C), 31.3, 30.9 (2C), 28.4 (3C); LC-MS: [M + H]<sup>+</sup> = 494.53–496.55, [M + H – BOC]<sup>+</sup> = 394.49–396.48; IR (KBr): ν cm<sup>–1</sup> 3479, 3347, 2922, 2850, 1688, 1674, 1622, 1587, 1466, 1452, 1247, 1215, 1175; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>26</sub>H<sub>40</sub>ClN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 494.2786, found 494.2766. To a solution of <i>tert</i>-butyl4-[[4-[3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxo-propyl]-1-piperidyl]methyl]piperid-ine-1-carboxylate (40 mg, 0.09 mmol) in EtOH (2 mL) was added HCl 37% (300 μL). The mixture was stirred at rt for 3 h and then concentrated under reduced pressure. The residue was then stirred into Et<sub>2</sub>O and filtered to afford 30 mg of compound <b>9</b>. Yellow powder (80%): mp >260 °C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.23 (br s, 1H), 9.09 (br s, 1H), 8.96 (br s, 1H), 7.53 (s, 1H), 6.46 (s, 1H), 3.99 (s, 3H), 3.45 (m, 2H), 3.22 (m, 2H), 2.91 (m, 2H), 2.81 (m, 6H), 2.11 (m, 1H), 1.96 (m, 2H), 1.76 (m, 2H), 1.63 (m, 2H), 1.46 (m, 3H), 1.38 (m, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 196.6, 159.6, 150.1, 131.1, 115.8, 109.3, 97.1, 60.4, 55.6, 52.3 (2C), 42.3 (2C), 39.7, 32.7, 30.2, 28.4 (2C), 28.3, 26.6 (2C); LC-MS: [M + H]<sup>+</sup> = 394.38–396.42; IR (KBr): ν cm<sup>–1</sup> 3390, 3296, 3194, 2938, 2732, 1660, 1625, 1593, 1449, 1417, 1212, 1180; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>33</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 394.2261, found 394.2269.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclohexylethyl)-4-piperidyl]propan-1-one (<b>11</b>)</h4><div class="NLM_p last">Yellow powder (40%): mp 169–171 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.76 (s, 1H), 6.23 (s, 1H), 4.42 (br s, 2H), 3.82 (s, 3H), 2.89 (m, 4H), 2.28 (m, 2H), 1.84 (m, 2H), 1.61 (m, 9H), 1.36 (m, 2H), 1.20 (m, 7H), 0.90 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 199.1, 159.5, 147.6, 132.2, 118.9, 111.2, 97.5, 57.0, 55.6, 54.0 (2C), 40.8, 36.5, 35.5, 34.4, 33.4 (2C), 32.0 (2C), 31.2, 26.6, 26.3 (2C); LC-MS: [M + H]<sup>+</sup> = 407.41–409.52; IR (KBr): ν cm<sup>–1</sup> 3486, 3324, 2918, 2847, 1637, 1621, 1571, 1453, 1304, 1212, 1173; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>23</sub>H<sub>36</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 407.2465, found 407.2468.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-[(2-methylcyclohexyl)methyl]-4-piperidyl] propan-1-one (<b>12</b>)</h4><div class="NLM_p last">Powder (49%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.75 (s, 1H, 1H*), 6.23 (s, 1H, 1H*), 4.43 (br s, 2H, 2H*), 3.81 (s, 3H, 3H*), 2.87 (m, 2H, 3H*), 2.81 (m, 2H), 2.74 (m, 1H*), 2.32 (dd, <i>J</i> = 11.8 Hz, <i>J</i> = 3.2 Hz, 1H*), 2.06 (m, 2H), 2.00 (m, 1H*), 1.92 (m, 1H*), 1.81 (m, 3H), 1.60 (m, 7H, 11H*), 1.38 (m, 6H, 3H*), 1.21 (m, 3H, 4H*), 0.87 (d, <i>J</i> = 5.8 Hz, 3H*), 0.80 (d, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 199.3 (C, C*), 159.5 (C, C*), 147.6 (C, C*), 132.2 (C, C*), 119.0 (C, C*), 111.3 (C, C*), 97.6 (C, C*), 63.7 (C*), 62.0 (C), 56.1 (C*), 55.7 (C, C*), 54.8 (C), 54.5 (C), 53.2 (C*), 41.0 (C), 41.0 (C*), 37.2 (C, C*), 36.6 (C*), 35.9 (C), 35.9 (C*), 33.0 (C), 32.4 (2C*), 32.4 (2C), 32.3 (C*), 31.5 (C*), 31.4 (C), 31.0 (C), 26.4 (C*), 26.4 (C), 26.3 (C*), 25.6 (C), 21.9 (C, C*), 20.5 (C*), 13.6 (C); LC-MS: [M + H]<sup>+</sup> = 407.54–409.63; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>23</sub>H<sub>36</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 407.2465, found 407.2458. The ratio of these 2 diastereoisomeres was obtained in proportions 3/1* according to the <sup>1</sup>H NMR spectra.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-(1-benzyl)-4-piperidyl)propan-1-one (<b>13</b>)</h4><div class="NLM_p last">Pale yellow oil (23%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.71 (s, 1H), 7.19 (m, 5H), 6.18 (s, 1H), 4.39 (s, 2H), 3.76 (s, 3H), 3.45 (s, 2H), 2.81 (m, 4H), 1.90 (br t, <i>J</i> = 10.2 Hz, 2H), 1.61 (br d, <i>J</i> = 9.2 Hz, 2H), 1.52 (q, <i>J</i> = 6.9 Hz, 2H), 1.22 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 199.2, 159.5, 147.7, 137.7, 132.3, 129.5 (2C), 128.2 (2C), 127.1, 118.9, 111.3, 97.5, 63.3, 55.6, 53.7 (2C), 40.8, 35.4, 31.9 (2C), 31.4; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>22</sub>H<sub>28</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 387.183382, found 387.183120.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(3-pyridylmethyl)-4-piperidyl]propan-1-one (<b>14</b>)</h4><div class="NLM_p last">Pale yellow oil (40%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.51 (d, <i>J</i> = 2.0 Hz, 1H), 8.50 (dd, <i>J</i> = 1.6, 4.8 Hz, 1H), 7.78 (s, 1H), 7.69 (dt, <i>J</i> = 1.6, 7.6 Hz, 1H), 7.25 (dd, <i>J</i> = 4.8, 8.0 Hz, 1H), 6.25 (s, 1H), 4.48 (s, 2H), 3.83 (s, 3H), 2.87 (m, 4H), 1.99 (br t, <i>J</i> = 10.2 Hz, 2H), 1.68 (br d, <i>J</i> = 9.2 Hz, 2H), 1.58 (q, <i>J</i> = 6.9 Hz, 2H), 1.24 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 199.3, 159.7, 150.7, 148.8, 147.9, 137.2, 133.7, 132.4, 123.6, 119.0, 111.4, 97.7, 60.5, 55.7, 53.8 (2C), 40.9, 35.4, 32.0 (2C), 31.2; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 388.178631, found 388.178595.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(4-pyridylmethyl)-4-piperidyl]propan-1-one (<b>15</b>)</h4><div class="NLM_p last">Pale yellow oil (45%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.52 (d, <i>J</i> = 6.0 Hz, 2H), 7.78 (s, 1H), 7.26 (d, <i>J</i> = 6.0 Hz, 2H), 6.25 (s, 1H), 4.50 (s, 2H), 3.83 (s, 3H), 3.47 (s, 2H), 2.89 (t, <i>J</i> = 7.6 Hz, 2H), 2.83 (br d, <i>J</i> = 11.2 Hz, 2H), 1.97 (br t, <i>J</i> = 10.8 Hz, 2H), 1.68 (br d, <i>J</i> = 9.2 Hz, 2H), 1.59 (q, <i>J</i> = 6.9 Hz, 2H), 1.26 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 199.3, 159.7, 149.8 (2C), 148.2, 147.9, 132.4, 124.2 (2C), 119.0, 111.4, 97.6, 62.2, 55.7, 54.1 (2C), 40.9, 35.4, 32.2 (2C), 31.3; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 388.178631, found 388.178502.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Procedure for the Preparation of Oximes (<b>16</b>–<b>17</b>)</h4><div class="NLM_p last">To a solution of compound <b>1</b> in pyridine was added alkoxyamine hydrochloride (3.6 equiv) in 3 portions every 2 h. The mixture was stirred at rt for 24 h. After dilution with water, the aqueous layer was extracted 3 times with AcOEt. The organic layers were combined, washed 5 times with brine, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The crude residue was purified on deactivated silica gel (gradient: DCM to DCM/AcOEt (9/1)) to provide the desired product.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>E</i>)1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-one oxime (<b>16</b>)</h4><div class="NLM_p last">White powder (35%): mp 194–196 °C; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 6.99 (s, 1H), 6.47 (s, 1H), 3.75 (s, 3H), 2.93 (m, 2H), 2.71 (m, 2H), 2.23 (d, <i>J</i> = 6.8 Hz, 2H), 2.02 (m, 2H), 1.72 (m, 8H), 1.55 (m, 1H), 1.28 (m, 7H), 0.93 (m, 2H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 159.8, 157.3, 145.9, 129.8, 115.8, 109.4, 98.2, 65.4, 54.6, 53.9 (2C), 35.2, 34.4, 31.8, 31.6 (2C), 30.8 (2C), 26.1, 25.7 (2C), 25.3; IR (KBr): ν cm<sup>–1</sup> 3368, 2925, 2850, 2815, 1620, 1508, 1461, 1449, 1412, 1336, 1254, 1214, 992; LC-MS: [M + H]<sup>+</sup> = 408.53–410.51; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>22</sub>H<sub>35</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 408.241231, found 408.240998.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Chloro-4-[(<i>E</i>)-C-[2-[1-(cyclohexylmethyl)-4-piperidyl]ethyl]-<i>N</i>-methoxy-carbon-imidoyl]-5-methoxyaniline (<b>17</b>)</h4><div class="NLM_p last">Yellow oil (42%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.12 (s, 1H), 6.25 (s, 1H), 4.10 (br s, 2H), 3.89 (s, 3H), 3.72 (s, 3H), 2.79 (m, 2H), 2.63 (m, 2H), 2.04 (d, <i>J</i> = 6.8 Hz, 2H), 1.65 (m, 9H), 1.44 (m, 1H), 1.22 (m, 8H), 0.83 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 159.9, 157.1, 144.2, 130.4, 117.0, 110.5, 98.5, 66.2, 61.5, 55.5, 54.5 (2C), 36.1, 35.2, 32.4, 32.1 (2C), 32.0 (2C), 29.7, 26.5, 26.2 (2C); LC-MS: [M + H]<sup>+</sup> = 422.54–424.53; IR (KBr): ν cm<sup>–1</sup> 2921, 2850, 1621, 1506, 1464, 1450, 1411, 1338, 1258, 1213, 1051; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>23</sub>H<sub>38</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 422.256882, found 422.256616.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-(cyclohexylmethyl)-4-piperidyl]propan-1-ol (<b>18</b>)</h4><div class="NLM_p last">To a solution of compound <b>1</b> (33 mg, 0.084 mmol) in MeOH was added NaBH<sub>4</sub> (25 mg, 0.673 mmol). The mixture was stirred for 3 h. After concentration, the residue was dissolved in DCM, washed with brine, dried over MgSO<sub>4</sub>, and then evaporated under reduced pressure. The crude product was purified on deactivated silica gel (gradient of elution: DCM to DCM/MeOH) to afford 20 mg of desired product. Pale yellow powder (62%): mp: 136–138 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.12 (s, 1H), 6.26 (s, 1H), 4.69 (dd, <i>J</i> = 7.5 Hz, <i>J</i> = 5.8 Hz, 1H), 4.00 (br s, 2H), 3.75 (s, 3H), 2.82 (m, 2H), 2.06 (d, <i>J</i> = 7.0 Hz, 2H), 1.79 (m, 2H), 1.67 (m, 10H), 1.45 (m, 1H), 1.36 (m, 1H), 1.19 (m, 6H), 0.83 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 156.2, 142.5, 127.5, 124.0, 110.6, 98.8, 70.0, 66.2, 55.4, 54.5 (2C), 35.8, 35.2, 34.4, 32.9, 32.3 (2C), 32.1 (2C), 26.8, 26.2 (2C); IR (KBr): ν cm<sup>–1</sup> 3393, 2920, 2850, 1622, 1580, 1504, 1466, 1412, 1209; LC-MS: [M + H]<sup>+</sup> = 395.64–397.64. HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>22</sub>H<sub>37</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 395.245983, found 395.245734.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-Amino-5-chloro-<i>N</i>-[[1-(cyclohexylmethyl)-4-piperidyl]methyl]-2-methoxybenzamide (<b>19</b>)</h4><div class="NLM_p last">Following the previous general procedure used for the deprotection and N-alkylation of <b>5</b>, <b>19</b> is obtained starting from <i>tert</i>-butyl 4-[[(4-amino-5-chloro-2-methoxybenzoyl)amino]methyl] piperidine-1-carboxylate (<b>20</b>). White powder (38%): mp 154–156 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.07 (s, 1H), 7.73 (t, <i>J</i> = 6.0 Hz, 1H), 6.27 (s, 1H), 4.39 (br s, 2H), 3.87 (s, 3H), 3.29 (m, 2H), 2.90 (m, 2H), 2.13 (d, <i>J</i> = 7.0 Hz, 2H), 1.90 (m, 2H), 1.66 (m, 8H), 1.48 (m, 1H), 1.36 (m, 2H), 1.16 (m, 3H), 0.84 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 164.6, 157.4, 146.6, 133.1, 112.0, 111.6, 97.9, 65.9, 56.2, 54.0 (2C), 45.1, 36.0, 35.1, 32.0 (2C), 29.7, 26.7 (2C), 26.1 (2C); LC-MS: [M + H]<sup>+</sup> = 394.59–396.58; IR (KBr): ν cm<sup>–1</sup> 3400, 2925, 2854, 1622, 1593, 1536, 1498, 1256; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>33</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 394.225581, found 394.225427.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>tert</i>-Butyl 4-[[(4-amino-5-chloro-2-methoxybenzoyl)amino]methyl]piperidine-1-carboxylate (<b>20</b>)<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></h4><div class="NLM_p last">To a solution of 4-amino-5-chloro-2-methoxybenzoic (94 mg, 0.467 mmol) in DMF (3 mL) were added Et<sub>3</sub>N (64 μL, 0.467 mmol) and <i>tert</i>-butyl 4-(aminomethyl)piperidine-1-carboxylate (100 mg, 0.467 mmol). The mixture was cooled to −5 °C, and HOBT (63 mg, 0.467 mmol) and EDCI·HCl (90 mg, 0.467 mmol) were then added. The mixture was then stirred for 24 h. After dilution with water, the solution was extracted 3 times with AcOEt. The organic layers were combined, washed 4 times with water, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was purified on silica gel (gradient of elution: DCM to DCM/AcOEt 7/3) to provide 155 mg of desired product. White powder (85%): mp 106–108 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.08 (s, 1H), 7.77 (t, <i>J</i> = 5.9 Hz, NH), 6.27 (s, 1H), 4.37 (br s, 2H), 4.09 (m, 2H), 3.72 (s, 3H), 3.30 (m, 2H), 2.66 (m, 2H), 1.70 (m, 3H), 1.42 (s, 9H), 1.16 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 164.7, 157.4, 154.9, 146.8, 133.1, 112.4, 111.6, 97.8, 79.4, 56.2, 45.0, 43.9 (2C), 36.5, 29.9 (2C), 28.5 (3C); LC-MS: [M + H]<sup>+</sup> = 398.53–400.52; IR (KBr): ν cm<sup>–1</sup> 3405, 3339, 2976, 2928, 2852, 1680, 1630, 1595, 1542, 1501, 1425, 1315, 1252, 1173, 1144.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> [1-(Cyclohexylmethyl)-4-piperidyl]methyl 4-amino-5-chloro-2-methoxybenzoate (<b>21</b>)</h4><div class="NLM_p last">To a suspension of 4-amino-5-chloro-2-methoxybenzoic acid (101 mg, 0.5 mmol) in dry THF (3 mL) was added CDI (89 mg, 0.55 mmol). The mixture was stirred at rt for 24 h, and then a solution of (1-(cyclohexylmethyl)piperidin-4-yl)methanol (106 mg, 0.50 mmol) in dry THF (2 mL) and NaH 60% (21 mg, 0.55 mmol) were added. This new mixture was stirred 3 days at rt and then concentrated under reduced pressure. The residue was dissolved in AcOEt, washed with water, dried over MgSO<sub>4</sub>, and concentrated under in vacuo. The crude product was then purified on silica gel (gradient of elution: DCM (100%) to AcOEt (100%)). White powder (31%): mp 128–130 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.81 (s, 1H), 6.29 (s, 1H), 4.45 (br s, 2H), 4.08 (d, <i>J</i> = 6.0 Hz, 2H), 3.84 (s, 3H), 2.88 (m, 2H), 2.10 (d, <i>J</i> = 7.1 Hz, 2H), 1.86 (m, 2H), 1.69 (m, 7H), 1.48 (m, 1H), 1.39 (m, 2H), 1.19 (m, 4H), 0.86 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 164.6, 160.2, 147.6, 133.2, 110.0, 109.9, 98.2, 68.9, 66.1, 56.0, 53.9 (2C), 35.6, 35.2, 32.0 (2C), 29.1 (2C), 26.8, 26.2 (2C); LC-MS: [M + H]<sup>+</sup> = 395.59–397.56; IR (KBr): ν cm<sup>–1</sup> 3473, 3330, 2920, 2850, 1695, 1621, 1599, 1449, 1234, 1109; HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>32</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 395.2101, found 395.2109.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> X-ray Crystallography</h3><div class="NLM_p">Single crystals of donecopride and compound <b>17</b> suitable for X-ray crystallographic analysis were obtained by slow evaporation from a mixture of chloroform/acetone and ethanol, respectively. Data for crystal structures analysis were collected at 150 K with a Bruker–Nonius Kappa CCD area detector diffractometer with graphite-monochromatized Mo K<sub>λ</sub> radiation (λ = 0.71073 Å). The structures were solved using direct methods and refined by full-matrix least-squares analysis on <i>F</i><sup>2</sup>.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Crystallographic Data of Donecopride</h4><div class="NLM_p last">Crystal size: 0.38 × 0.25 × 0.09 mm. Formula C<sub>22</sub>H<sub>33</sub>ClN<sub>2</sub>O<sub>2</sub>, formula weight 392.95, crystal system triclinic, space group <i>P</i>-1, <i>a</i> = 10.5505(3) Å, <i>b</i> = 10.6906(4) Å, <i>c</i> = 19.8075(6) Å, α = 83.6320(10)°, β = 75.3140(10)°, γ = 88.2010(10)°, <i>V</i> = 2147.78(12) Å<sup>3</sup>, <i>Z</i> = 4, calculated density = 1.215 g/cm<sup>3</sup>, μ = 0.197 mm<sup>–1</sup>, <i>R</i><sub>int</sub> = 0.041, <i>R</i>[<i>F</i>2 > 2σ(<i>F</i>2)] = 0.070, <i>wR</i>(<i>F</i>2) = 0.196.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Crystallographic Data of Compound <b>16</b></h4><div class="NLM_p last">Crystal size: 0.42 × 0.38 × 0.21 mm. Formula C<sub>22</sub>H<sub>34</sub>ClN<sub>3</sub>O<sub>2</sub>, formula weight 407.97, crystal system monoclinic, space group <i>P</i>2<sub>1</sub>/<i>c</i>, <i>a</i> = 12.0789(5) Å, <i>b</i> = 9.9591(5) Å, <i>c</i> = 19.5343(7) Å, β = 104.580(2)°, <i>V</i> = 2274.20(17) Å<sup>3</sup>, Z = 4, calculated density = 1.192 g/cm<sup>3</sup>, μ = 0.189 mm<sup>–1</sup>, <i>R</i><sub>int</sub> = 0.026, <i>R</i>[<i>F</i>2 > 2σ(<i>F</i>2)] = 0.040, <i>wR</i>(<i>F</i>2) = 0.113.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Program(s) Used to Solve Structures: SHELXS–97<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></h4><div class="NLM_p last">Program(s) used to refine structures: SHELXL–2014.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Software used to prepare material for publication: SHELXL–2014. Crystallographic data have been deposited at the Cambridge Crystallographic Data Centre, CCDC no. 1045006 (donecopride) and CCDC no. 1045005 (<b>16</b>). Copies of this information may be obtained free of charge from the Director, CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK (+44-1223-336408; E-mail: <a href="/cdn-cgi/l/email-protection#f99d9c89968a908db99a9a9d9ad79a9894d7989ad78c92"><span class="__cf_email__" data-cfemail="4d29283d223e24390d2e2e292e632e2c20632c2e633826">[email protected]</span></a> or <a href="http://www.ccdc.cam.ac.uk" class="extLink">http://www.ccdc.cam.ac.uk</a>).</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> In Vitro Biological Studies</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Pharmacological Characterization of Drugs on Guinea Pig 5-HT<sub>4</sub>R</h4><div class="NLM_p">Binding to native 5-HT<sub>4</sub>R from guinea pig was determined using the method of Grossman.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> For membrane preparations male guinea pigs (300–350 g, Charles River) were subjected to euthanasia by cervical dislocation and decapitated. Brains were rapidly removed at 4 °C, and striatal regions carefully dissected and pooled. The tissues were then suspended in 10 volumes of HEPES buffer 50 mM pH 7.4 at 4 °C. After homogenization at 4 °C (Ultra-Turrax, maximal speed, 15 s) and ultracentrifugation (23,000<i>g</i>, 60 min, 4 °C), the pellet was resuspended in 10 volumes of HEPES buffer 50 mM pH 7.4 at 4 °C in order to obtain a tissue concentration of about 100 mg protein/mL. The protein concentration was determined by the method of Lowry<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> using bovine serum albumin as standard.</div><div class="NLM_p">For radioligand binding studies, 600 μg of membrane was incubated in duplicate at 37 °C for 30 min with <b>22</b> (PerkinElmer), fixed concentration of compound, and HEPES buffer 50 mM pH 7.4 at 37 °C. Incubation was terminated by rapid vacuum filtration through 0.5% polyethylenimine-presoaked Whatman GF/B filters (Alpha Biotech) using a Brandel Cell Harvester. Filters were subsequently washed three times with 4 mL of HEPES buffer 50 mM pH 7.4 at 4 °C.</div><div class="NLM_p">The method was validated from saturation studies: 6 concentrations of <b>22</b> were used to give final concentrations of 0.02–0.8 nM; nonspecific binding of <b>22</b> was defined in the presence of 30 μM serotonin to determine the <i>K</i><sub>d</sub> and the Bmax.</div><div class="NLM_p last">For competition studies, <b>22</b> was used to give a final concentration of 0.1 nM. Percentages of inhibition of the binding of <b>22</b> were obtained for concentrations of 10–6 and 10–8 M of the ligands tested. For some of these compounds, affinity constants were calculated from 5-point inhibition curves using the EBDA-Ligand software and expressed as <i>K</i><sub>i</sub> ± SD.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Pharmacological Characterization of Drugs on Human 5-HT<sub>4</sub>R</h4><div class="NLM_p">The method was validated from saturation studies: six concentrations of <b>22</b> were used to give final concentrations of 0.0625–2 nM, and nonspecific binding of <b>22</b> was defined in the presence of 30 μM serotonin to determine the <i>K</i><sub>d</sub> and the Bmax. For competition studies, 2.5 μg of proteins (5-HT<sub>4B</sub> membrane preparations, HTS110M, Millipore. Millipore’s 5-HT<sub>4B</sub> membrane preparations are crude membrane preparations made from their proprietary stable recombinant cell lines to ensure high level of GPCR surface expression) were incubated in duplicate at 25 °C for 60 min in the absence or the presence of 10<sup>–6</sup> or 10<sup>–8</sup> M of each drug and 0.2 nM <b>22</b> (VT 240, ViTrax) in 25 mM Tris buffer (pH 7.4, 25 °C). At the end of the incubation, homogenates were filtered through Whatman GF/C filters (Alpha Biotech) presoaked with 0.5% polyethylenimine using a Brandel cell harvester. Filters were subsequently washed three times with 4 mL of ice-cold 25 mM Tris buffer (pH 7.4, 4 °C). Nonspecific binding was evaluated in parallel in the presence of 30 μM serotonin.</div><div class="NLM_p last">For some of these compounds, affinity constants were calculated from 5-point inhibition curves using the EBDA-Ligand software and expressed as <i>K</i><sub>i</sub> ± SD.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Determination of cAMP Production</h4><div class="NLM_p last">COS-7 cells were grown in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% dialyzed fetal calf serum (dFCS) and antibiotics. Cells were transiently transfected with plasmid encoding HA-tagged 5-HT<sub>4</sub>R, then seeded in 24-well plates (70,000 cells/well). Twenty-four hrs after transfection, cells were exposed to the indicated concentrations of 5-HT<sub>4</sub>R ligands in the presence of 0.1 mM <span class="smallcaps smallerCapital">l</span>-ascorbic acid and 0.1 mM of the phosphodiesterase inhibitor RO-20–1724, at 37 °C in 250 μL of HBS (20 mM HEPES; 150 mM NaCl; 4.2 mM KCl; 0.9 mM CaCl<sub>2</sub>; 0.5 mM MgCl<sub>2</sub>; 0.1% glucose; 0.1% BSA). After 10 min, cells were then lysed by addition of the same volume of Triton-X100 (0.1%). Quantification of cAMP production was performed by HTRF by using the cAMP Dynamic kit (Cisbio Bioassays) according to the manufacturer’s instructions.</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> In Vitro Tests of AChE and BuChE Biological Activity</h4><div class="NLM_p">Inhibitory capacity of compounds on AChE biological activity was evaluated through the use of the spectrometric method of Ellman.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Acetyl- or butyrylthiocholine iodide and 5,5-dithiobis(2-nitrobenzoic) acid (DTNB) were purchased from Sigma-Aldrich. Lyophilized BuChE from equine serum (Sigma-Aldrich) was dissolved in 0.2 M phosphate buffer pH 7.4 such as to have enzyme solutions stock with 2.5 units/mL enzyme activity. AChE from human erythrocytes (buffered aqueous solution, ≥500 units/mg protein (BCA), Sigma-Aldrich) was diluted in 20 mM HEPES buffer pH 8, 0.1% Triton X-100 such as to have enzyme solution with 0.25 unit/mL enzyme activity. In the procedure, 100 μL of 0.3 mM DTNB dissolved in phosphate buffer pH 7.4 were added into the 96-well plate followed by 50 μL of test compound solution and 50 μL of enzyme (0.05 U final). After 5 min of preincubation at 25 °C, the reaction was then initiated by the injection of 50 μL of 10 mM acetyl- or butyrylthiocholine iodide solution. The hydrolysis of acetyl- or butyrylthiocholine was monitored by the formation of yellow 5-thio-2-nitrobenzoate anion as the result of the reaction of DTNB with thiocholine, released by the enzymatic hydrolysis of acetyl- or butyrylthiocholine, at a wavelength of 412 nm using a 96-well microplate plate reader (TECAN Infinite M200, Lyon, France). Test compounds were dissolved in analytical grade DMSO. Donepezil was used as a reference standard. The rate of absorbance increase at 412 nm was followed every minute for 10 min. Assays were performed with a blank containing all components except acetyl- or butyrylthiocholine, in order to account for nonenzymatic reaction. The reaction slopes were compared and the percent inhibition due to the presence of test compounds was calculated by the following expression: 100 – (<i>v</i><sub>i</sub>/<i>v</i><sub>0</sub> × 100), where <i>v</i><sub>i</sub> is the rate calculated in the presence of inhibitor and <i>v</i><sub>0</sub> is the enzyme activity.</div><div class="NLM_p last">First screening of AChE and BuChE activity was carried out at a 10<sup>–6</sup> or 10<sup>–5</sup> M concentration of compounds under study. For the compounds with significant inhibition (≥50%), IC<sub>50</sub> values were determined graphically by plotting the % inhibition versus the logarithm of six inhibitor concentrations in the assay solution using the Origin software.</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Propidium Competition Assay</h4><div class="NLM_p last">Propidium exhibits an increase in fluorescence on binding to AChE PAS, making it a useful probe for competitive ligand binding to the enzyme.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Fluorescence was measured in a Tecan Infinite M200 plate reader. Measurements were carried out in 200 μL final in 96-well plates. Five U (<i>ee</i>)AChE in 1 mM Tris/HCl, pH 8.0 buffer was incubated for 6 h at 25 °C, with a 150 μL 10<sup>–5</sup> M solution of tested compounds. One micromolar propidium iodide 50 μL solution was added 10 min before fluorescence measurement. The excitation wavelength was 535 nm, and that of emission, 595 nm. Each assay was repeated two different times.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Docking Studies</h3><div class="NLM_p">For each docked compound a preliminary calculation on its protonation state at pH 7.4 was carried out using standard tools of the ChemAxon Package (<a href="http://www.chemaxon.com/" class="extLink">http://www.chemaxon.com/</a>), and the majority microspecies protonated on one or two nitrogen atoms at this pH was used for docking studies.</div><div class="NLM_p">The homology model of the (<i>h</i>)5-HT<sub>4</sub>Rwas built using the high-resolution (2.4 Å) crystal structure of the (<i>h</i>)β2 adrenergic receptor-T4 lysozyme fusion protein bound to carazolol (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RH1">2RH1</a>) under the procedure described.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">The crystallographic coordinates of (<i>h</i>)AChE used for docking studies were obtained from X-ray structure of the DPZ/AChE complex (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>, a structure refined to 2.35 Å with an <i>R</i> factor of 17.7%).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><div class="NLM_p">The docking of donecopride into the (<i>h</i>)5-HT<sub>4</sub>R was carried out with the GOLD program (v5.0) using the default parameters.<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81, 82)</a> This program applies a genetic algorithm to explore conformational spaces and ligand binding modes. To evaluate the proposed ligand positions, the ChemPLP fitness function was applied in these docking studies. The binding site in the 5-HT<sub>4</sub>R model was defined as a 10 Å sphere centered on the aspartic acid residue Asp<sub>100</sub>. Because the mutagenesis studies have shown that the interaction between the positively ionizable amine of ligands and Asp<sub>100</sub> of 5-HT<sub>4</sub>R is crucial for ligand binding, a hydrogen-bond constraint between positively ionizable amine ligand and OD atom of Asp<sub>100</sub> was used during the docking. Furthermore, special attention was paid during the docking procedure to the following amino acids in the binding site, which were kept flexible: Arg<sub>96</sub>, Asp<sub>100</sub>, Thr<sub>104</sub>, Tyr<sub>192</sub>, Ser<sub>197</sub>, and Trp<sub>294</sub>.</div><div class="NLM_p last">Docking of donecopride into (<i>h</i>)AChE was carried out also by means of the GOLD program with the default parameters. To evaluate the proposed ligand poses, the ChemPLP fitness function was applied. The binding site in the AChE model was defined as a 7 Å sphere from the cocrystallized ligand, DPZ and a water molecule interacting with protonated piperidine ring of DPZ was conserved during the docking (residue number 931).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> In Vivo Biological Studies</h3><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Animals</h4><div class="NLM_p last">Adult male NMRI mice (3 months old, weighing 35–40g) from Janvier laboratories (Le Genest-Saint-Isle, France) were used to perform experiments. Mice were housed by 10 in standard polycarbonate cages in standard controlled conditions (22 ± 2 °C, 55 ± 10% humidity) with a reversed 12h light/dark cycle (light on at 7 pm). Food and water were available ad libitum in the home cage. All experiments were conducted (between 9 am and 3 pm) during the active–dark phase of the cycle and were in agreement with the European Directives and French law on animal experimentation (personal authorization no. 14–17 for M.B. and 14–60 for T.F.).</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> CNS Activity and Acute Toxicity Test</h4><div class="NLM_p last">Behavioral and neurological changes induced by graded doses (1, 10, 100 mg/kg) of the tested derivatives were evaluated in mice, in groups of four, by a standardized observation technique at different times (30 min and 3 and 24 h) after IP administration.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Major changes of behavioral data (for example, hypo- or hyperactivity, ataxia, tremors, convulsion, etc.) were noted in comparison to the control group. The approximate DL<sub>50</sub> of the compounds were also calculated through the quantification of mortality after 24 h. Amphetamine (2 mg/kg) and chlorpromazine (10 mg/kg) were used as stimulant and depressive references, respectively.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Locomotor Activity</h4><div class="NLM_p last">Locomotion of mice was measured using an actimeter (Imetronic) through infrared detection. Eight individual removable polycarbonate cages (21 cm length, 7 cm wide, and 12 cm high), where each mouse was placed, are disposed in the actimeter. Locomotor activity was measured by recording the number of interruption of beams of the red light over a period of 30 min through an attached recording system to the actimeter. Donecopride was tested at 1, 3, and 10 mg/kg. Amphetamine (2 mg/kg), chlorpromazine (10 mg/kg), and association <b>2</b> (0.1 mg/kg)-DPZ (0.3 mg/kg) were used as stimulant, depressive, and pharmacological references, respectively.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Spatial Working Memory</h4><div class="NLM_p last">Antiamnesiant activity of tested compounds was evaluated by reversal of scopolamine (0.5 mg/kg)-induced deficit on spontaneous alternation behavior in the Y maze test.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> The Y maze made of gray plastic consisted of three equally spaced arms (21 cm long, 7 cm wide with walls 15 cm high). The mouse was placed at the end of one of the arms and allowed to move freely through the maze during a 5 min session, while the sequence of arm entries was recorded by an observer. An arm entry was scored when all four feet crossed into the arm. An alternation was defined as entries into all three arms on a consecutive occasion. The number of possible alternation is thus the total number of arm entries minus two; the percentage of alternation was calculated as (actual alternation/possible alternation) 100. Donecopride was tested at 0.1, 0.3, 3, and 10 mg/kg. Different additional groups (DPZ (0.3 mg/kg) and association <b>2</b> (0.1 mg/kg) + DPZ (0.3 mg/kg)) were tested as clinical and pharmacological references, respectively.</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Forced Swimming Test</h4><div class="NLM_p last">The FST<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> was carried out in mice individually forced to swim during 6 min in an open cylindrical container (diameter 12 cm, height 20 cm) with a water depth of 13 cm at 23–24 °C.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The duration of immobility, after a delay of 2 min, was measured during the last 4 min. Each mouse was judged to be immobile when it ceased struggling and remained floating motionless in the water, making only those movements necessary to keep its head above water. Animals were not pretested. Donecopride was tested at 0.3 and 3 mg/kg. Imipramine (16 mg/kg) was used as clinical reference.</div></div><div id="sec5_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Pharmacological Treatments</h4><div class="NLM_p last"><b>2</b> and DPZ hydrochloride were purchased from Tocris (Cookson, UK). Amphetamine (+)-α-methylphenethylamine hemisulfate, chlorpromazine hydrochloride, imipramine hydrochloride, and scopolamine hydrobromide were purchased from Sigma (France). All those pharmacological compounds were dissolved in NaCl 0.9% as the vehicle and were administered IP 30 min before tests, except DPZ and scopolamine which were SC administered 20 and 30 min, respectively, before tests.</div></div><div id="sec5_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Statistical Analysis</h4><div class="NLM_p last">Results were expressed as mean ± SD and were analyzed by one way analysis of variance (ANOVA), with Statview software. In case of significance, a SNK (Student–Newman–Keuls) post hoc test was realized. Additionally, for the spontaneous alternation test, the percentage of alternation was compared to a theoretical 50% value (random alternation) by an univariate <i>t</i> test. Differences were considered as statistically significant if the <i>p</i> value was strictly under 0.05.</div></div><div id="sec5_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Cerebrospinal Fluid (CSF) Collection and sAPPα Quantification</h4><div class="NLM_p last">To explore the effect of acute injection of donecopride on sAPPα release in vivo, two different groups of WT C57BL/6 mice (n = 7/group) received one IP injection of vehicle (0.9% w/v NaCl; 0.2% dimethyl sulfoxide in water) or donecopride (1 mg/kg). 90 min postinjection, mice were anesthetized and mounted onto a stereotaxic instrument. The neck skin was cut, and subcutaneous tissue and muscles separated with the help of microretractors (Fine Science Tools, Heidelberg, Germany). Mice were then laid down so that the head formed an angle of about 135° with the body.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> A capillary tube (Borosilicate glass, B100-75-10, Sutter Instruments, Novato, California, U.S.A.) was used to punch the dura mater of the cisterna magna. CSF was collected by capillary action and transferred to 0.5 mL microtubes, immediately frozen in dry ice and stored at −80 °C until use. Once thawed, samples were heated at 60 °C for 5 min as described in literature<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and analyzed without further freezing–thawing cycles. ELISA kits from IBL International (Hamburg, Germany) for the dosage of sAPPα (mouse/rat sAPPα assay kit, no. 27415) were used according to the manufacturer’s instructions. Reactions were read at 620 and 450 nm using an Infinite 2000 luminescence counter. The sAPPα ELISA kits enable the precise and selective quantification of sAPPα versus sAPPβ.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00115">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16611" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16611" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Primary binding test for Donecopride toward a broad range of receptors. ORTEP diagram of <b>17</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00115/suppl_file/jm5b00115_si_001.pdf">jm5b00115_si_001.pdf (307.36 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00115" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52436" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52436" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Rochais</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#07646f756e747368776f62297568646f666e744772696e64666269296175"><span class="__cf_email__" data-cfemail="f89b908a918b8c9788909dd68a979b9099918bb88d96919b999d96d69e8a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Dallemagne</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#06766772746f656d2862676a6a636b676168634673686f65676368286074"><span class="__cf_email__" data-cfemail="6818091c1a010b03460c0904040d05090f060d281d06010b090d06460e1a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cédric Lecoutey</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence Gaven</span> - <span class="hlFld-Affiliation affiliation">CNRS,
UMR-5203, Institut de Génomique Fonctionnelle, F-34000 Montpellier, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm,
U1191, F-34000 Montpellier, France</span>; 
    <span class="hlFld-Affiliation affiliation">Université
de Montpellier, UMR-5203, F-34000 Montpellier, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrizia Giannoni</span> - <span class="hlFld-Affiliation affiliation">CNRS,
UMR-5203, Institut de Génomique Fonctionnelle, F-34000 Montpellier, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm,
U1191, F-34000 Montpellier, France</span>; 
    <span class="hlFld-Affiliation affiliation">Université
de Montpellier, UMR-5203, F-34000 Montpellier, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katia Hamidouche</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
GMPc5 (Groupe Mémoire et Plasticité comportementale), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Damien Hedou</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emmanuelle Dubost</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Genest</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samir Yahiaoui</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Freret</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
GMPc5 (Groupe Mémoire et Plasticité comportementale), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valentine Bouet</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
GMPc5 (Groupe Mémoire et Plasticité comportementale), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">François Dauphin</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
GMPc5 (Groupe Mémoire et Plasticité comportementale), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jana Sopkova de Oliveira Santos</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Céline Ballandonne</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophie Corvaisier</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span>; 
    <span class="hlFld-Affiliation affiliation">UNICAEN,
GMPc5 (Groupe Mémoire et Plasticité comportementale), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aurélie Malzert-Fréon</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Remi Legay</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
CERMN (Centre d’Etudes et de Recherche sur le Médicament
de Normandie), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Boulouard</span> - <span class="hlFld-Affiliation affiliation">UNICAEN,
GMPc5 (Groupe Mémoire et Plasticité comportementale), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvie Claeysen</span> - <span class="hlFld-Affiliation affiliation">CNRS,
UMR-5203, Institut de Génomique Fonctionnelle, F-34000 Montpellier, France</span>; 
    <span class="hlFld-Affiliation affiliation">Inserm,
U1191, F-34000 Montpellier, France</span>; 
    <span class="hlFld-Affiliation affiliation">Université
de Montpellier, UMR-5203, F-34000 Montpellier, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3619-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by funding from the Conseil Régional de Basse Normandie, France (Dispositif de Soutien aux Projets de Recherche Emergents), French Agence Nationale de la Recherche Projects MALAD ANR-12-JS007-0012-01 and ADAMGUARD ANR-12-BSV4-008-01, and Ligue Européenne Contre la Maladie d’Alzheimer Grant 12721. The authors gratefully acknowledge the CRIHAN (Centre de Ressources Informatiques de Haute Normandie) as well as the European Community (FEDER) for the molecular modelling software. English language editing of this manuscript was provided by Journal Prep.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AChEI</td><td class="NLM_def"><p class="first last">acetylcholinesterase inhibitor</p></td></tr><tr><td class="NLM_term">CAS</td><td class="NLM_def"><p class="first last">catalytic anionic site</p></td></tr><tr><td class="NLM_term">DBS</td><td class="NLM_def"><p class="first last">dual-binding site</p></td></tr><tr><td class="NLM_term">DPZ</td><td class="NLM_def"><p class="first last">donepezil</p></td></tr><tr><td class="NLM_term">MTDL</td><td class="NLM_def"><p class="first last">multitarget-directed ligands</p></td></tr><tr><td class="NLM_term">PAS</td><td class="NLM_def"><p class="first last">peripheral anionic site</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 89 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Stelzmann, R.</span><span> </span><span class="NLM_article-title">An English translation of Alzheimer’s 1907 paper, “Über eine eigenartige erkankung der hirnrinde</span> <span class="citation_source-journal">Clinical Anat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1002%2Fca.980080612" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=429-431&author=R.+Stelzmann&title=An+English+translation+of+Alzheimer%E2%80%99s+1907+paper%2C+%E2%80%9C%C3%9Cber+eine+eigenartige+erkankung+der+hirnrinde"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fca.980080612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fca.980080612%26sid%3Dliteratum%253Aachs%26aulast%3DStelzmann%26aufirst%3DR.%26atitle%3DAn%2520English%2520translation%2520of%2520Alzheimer%25E2%2580%2599s%25201907%2520paper%252C%2520%25E2%2580%259C%25C3%259Cber%2520eine%2520eigenartige%2520erkankung%2520der%2520hirnrinde%26jtitle%3DClinical%2520Anat.%26date%3D1995%26volume%3D1%26spage%3D429%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span> </span><span class="NLM_article-title">World Alzheimer Report 2013: the global economic impact of dementia</span>. Alzheimer’s Disease International Home Page. <a href="http://www.alz.co.uk" class="extLink">http://www.alz.co.uk</a> (accessed December 12,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Alzheimer+Report+2013%3A+the+global+economic+impact+of+dementia.+Alzheimer%E2%80%99s+Disease+International+Home+Page.+http%3A%2F%2Fwww.alz.co.uk+%28accessed+December+12%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DWorld%2520Alzheimer%2520Report%25202013%253A%2520the%2520global%2520economic%2520impact%2520of%2520dementia%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%2520Home%2520Page%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Mount, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downton, C.</span><span> </span><span class="NLM_article-title">Alzheimer disease: progress or profit?</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1038%2Fnm0706-780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=16829947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1eks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=780-784&author=C.+Mountauthor=C.+Downton&title=Alzheimer+disease%3A+progress+or+profit%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease: progress or profit?</span></div><div class="casAuthors">Mount, Claire; Downton, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">780-784</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp458aEz9g7-rVg90H21EOLACvtfcHk0ljDjsrNQpxadQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1eks7s%253D&md5=53e9af938ef93beee99bc9a7feb7eeea</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm0706-780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0706-780%26sid%3Dliteratum%253Aachs%26aulast%3DMount%26aufirst%3DC.%26aulast%3DDownton%26aufirst%3DC.%26atitle%3DAlzheimer%2520disease%253A%2520progress%2520or%2520profit%253F%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D780%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Melnikova, I.</span><span> </span><span class="NLM_article-title">Therapies for Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=341-342&author=I.+Melnikova&title=Therapies+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelnikova%26aufirst%3DI.%26atitle%3DTherapies%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D341%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target design strategies in the context of Alzheimer’s disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the diving forces</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1914</span><span class="NLM_x">–</span> <span class="NLM_lpage">1923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1007%2Fs11064-014-1250-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=24493627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=1914-1923&author=M.+Rosiniauthor=E.+Simoniauthor=A.+Minariniauthor=C.+Melchiorre&title=Multi-target+design+strategies+in+the+context+of+Alzheimer%E2%80%99s+disease%3A+acetylcholinesterase+inhibition+and+NMDA+receptor+antagonism+as+the+diving+forces"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target Design Strategies in the Context of Alzheimer's Disease: Acetylcholinesterase Inhibition and NMDA Receptor Antagonism as the Driving Forces</span></div><div class="casAuthors">Rosini, Michela; Simoni, Elena; Minarini, Anna; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1914-1923</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In recent years, the multi-target-directed ligand concept has been used to design a variety of mols. hitting different biol. targets for Alzheimer's disease.  We have sought to combine, in the same mol., the neuroprotective action of N-methyl-D-aspartate receptor antagonism with the symptomatic relief offered by cholinergic activity through acetylcholinesterase inhibition.  This strategy could potentially maintain the pos. outcomes of memantine-acetylcholinesterase inhibitor combinations, but with the benefits of a single mol. therapy.  Herein, we discuss selected examples of multifunctional compds., which we rationally designed to simultaneously modulate these targets.  We also examine the intertwined relationship between acetylcholinesterase, N-methyl-D-aspartate receptors, and other active players in the neurotoxic cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1nvk7HjF3w7Vg90H21EOLACvtfcHk0lik1IYiTCBlOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtb4%253D&md5=00aaa680058bb58d9aec21c0648e60ee</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs11064-014-1250-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-014-1250-1%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target%2520design%2520strategies%2520in%2520the%2520context%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520acetylcholinesterase%2520inhibition%2520and%2520NMDA%2520receptor%2520antagonism%2520as%2520the%2520diving%2520forces%26jtitle%3DNeurochem.%2520Res.%26date%3D2014%26volume%3D39%26spage%3D1914%26epage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, J.</span><span> </span><span class="NLM_article-title">Can the pharmaceutical industry reduce attrition rates?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=711-715&author=I.+Kolaauthor=J.+Landis&title=Can+the+pharmaceutical+industry+reduce+attrition+rates%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKola%26aufirst%3DI.%26aulast%3DLandis%26aufirst%3DJ.%26atitle%3DCan%2520the%2520pharmaceutical%2520industry%2520reduce%2520attrition%2520rates%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D711%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uliassi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Two diseases, one approach: multitarget drug discovery in Alzheimer’s and neglected tropical diseases</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=853-861&author=F.+Pratiauthor=E.+Uliassiauthor=M.+L.+Bolognesi&title=Two+diseases%2C+one+approach%3A+multitarget+drug+discovery+in+Alzheimer%E2%80%99s+and+neglected+tropical+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DTwo%2520diseases%252C%2520one%2520approach%253A%2520multitarget%2520drug%2520discovery%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520neglected%2520tropical%2520diseases%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D853%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">From magic bullets to designed multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FS1359-6446%2804%2903163-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=15279847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=641-651&author=R.+Morphyauthor=C.+Kayauthor=Z.+Rankovic&title=From+magic+bullets+to+designed+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">From magic bullets to designed multiple ligands</span></div><div class="casAuthors">Morphy, Richard; Kay, Corinne; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">641-651</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  A major trend in medicinal chem. in the coming years will be the rational design of ligands that are capable of modulating multiple disease-relevant targets in a specific manner.  Increasingly, it is being recognized that a balanced modulation of several targets can provide a superior therapeutic effect and side effect profile compared to the action of a selective ligand.  Rational approaches in which structural features from selective ligands are combined have produced designed multiple ligands that span a wide variety of targets and target classes.  A key challenge in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile.  An anal. of literature examples reveals trends and insights that might help medicinal chemists discover the next generation of these types of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcsGpfzZok5rVg90H21EOLACvtfcHk0lik1IYiTCBlOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D&md5=cd2491baad707043dbee4f59ccad9e1d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903163-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903163-0%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DKay%26aufirst%3DC.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFrom%2520magic%2520bullets%2520to%2520designed%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D641%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lik1IYiTCBlOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Espinoza-Fonseca, L. M.</span><span> </span><span class="NLM_article-title">The benefits of the multi-target approach in drug design and discovery</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">896</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2Fj.bmc.2005.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=16203151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=896-897&author=L.+M.+Espinoza-Fonseca&title=The+benefits+of+the+multi-target+approach+in+drug+design+and+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The benefits of the multi-target approach in drug design and discovery</span></div><div class="casAuthors">Espinoza-Fonseca, L. Michel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">896-897</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Promiscuous binding has been considered to be a problem in the design and development of new drugs against a given disease.  However, promiscuity in mol. recognition is not all bad news, and scientists are currently taking advantage of the emerging promiscuous binding' or multi-target approach' in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocGqPWnEVzk7Vg90H21EOLACvtfcHk0ljkwKcU8h9PuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOjuw%253D%253D&md5=3daf3304b9bc2c60575b5e3003e89897</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DEspinoza-Fonseca%26aufirst%3DL.%2BM.%26atitle%3DThe%2520benefits%2520of%2520the%2520multi-target%2520approach%2520in%2520drug%2520design%2520and%2520discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D896%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Fragments, network biology and designing multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=156-160&author=R.+Morphyauthor=Z.+Rankovic&title=Fragments%2C+network+biology+and+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFragments%252C%2520network%2520biology%2520and%2520designing%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D156%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Korcsmáros, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalay, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böde, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovács, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csermely, P.</span><span> </span><span class="NLM_article-title">How to design multi-target drugs</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=799-808&author=T.+Korcsm%C3%A1rosauthor=M.+S.+Szalayauthor=C.+B%C3%B6deauthor=I.+A.+Kov%C3%A1csauthor=P.+Csermely&title=How+to+design+multi-target+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKorcsm%25C3%25A1ros%26aufirst%3DT.%26aulast%3DSzalay%26aufirst%3DM.%2BS.%26aulast%3DB%25C3%25B6de%26aufirst%3DC.%26aulast%3DKov%25C3%25A1cs%26aufirst%3DI.%2BA.%26aulast%3DCsermely%26aufirst%3DP.%26atitle%3DHow%2520to%2520design%2520multi-target%2520drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D799%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Bolognesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzi, R.</span><span> </span><span class="NLM_article-title">Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4882</span><span class="NLM_x">–</span> <span class="NLM_lpage">4897</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=4882-4897&author=M.+Bolognesiauthor=R.+Banzi&title=Novel+class+of+quinone-bearing+polyamines+as+multi-target-directed+ligands+to+combat+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%26aulast%3DBanzi%26aufirst%3DR.%26atitle%3DNovel%2520class%2520of%2520quinone-bearing%2520polyamines%2520as%2520multi-target-directed%2520ligands%2520to%2520combat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D10%26spage%3D4882%26epage%3D4897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Meunier, B.</span><span> </span><span class="NLM_article-title">Hybrid molecules with a dual mode of action: dream or reality?</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar7000843" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=69-77&author=B.+Meunier&title=Hybrid+molecules+with+a+dual+mode+of+action%3A+dream+or+reality%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Far7000843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far7000843%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DB.%26atitle%3DHybrid%2520molecules%2520with%2520a%2520dual%2520mode%2520of%2520action%253A%2520dream%2520or%2520reality%253F%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D69%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+Bolognesi&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0ljkwKcU8h9PuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Morphy, R.; Rankovic, Z.</span><span> </span><span class="NLM_article-title">Multi-Target Drugs. Strategies and challenges for medicinal chemists</span>. In  <span class="citation_source-book">The Practice of Medicinal Chemistry</span>, <span class="NLM_edition">3</span>rd ed; <span class="NLM_contrib-group">Wermuth, C. G.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FB978-0-12-374194-3.00027-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=549-571&author=R.+Morphy&author=Z.+Rankovicauthor=C.+G.+Wermuth&title=The+Practice+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-374194-3.00027-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-374194-3.00027-5%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DMulti-Target%2520Drugs.%2520Strategies%2520and%2520challenges%2520for%2520medicinal%2520chemists%26btitle%3DThe%2520Practice%2520of%2520Medicinal%2520Chemistry%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26pub%3DElsevier%26date%3D2008%26spage%3D549%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designing multiple ligands - medicinal chemistry strategies and challenges</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F138161209787315594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=19199984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=587-600&author=R.+Morphyauthor=Z.+Rankovic&title=Designing+multiple+ligands+-+medicinal+chemistry+strategies+and+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Designing multiple ligands - medicinal chemistry strategies and challenges</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">587-600</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It has been widely recognized over the recent years that parallel modulation of multiple biol. targets can be beneficial for treatment of diseases with complex etiologies such as cancer asthma, and psychiatric disease.  In this article, current strategies for the generation of ligands with a specific multi-target profile (designed multiple ligands or DMLs) are described and a no. of illustrative example are given.  Designing multiple ligands is frequently a challenging endeavor for medicinal chemists, with the need to appropriately balance affinity for 2 or more targets while obtaining physicochem. and pharmacokinetic properties that are consistent with the administration of an oral drug.  Given that the properties of DMLs are influenced to a large extent by the proteomic superfamily to which the targets belong and the lead generation strategy that is pursued, an early assessment of the feasibility of any given DML project is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUo6NjoK5D-LVg90H21EOLACvtfcHk0lhogrknCCPQJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D&md5=fa34039be6e9c3b489f530fc74fd0346</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F138161209787315594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787315594%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigning%2520multiple%2520ligands%2520-%2520medicinal%2520chemistry%2520strategies%2520and%2520challenges%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D587%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span> </span><span class="NLM_article-title">Polyamines in drug discovery: from the universal template approach to the multitarget-directed ligand design strategy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5906</span><span class="NLM_x">–</span> <span class="NLM_lpage">5914</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100293f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5906-5914&author=C.+Melchiorreauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiatti&title=Polyamines+in+drug+discovery%3A+from+the+universal+template+approach+to+the+multitarget-directed+ligand+design+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm100293f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100293f%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26atitle%3DPolyamines%2520in%2520drug%2520discovery%253A%2520from%2520the%2520universal%2520template%2520approach%2520to%2520the%2520multitarget-directed%2520ligand%2520design%2520strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5906%26epage%3D5914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Why design multi-target drugs?</span> In  <span class="citation_source-book">Designing Multi-Target Drugs</span>; <span class="NLM_contrib-group">Morphy, J. R.; Harris, C. J.</span>, Eds.; <span class="NLM_publisher-name">RCS Publishing</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">394</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=394&author=A.+L.+Hopkinsauthor=J.+R.+Morphy&author=C.+J.+Harris&title=Designing+Multi-Target+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DWhy%2520design%2520multi-target%2520drugs%253F%26btitle%3DDesigning%2520Multi-Target%2520Drugs%26aulast%3DMorphy%26aufirst%3DJ.%2BR.%26pub%3DRCS%2520Publishing%26date%3D2012%26spage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. T.</span><span> </span><span class="NLM_article-title">Multi-target drugs: The trend of drug research and development</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e40262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1371%2Fjournal.pone.0040262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=22768266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVaisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e40262&author=J.+J.+Luauthor=W.+Panauthor=Y.+J.+Huauthor=Y.+T.+Wang&title=Multi-target+drugs%3A+The+trend+of+drug+research+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target drugs: the trend of drug research and development</span></div><div class="casAuthors">Lu, Jin-Jian; Pan, Wei; Hu, Yuan-Jia; Wang, Yi-Tao</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e40262</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Summarizing the status of drugs in the market and examg. the trend of drug research and development is important in drug discovery.  In this study, we compared the drug targets and the market sales of the new mol. entities approved by the U.S. Food and Drug Administration from Jan. 2000 to Dec. 2009.  Two networks, namely, the target-target and drug-drug networks, have been set up using the network anal. tools.  The multi-target drugs have much more potential, as shown by the network visualization and the market trends.  We discussed the possible reasons and proposed the rational strategies for drug research and development in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrapZATY1GnWbVg90H21EOLACvtfcHk0lhogrknCCPQJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVaisr8%253D&md5=79489aaf7a36ee9c30287621a7244a6a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0040262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0040262%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%2BJ.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DY.%2BJ.%26aulast%3DWang%26aufirst%3DY.%2BT.%26atitle%3DMulti-target%2520drugs%253A%2520The%2520trend%2520of%2520drug%2520research%2520and%2520development%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De40262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">The physicochemical challenges of designing multiple ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4961</span><span class="NLM_x">–</span> <span class="NLM_lpage">4970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4961-4970&author=R.+Morphyauthor=Z.+Rankovic&title=The+physicochemical+challenges+of+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The Physicochemical Challenges of Designing Multiple Ligands</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4961-4970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. designed to bind more than one target can provide a therapeutic benefit relative to highly target-selective ligands.  The physicochem. properties of designed multiple ligands were found to be less druglike than those for preclin. compds. in general.  These properties are controlled by the superfamily to which the targets belong and the lead discovery strategy that was followed.  The properties for peptide G-protein-coupled receptor (GPCR) ligands were the least favorable for oral delivery, whereas transporter, monoamine GPCR, and oxidase ligands were the most druglike.  The lead discovery strategy, framework combination or screening, exerts a profound influence on the property values.  Combining the frameworks from two selective ligands often results in large, complex dual ligands, but druglike ligands can be achieved if the degree of framework overlap is maximized and the size of the selective ligands minimized.  For some target combinations, a screening approach may provide a route to smaller, less complex leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonGHbXyxgv4LVg90H21EOLACvtfcHk0lhogrknCCPQJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D&md5=c7a227848516d0aa58ed037a582943fe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0603015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603015%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DThe%2520physicochemical%2520challenges%2520of%2520designing%2520multiple%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4961%26epage%3D4970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Schmitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhardt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeller, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuser, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolich, L.</span><span> </span><span class="NLM_article-title">Combination therapy in Alzheimer’s disease: a review of current evidence</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=827-844&author=B.+Schmittauthor=T.+Bernhardtauthor=H.+J.+Moellerauthor=I.+Heuserauthor=L.+Frolich&title=Combination+therapy+in+Alzheimer%E2%80%99s+disease%3A+a+review+of+current+evidence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DB.%26aulast%3DBernhardt%26aufirst%3DT.%26aulast%3DMoeller%26aufirst%3DH.%2BJ.%26aulast%3DHeuser%26aufirst%3DI.%26aulast%3DFrolich%26aufirst%3DL.%26atitle%3DCombination%2520therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520review%2520of%2520current%2520evidence%26jtitle%3DCNS%2520Drugs%26date%3D2004%26volume%3D18%26spage%3D827%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Progress in acetylcholinesterase inhibitors for Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1517%2F13543776.16.6.811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVOhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=811-823&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=Progress+in+acetylcholinesterase+inhibitors+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in acetylcholinesterase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Bolognesi, Maria Laura; Minarini, Anna; Tumiatti, Vincenzo; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">811-823</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Current pharmacotherapy of Alzheimer's disease (AD) involves drugs that are known as acetylcholinesterase inhibitors (AChEIs), which increase the acetylcholine concn. in the brain.  Although effective in improving cognitive, behavioral and functional impairments, these drugs are not able to alter disease progression.  In this review, the recent patent literature on AChEIs from 2002 to early 2005 will be discussed, focusing attention on the novel analogs of the approved drugs, as well as on the most important AD therapeutic advances.  The clin. efficacy of AChEIs will probably be enhanced by their combination with other drugs acting through different pharmacol. mechanisms.  As the neuronal loss comprises more than the forebrain cholinergic system, the weak effectiveness of AChEIs is not surprising.  Besides the cholinergic hypothesis' approaches, new treatments are emerging based on multipotent compds. able to target the underlying pathogenic mechanisms of AD; these treatments are summarized herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptSL4AfWXbaLVg90H21EOLACvtfcHk0lg5iMGgdo8VqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVOhu7g%253D&md5=1094dc53e60353b61a4ac6fe0cbbfee8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F13543776.16.6.811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.16.6.811%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DProgress%2520in%2520acetylcholinesterase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D811%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zhang, H.-Y.</span><span> </span><span class="NLM_article-title">One-compound-multiple-targets strategy to combat Alzheimer’s disease</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=5260-5264&author=H.-Y.+Zhang&title=One-compound-multiple-targets+strategy+to+combat+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Y.%26atitle%3DOne-compound-multiple-targets%2520strategy%2520to%2520combat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D5260%26epage%3D5264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F156720506779025288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=17168653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=541-550&author=M.+B.+Youdim&title=The+path+from+anti+Parkinson+drug+selegiline+and+rasagiline+to+multifunctional+neuroprotective+anti+Alzheimer+drugs+ladostigil+and+m30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and M30</span></div><div class="casAuthors">Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">541-550</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The therapeutic use of enzyme inhibitors in treatment of neurodegenerative diseases has its origin in the anti Parkinson action of the selective monoamine oxidase (MAO) B inhibitor, 1-deprenyl (selegiline), a failed anti depressant in 1975.  This led to further development of MAO- A and B, catechol-O-methyltansferase and cholinestrerase inhibitors as anti Parkinson and Alzheimer drugs.  One of the main reasons for the cognitive deficit in dementia of the Alzheimer' type (AD) and in dementia with Lewy bodies (DLB) is degeneration of cholinergic cortical neurons and synaptic plasticity.  This led to a correlation that similar to Parkinson's Disease (PD), cholinesterase inhibitors (ChEI) may also have therapeutic activity in AD.  Significant percentage of AD and DLB subjects also nigrostriatal dopaminergic, locus ceruleous noradrenergic and raphe nucleus serotoninergic neurons.  The present ChEI anti AD drugs have limited symptomatic activity and devoid of neuroprotective property that is needed for disease modifying action.  It is becoming clear that there are no magic bullets for neurodegenerative disorders and shut gun approach is needed either as polypharmacol. or drugs with multiple activity at different target sites in the CNS.  The complex pathol. of AD as well as cascade of events that leads to the neurodegenerative process has led us to develop several multifunctional neuroprotective drugs with several CNS targets with possible disease modifying activity.  Employing the pharmacophore of our antiparkinson drug rasagiline (Azilect, Agilect, N-propagrgyl-1R-aminoindan) we have developed a novel multifunctional neuroprotective drug, ladostigil [TV-3326 (N-propargyl-3R-aminoindan-5yl)-Et methylcarbamate], with both cholinesterase-butyrylesterase (Ch-BuE) and brain selective monoamine-oxidase (MAO) AB inhibitory activities possessing the neuroprotective-neurescue propargyl moiety, as potential treatment of AD and DLB and PD with dementias.  Since brain MAO and iron increase in AD, PD and aging, that could lead to iron dependent oxidative stress neurodegeneration, we have developed another series of multifunctional drugs (M30 HLA-20 series) which are brain permeable iron chelators- brain selective MAO inhibitors and possess the propargyl neuroprotective moiety.  These series of drugs have the ability of regulating and processing APP (amyloid precursor protein) and reducing Aβ peptide, since APP is a metaloprotein, with an iron responsive element 5''UTR similar to transferring and ferritin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUf6C6njrCALVg90H21EOLACvtfcHk0lg5iMGgdo8VqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrF&md5=33be9cc15d120660265a0927b176d0dd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F156720506779025288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506779025288%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DThe%2520path%2520from%2520anti%2520Parkinson%2520drug%2520selegiline%2520and%2520rasagiline%2520to%2520multifunctional%2520neuroprotective%2520anti%2520Alzheimer%2520drugs%2520ladostigil%2520and%2520m30%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D541%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Multifunctional neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimer’s and Parkinson’s diseases</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1358%2Fdof.2006.031.05.985904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFyntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=447-460&author=C.+J.+Van+der+Schyfauthor=W.+J.+Geldenhuysauthor=M.+B.+Youdim&title=Multifunctional+neuroprotective+drugs+for+the+treatment+of+cognitive+and+movement+impairment+disorders%2C+including+Alzheimer%E2%80%99s+and+Parkinson%E2%80%99s+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimer's and Parkinson's diseases</span></div><div class="casAuthors">Van der Schyf, Cornelis J.; Geldenhuys, Werner J.; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">447-460</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The concept of targeting multiple disease etiologies that lead to cognitive and movement impairment in neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and stroke, is challenging the widely held assumption that "silver bullet" agents are superior to "dirty drugs" in the pharmacol. treatment of these diseases.  Accumulating evidence in the literature suggests that a drug with two or more mechanisms of action targeted at multiple etiologies of the same disease may offer greater therapeutic benefit in certain disorders than a drug that targets only one disease etiol.  In addn., the use of a single such multifunctional drug possessing several pharmacol. active moieties may yield a more favorable side effect profile than a combination of several drugs that individually target the same disease etiologies.  In this review, we offer a synopsis of therapeutic strategies and novel investigative drugs developed in our own and other labs. that modulate multiple disease targets assocd. with cognitive and movement impairment disorders, including cognitive decline assocd. with Alzheimer's disease, Parkinson's disease with dementia and movement deficits in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXfldsPAa7krVg90H21EOLACvtfcHk0lg5iMGgdo8VqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFyntbk%253D&md5=4899ea8eef04811b55f1c4638898dc42</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.05.985904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.05.985904%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMultifunctional%2520neuroprotective%2520drugs%2520for%2520the%2520treatment%2520of%2520cognitive%2520and%2520movement%2520impairment%2520disorders%252C%2520including%2520Alzheimer%25E2%2580%2599s%2520and%2520Parkinson%25E2%2580%2599s%2520diseases%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D447%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bajda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzior, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignasik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malawska, B.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands in Alzheimer’s disease treatment</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4949</span><span class="NLM_x">–</span> <span class="NLM_lpage">4975</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F092986711797535245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=22050745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4949-4975&author=M.+Bajdaauthor=N.+Guziorauthor=M.+Ignasikauthor=B.+Malawska&title=Multi-target-directed+ligands+in+Alzheimer%E2%80%99s+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed ligands in Alzheimer's disease treatment</span></div><div class="casAuthors">Bajda, M.; Guzior, N.; Ignasik, M.; Malawska, B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4949-4975</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Among the various drug discovery methods, a very promising modern approach consists in designing multi-target-directed ligands (MTDLs).  This methodol. has been specifically developed for treatment of disorders with complex pathol. mechanisms.  One such disorder is Alzheimer's disease (AD), currently the most common multifactorial neurodegenerative disease.  AD is related to increased levels of the amyloid β peptide (Aβ) and the hyperphosphorylated tau protein, along with loss of neurons and synapses.  Moreover, there is some evidence pointing to the role of oxidative stress, metal ion deregulation, inflammation and cell cycle regulatory failure in its pathogenesis.  There are many attractive targets for the development of anti-AD drugs, and the multi-factor nature of this disease calls for multi-target-directed compds. which can be beneficial for AD treatment.  This review presents the discovery of dual- and multi-acting anti-AD drug candidates, focusing on the novel design strategy and the compds. it yields - particularly hybrids obtained by linking structurally active moieties interacting with different targets.  The first group of compds. includes cholinesterase inhibitors acting as dual binding site inhibitors and/or inhibitors with addnl. properties.  These compds. are characterized by increased potency against acetylcholinesterase (AChE) and Aβ plaque formation with addnl. properties such as antioxidant activity, neuroprotective, and metal-complexing property, voltage-dependent calcium channel antagonistic activity, inhibitory activity against glutamate-induced excitotoxicity, histamine H3 receptor antagonism, cannabinoid CB1 receptor antagonism and β-secretase (BACE1) inhibition.  A novel class of compds. represents the combination of dual BACE1 inhibitors with metal chelators, and dual modulators of γ-secretase with peroxisome proliferator-activated receptor γ (PPARγ).  We have reviewed the latest reports (2008-2011) presenting new multi-target-directed compds. in Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZHSluHvxy4bVg90H21EOLACvtfcHk0lh_iBaG06RYmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F&md5=c8f35f849c399d43c90570f71ca10e13</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F092986711797535245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797535245%26sid%3Dliteratum%253Aachs%26aulast%3DBajda%26aufirst%3DM.%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DIgnasik%26aufirst%3DM.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DMulti-target-directed%2520ligands%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4949%26epage%3D4975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Carmo Carreiras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesus Perry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paula Francisco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, A.</span><span> </span><span class="NLM_article-title">The multifactorial nature of Alzheimer’s disease for developing potential therapeutics</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1745</span><span class="NLM_x">–</span> <span class="NLM_lpage">1770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F15680266113139990135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=23931435" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1745-1770&author=M.+Carmo+Carreirasauthor=E.+Mendesauthor=M.+Jesus+Perryauthor=A.+Paula+Franciscoauthor=J.+Marco-Contellesauthor=M.+Carreirasauthor=M.+Perryauthor=A.+Francisco&title=The+multifactorial+nature+of+Alzheimer%E2%80%99s+disease+for+developing+potential+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990135%26sid%3Dliteratum%253Aachs%26aulast%3DCarmo%2BCarreiras%26aufirst%3DM.%26aulast%3DMendes%26aufirst%3DE.%26aulast%3DJesus%2BPerry%26aufirst%3DM.%26aulast%3DPaula%2BFrancisco%26aufirst%3DA.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DCarreiras%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DM.%26aulast%3DFrancisco%26aufirst%3DA.%26atitle%3DThe%2520multifactorial%2520nature%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520for%2520developing%2520potential%2520therapeutics%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1745%26epage%3D1770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=115-129&author=W.+J.+Geldenhuysauthor=C.+J.+Van+der+Schyf&title=Designing+drugs+with+multi-target+activity%3A+the+next+step+in+the+treatment+of+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DDesigning%2520drugs%2520with%2520multi-target%2520activity%253A%2520the%2520next%2520step%2520in%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D115%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">León, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Le%C3%B3nauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0lh_iBaG06RYmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span> </span><span class="NLM_article-title">New multi-target-directed small molecules against Alzheimer’s disease: a combination of resveratrol and clioquinol</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5936</span><span class="NLM_x">–</span> <span class="NLM_lpage">5944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=5936-5944&author=F.+Maoauthor=J.+Yanauthor=J.+Liauthor=X.+Jiaauthor=H.+Miaoauthor=Y.+Sunauthor=L.+Huangauthor=X.+Li&title=New+multi-target-directed+small+molecules+against+Alzheimer%E2%80%99s+disease%3A+a+combination+of+resveratrol+and+clioquinol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DNew%2520multi-target-directed%2520small%2520molecules%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520combination%2520of%2520resveratrol%2520and%2520clioquinol%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2014%26volume%3D12%26spage%3D5936%26epage%3D5944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Tacrine derivatives and Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1825</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F092986710791111206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=20345341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFCnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1825-1838&author=V.+Tumiattiauthor=A.+Minariniauthor=M.+L.+Bolognesiauthor=A.+Milelliauthor=M.+Rosiniauthor=C.+Melchiorre&title=Tacrine+derivatives+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine derivatives and Alzheimer's disease</span></div><div class="casAuthors">Tumiatti, V.; Minarini, A.; Bolognesi, M. L.; Milelli, A.; Rosini, M.; Melchiorre, C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1825-1838</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  To date, the pharmacotherapy of Alzheimer's disease (AD) has relied on acetylcholinesterase (AChE) inhibitors (AChEIs) and, more recently, an N-methyl-D-aspartate receptor (NMDAR) antagonist.  AD is a multifactorial syndrome with several target proteins contributing to its etiol.  "Multi-target-directed ligands" (MTDLs) have great potential for treating complex diseases such as AD because they can interact with multiple targets.  The design of compds. that can hit more than one specific AD target thus represents an innovative strategy for AD treatment.  Tacrine was the first AChEI introduced in therapy.  Recent studies have demonstrated its ability to interact with different AD targets.  Furthermore, numerous tacrine homo- and heterodimers were developed with the aim of improving and enlarging its biol. profile beyond its ability to act as an AChEI.  Several tacrine hybrid derivs. were designed and synthesized with the same goal.  This review will focus on and summarize the last 2 years of research into the development of tacrine derivs. able to hit AD targets beyond simple AChE inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoAUhZIxP33LVg90H21EOLACvtfcHk0ljfK7SDU64-uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFCnu78%253D&md5=0506197d9fdaa47d5a76bdf2099cf483</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F092986710791111206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791111206%26sid%3Dliteratum%253Aachs%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DTacrine%2520derivatives%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D1825%26epage%3D1838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Agis-Torres, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söllhuber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Montero, J. M.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F1570159X113116660047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=24533013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksFSnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=2-36&author=A.+Agis-Torresauthor=M.+S%C3%B6llhuberauthor=M.+Fernandezauthor=J.+M.+Sanchez-Montero&title=Multi-target-directed+ligands+and+other+therapeutic+strategies+in+the+search+of+a+real+solution+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease</span></div><div class="casAuthors">Agis-Torres, Angel; Sollhuber, Monica; Fernandez, Maria; Sanchez-Montero, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-36</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The lack of an adequate therapy for Alzheimer's Disease (AD) contributes greatly to the continuous growing amt. of papers and reviews, reflecting the important efforts made by scientists in this field.  It is well known that AD is the most common cause of dementia, and up-to-date there is no prevention therapy and no cure for the disease, which contrasts with the enormous efforts put on the task.  On the other hand many aspects of AD are currently debated or even unknown.  This review offers a view of the current state of knowledge about AD which includes more relevant findings and processes that take part in the disease; it also shows more relevant past, present and future research on therapeutic drugs taking into account the new paradigm "Multi-Target-Directed Ligands" (MTDLs).  In our opinion, this paradigm will lead from now on the research toward the discovery of better therapeutic solns., not only in the case of AD but also in other complex diseases.  This review highlights the strategies followed by now, and focuses other emerging targets that should be taken into account for the future development of new MTDLs.  Thus, the path followed in this review goes from the pathol. and the processes involved in AD to the strategies to consider in on-going and future researches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocAfdyZkil7LVg90H21EOLACvtfcHk0ljfK7SDU64-uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksFSnsb8%253D&md5=ddb64c9aea98b442eef32bd03e050fb2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F1570159X113116660047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X113116660047%26sid%3Dliteratum%253Aachs%26aulast%3DAgis-Torres%26aufirst%3DA.%26aulast%3DS%25C3%25B6llhuber%26aufirst%3DM.%26aulast%3DFernandez%26aufirst%3DM.%26aulast%3DSanchez-Montero%26aufirst%3DJ.%2BM.%26atitle%3DMulti-target-directed%2520ligands%2520and%2520other%2520therapeutic%2520strategies%2520in%2520the%2520search%2520of%2520a%2520real%2520solution%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2014%26volume%3D12%26spage%3D2%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budriesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors based on a polyamine backbone for potential use against Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4186</span><span class="NLM_x">–</span> <span class="NLM_lpage">4189</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9810452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4186-4189&author=C.+Melchiorreauthor=V.+Andrisanoauthor=M.+L.+Bolognesiauthor=R.+Budriesiauthor=A.+Cavalliauthor=V.+Cavriniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatini&title=Acetylcholinesterase+inhibitors+based+on+a+polyamine+backbone+for+potential+use+against+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm9810452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9810452%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520based%2520on%2520a%2520polyamine%2520backbone%2520for%2520potential%2520use%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4186%26epage%3D4189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">3-(4-{[Benzyl(methyl)amino]methyl}-phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation: A dual function lead for Alzheimer’s disease therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2282</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0340602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2279-2282&author=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Cavalli&title=3-%284-%7B%5BBenzyl%28methyl%29amino%5Dmethyl%7D-phenyl%29-6%2C7-dimethoxy-2H-2-chromenone+%28AP2238%29+inhibits+both+acetylcholinesterase+and+acetylcholinesterase-induced+%CE%B2-amyloid+aggregation%3A+A+dual+function+lead+for+Alzheimer%E2%80%99s+disease+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0340602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0340602%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3D3-%25284-%257B%255BBenzyl%2528methyl%2529amino%255Dmethyl%257D-phenyl%2529-6%252C7-dimethoxy-2H-2-chromenone%2520%2528AP2238%2529%2520inhibits%2520both%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520%25CE%25B2-amyloid%2520aggregation%253A%2520A%2520dual%2520function%2520lead%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2279%26epage%3D2282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FS0006-2952%2802%2901514-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=12527333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=407-416&author=M.+Bartoliniauthor=C.+Bertucciauthor=V.+Cariniauthor=V.+Andrisano&title=beta-Amyloid+aggregation+induced+by+human+acetylcholinesterase%3A+inhibition+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span></div><div class="casAuthors">Bartolini, Manuela; Bertucci, Carlo; Cavrini, Vanni; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The aggregation of β-amyloid (1-40) (Aβ) induced by human recombinant acetylcholinesterase (HuAChE) was studied by means of CD (CD) and by thioflavin T fluorescence spectroscopy.  Aβ was incubated alone and with HuAChE.  The kinetic of fibrils formation was followed for 48 h.  The increasing β-conformation content induced by HuAChE, preliminary to the formation of Aβ fibrils, was detd. by CD.  This phenomenon was found to be related to the thioflavin T emission of fluorescence at 490 nm.  Incubation expts. were performed in the presence of known AChE inhibitors (physostigmine, edrophonium, decamethonium, propidium) and drugs used for Alzheimer's disease (AD) (tacrine, donepezil), to test their capability of preventing the HuAChE-induced Aβ aggregation.  The non-competitive or mixed mode of AChE inhibition was confirmed to be an essential feature.  At 100 μM propidium, decamethonium, donepezil and physostigmine were found to inhibit the HuAChE-induced Aβ aggregation by 82, 25, 22 and 30%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2eDGIBesVCbVg90H21EOLACvtfcHk0ljFZCO1Xba3eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D&md5=51d1021e8be93014f0b15a61db241392</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901514-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901514-9%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DCarini%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3Dbeta-Amyloid%2520aggregation%2520induced%2520by%2520human%2520acetylcholinesterase%253A%2520inhibition%2520studies%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D65%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Bolognesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-β aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049156q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=24-27&author=M.+Bolognesiauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=R.+Banziauthor=C.+Melchiorre&title=Propidium-based+polyamine+ligands+as+potent+inhibitors+of+acetylcholinesterase+and+acetylcholinesterase-induced+amyloid-%CE%B2+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm049156q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049156q%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBanzi%26aufirst%3DR.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DPropidium-based%2520polyamine%2520ligands%2520as%2520potent%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520amyloid-%25CE%25B2%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D24%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span> </span><span class="NLM_article-title">Searching for the multi-target-directed ligands against Alzheimer’s disease: discovery of quinoxaline-based hybrid compounds with AChE, H<sub>3</sub>R and BACE 1 inhibitory activities</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7158</span><span class="NLM_x">–</span> <span class="NLM_lpage">7167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=7158-7167&author=W.+Huangauthor=L.+Tangauthor=Y.+Shiauthor=S.+Huangauthor=L.+Xuauthor=R.+Shengauthor=P.+Wuauthor=J.+Liauthor=N.+Zhouauthor=Y.+Hu&title=Searching+for+the+multi-target-directed+ligands+against+Alzheimer%E2%80%99s+disease%3A+discovery+of+quinoxaline-based+hybrid+compounds+with+AChE%2C+H3R+and+BACE+1+inhibitory+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DSearching%2520for%2520the%2520multi-target-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520discovery%2520of%2520quinoxaline-based%2520hybrid%2520compounds%2520with%2520AChE%252C%2520H3R%2520and%2520BACE%25201%2520inhibitory%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D7158%26epage%3D7167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, R.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer’s disease therapy</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4717</span><span class="NLM_x">–</span> <span class="NLM_lpage">4725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4717-4725&author=Y.+Liauthor=P.+Pengauthor=L.+Tangauthor=Y.+Huauthor=Y.+Huauthor=R.+Sheng&title=Design%2C+synthesis+and+evaluation+of+rivastigmine+and+curcumin+hybrids+as+site-activated+multitarget-directed+ligands+for+Alzheimer%E2%80%99s+disease+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520rivastigmine%2520and%2520curcumin%2520hybrids%2520as%2520site-activated%2520multitarget-directed%2520ligands%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4717%26epage%3D4725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcclymont, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Inhibition of acetylcholinesterase, β-amyloid aggregation, and NMDA receptors in Alzheimer’s disease: a promising direction for the multi-target-directed ligands gold rush</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4381</span><span class="NLM_x">–</span> <span class="NLM_lpage">4384</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800577j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4381-4384&author=M.+Rosiniauthor=E.+Simoniauthor=M.+Bartoliniauthor=A.+Cavalliauthor=L.+Ceccariniauthor=N.+Pascuauthor=D.+W.+Mcclymontauthor=A.+Tarozziauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=V.+Tumiattiauthor=V.+Andrisanoauthor=I.+R.+Mellorauthor=C.+Melchiorre&title=Inhibition+of+acetylcholinesterase%2C+%CE%B2-amyloid+aggregation%2C+and+NMDA+receptors+in+Alzheimer%E2%80%99s+disease%3A+a+promising+direction+for+the+multi-target-directed+ligands+gold+rush"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm800577j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800577j%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DCeccarini%26aufirst%3DL.%26aulast%3DPascu%26aufirst%3DN.%26aulast%3DMcclymont%26aufirst%3DD.%2BW.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DMellor%26aufirst%3DI.%2BR.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DInhibition%2520of%2520acetylcholinesterase%252C%2520%25CE%25B2-amyloid%2520aggregation%252C%2520and%2520NMDA%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520promising%2520direction%2520for%2520the%2520multi-target-directed%2520ligands%2520gold%2520rush%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4381%26epage%3D4384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Muñoz-Ruiz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Palomero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorronsoro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Monte-Millán, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenzuela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usán, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Austria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7223</span><span class="NLM_x">–</span> <span class="NLM_lpage">7233</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7223-7233&author=P.+Mu%C3%B1oz-Ruizauthor=L.+Rubioauthor=E.+Garc%C3%ADa-Palomeroauthor=I.+Dorronsoroauthor=M.+del+Monte-Mill%C3%A1nauthor=R.+Valenzuelaauthor=P.+Us%C3%A1nauthor=C.+de+Austriaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=A.+Bidon-Chanalauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=M.+Medinaauthor=A.+Mart%C3%ADnez&title=Design%2C+synthesis%2C+and+biological+evaluation+of+dual+binding+site+acetylcholinesterase+inhibitors%3A+new+disease-modifying+agents+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm0503289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503289%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Ruiz%26aufirst%3DP.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3Ddel%2BMonte-Mill%25C3%25A1n%26aufirst%3DM.%26aulast%3DValenzuela%26aufirst%3DR.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3Dde%2BAustria%26aufirst%3DC.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitors%253A%2520new%2520disease-modifying%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7223%26epage%3D7233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valgimigli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compounds against Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6446</span><span class="NLM_x">–</span> <span class="NLM_lpage">6449</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701225u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6446-6449&author=M.+L.+Bolognesiauthor=A.+Cavalliauthor=L.+Valgimigliauthor=M.+Bartoliniauthor=M.+Rosiniauthor=V.+Andrisanoauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+drug+design+strategy%3A+from+a+dual+binding+site+acetylcholinesterase+inhibitor+to+a+trifunctional+compounds+against+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm701225u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701225u%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DValgimigli%26aufirst%3DL.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520drug%2520design%2520strategy%253A%2520from%2520a%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitor%2520to%2520a%2520trifunctional%2520compounds%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6446%26epage%3D6449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">960</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=960-967&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=From+dual+binding+site+acetylcholinesterase+inhibitors+to+multi-target-directed+ligands+%28MTDLs%29%3A+a+step+forward+in+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DFrom%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitors%2520to%2520multi-target-directed%2520ligands%2520%2528MTDLs%2529%253A%2520a%2520step%2520forward%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D960%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Z.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.-Z.</span><span> </span><span class="NLM_article-title">Bis(9)-(−)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2013&pages=138-143&author=T.+Liuauthor=Z.+Xiaauthor=W.-W.+Zhangauthor=J.+Xuauthor=X.-X.+Geauthor=J.+Liauthor=Y.+Cuiauthor=Z.-B.+Qiuauthor=J.+Xuauthor=Q.+Xieauthor=H.+Wangauthor=H.-Z.+Chen&title=Bis%289%29-%28%E2%88%92%29-nor-meptazinol+as+a+novel+dual-binding+AChEI+potently+ameliorates+scopolamine-induced+cognitive+deficits+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.-W.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DX.-X.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DZ.-B.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.-Z.%26atitle%3DBis%25289%2529-%2528%25E2%2588%2592%2529-nor-meptazinol%2520as%2520a%2520novel%2520dual-binding%2520AChEI%2520potently%2520ameliorates%2520scopolamine-induced%2520cognitive%2520deficits%2520in%2520mice%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2013%26volume%3D104%26spage%3D138%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeloni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrelia, S.</span><span> </span><span class="NLM_article-title">Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1003</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=997-1003&author=A.+Minariniauthor=A.+Milelliauthor=V.+Tumiattiauthor=M.+Rosiniauthor=E.+Simoniauthor=M.+L.+Bolognesiauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=E.+Motoriauthor=C.+Angeloniauthor=S.+Hrelia&title=Cystamine-tacrine+dimer%3A+a+new+multi-target-directed+ligand+as+potential+therapeutic+agent+for+Alzheimer%E2%80%99s+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMotori%26aufirst%3DE.%26aulast%3DAngeloni%26aufirst%3DC.%26aulast%3DHrelia%26aufirst%3DS.%26atitle%3DCystamine-tacrine%2520dimer%253A%2520a%2520new%2520multi-target-directed%2520ligand%2520as%2520potential%2520therapeutic%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D997%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Holmquist, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuchbury, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berbaum, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muscat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hager, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Münch, G.</span><span> </span><span class="NLM_article-title">Lipoic acid as a novel treatment for Alzheimer’s disease and related dementias</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2Fj.pharmthera.2006.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=16989905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFCkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2007&pages=154-164&author=L.+Holmquistauthor=G.+Stuchburyauthor=K.+Berbaumauthor=S.+Muscatauthor=S.+Youngauthor=K.+Hagerauthor=J.+Engelauthor=G.+M%C3%BCnch&title=Lipoic+acid+as+a+novel+treatment+for+Alzheimer%E2%80%99s+disease+and+related+dementias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Lipoic acid as a novel treatment for Alzheimer's disease and related dementias</span></div><div class="casAuthors">Holmquist, Lina; Stuchbury, Grant; Berbaum, Katrin; Muscat, Sonja; Young, Simon; Hager, Klaus; Engel, Juergen; Muench, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154-164</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder that destroys patient memory and cognition, communication ability with the social environment and the ability to carry out daily activities.  Despite extensive research into the pathogenesis of AD, a neuroprotective treatment - particularly for the early stages of disease - remains unavailable for clin. use.  In this review, we advance the suggestion that lipoic acid (LA) may fulfil this therapeutic need.  A naturally occurring precursor of an essential cofactor for mitochondrial enzymes, including pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH), LA has been shown to have a variety of properties which can interfere with pathogenic principles of AD.  For example, LA increases acetylcholine (ACh) prodn. by activation of choline acetyltransferase and increases glucose uptake, thus supplying more acetyl-CoA for the prodn. of ACh.  LA chelates redox-active transition metals, thus inhibiting the formation of hydroxyl radicals and also scavenges reactive oxygen species (ROS), thereby increasing the levels of reduced glutathione.  Via the same mechanisms, downregulation redox-sensitive inflammatory processes is also achieved.  Furthermore, LA can scavenge lipid peroxidn. products such as hydroxynonenal and acrolein.  The reduced form of LA, dihydrolipoic acid (DHLA), is the active compd. responsible for most of these beneficial effects.  R-α-LA can be applied instead of DHLA, as it is reduced by mitochondrial lipoamide dehydrogenase, a part of the PDH complex.  In this review, the properties of LA are explored with particular emphasis on how this agent, particularly the R-α-enantiomer, may be effective to treat AD and related dementias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcoiEDmF4ru7Vg90H21EOLACvtfcHk0liaBaZZPrFAYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFCkug%253D%253D&md5=9de980ce1a7f7c2b1c13ed92e36d9b5f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DHolmquist%26aufirst%3DL.%26aulast%3DStuchbury%26aufirst%3DG.%26aulast%3DBerbaum%26aufirst%3DK.%26aulast%3DMuscat%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DHager%26aufirst%3DK.%26aulast%3DEngel%26aufirst%3DJ.%26aulast%3DM%25C3%25BCnch%26aufirst%3DG.%26atitle%3DLipoic%2520acid%2520as%2520a%2520novel%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520dementias%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D113%26spage%3D154%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1269-1274&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=Lipoic+acid%2C+a+lead+structure+for+multi-target-directed+drugs+for+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DLipoic%2520acid%252C%2520a%2520lead%2520structure%2520for%2520multi-target-directed%2520drugs%2520for%2520neurodegeneration%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1269%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">MTDL design strategy in the context of Alzheimer’s disease: from lipocrine to memoquin and beyond</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F138161209787315585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=19199985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=601-613&author=M.+L.+Bolognesiauthor=M.+Rosiniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=A.+Minariniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=MTDL+design+strategy+in+the+context+of+Alzheimer%E2%80%99s+disease%3A+from+lipocrine+to+memoquin+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond</span></div><div class="casAuthors">Bolognesi, M. L.; Rosini, M.; Andrisano, V.; Bartolini, M.; Minarini, A.; Tumiatti, V.; Melchiorre, C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">601-613</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The multifunctional nature of Alzheimer's disease (AD) provides the logical foundation for the development of an innovative drug design strategy centered on multi-target-directed-ligands (MTDLs).  In recent years, the MTDL concept has been exploited to design different ligands hitting different biol. targets.  Our first rationally designed MTDL was the polyamine caproctamine (1), which provided a synergistic cholinergic action against AD by antagonizing muscarinic M2 autoreceptors and inhibiting acetylcholinesterase (AChE).  Lipocrine (7) represented the next step in our research.  Due to its ability to inhibit AChE catalytic and non-catalytic functions together with oxidative stress, 7 emerged as an interesting pharmacol. tool for investigating the neurodegenerative mechanism underlying AD.  Memoquin (9) is a quinone-bearing polyamine endowed with a unique multifunctional profile.  With its development, we arrived at the proof of concept of the MTDL drug discovery approach.  Expts. in vitro and in vivo confirmed its multimodal mechanisms of action and its interaction with different end-points of the neurotoxic cascade leading to AD.  More recently, the MTDL approach led to carbacrine (12).  In addn. to the multiple activities displayed by 7, 12 displayed an interesting modulation of NMDA receptor activity.  The pivotal role played by this target in AD pathogenesis suggests that 12 may be a promising new chem. entity in the MTDL gold rush.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3C4yyVzh8SrVg90H21EOLACvtfcHk0liaBaZZPrFAYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSns7o%253D&md5=28c160f9fa0b9cbb16403d14aab2cf3d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.2174%2F138161209787315585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787315585%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMTDL%2520design%2520strategy%2520in%2520the%2520context%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520from%2520lipocrine%2520to%2520memoquin%2520and%2520beyond%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D601%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Memoquin: A multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer’s disease</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=152-162&author=M.+L.+Bolognesiauthor=A.+Cavalliauthor=C.+Melchiorre&title=Memoquin%3A+A+multi-target-directed+ligand+as+an+innovative+therapeutic+opportunity+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMemoquin%253A%2520A%2520multi-target-directed%2520ligand%2520as%2520an%2520innovative%2520therapeutic%2520opportunity%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D152%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020120c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Miskolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+Youdimauthor=M.+Weinstock&title=Novel+dual+inhibitors+of+AChE+and+MAO+derived+from+hydroxy+aminoindan+and+phenethylamine+as+potential+treatment+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm020120c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020120c%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520dual%2520inhibitors%2520of%2520AChE%2520and%2520MAO%2520derived%2520from%2520hydroxy%2520aminoindan%2520and%2520phenethylamine%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5260%26epage%3D5279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yogev-Falach, M.</span><span> </span><span class="NLM_article-title">Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective- neurorescue drugs: ladostigil</span> <span class="citation_source-journal">Neurotoxic. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1007%2FBF03033355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=17197368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFekt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=181-192&author=M.+B.+Youdimauthor=T.+Amitauthor=O.+Bar-Amauthor=O.+Weinrebauthor=M.+Yogev-Falach&title=Implications+of+co-morbidity+for+etiology+and+treatment+of+neurodegenerative+diseases+with+multifunctional+neuroprotective-+neurorescue+drugs%3A+ladostigil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil</span></div><div class="casAuthors">Youdim, Moussa B. H.; Amit, Tamar; Bar-Am, Orit; Weinreb, Orly; Yogev-Falach, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3,4</span>),
    <span class="NLM_cas:pages">181-192</span>CODEN:
                <span class="NLM_cas:coden">NURRFI</span>;
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    
            (<span class="NLM_cas:orgname">F. P. Graham Publishing Co.</span>)
        </div><div class="casAbstract">A review.  The recent therapeutic approach in which drug candidates are designed to possess diverse pharmacol. properties and act on multiple targets has stimulated the development of several multifunction drugs.  These include ladostigil (TV3326) [(N-propargyl-(3R) aminoindan-5yl)-Et Me carbamate], which combines the pharmacophore-neuroprotective effects of rasagiline, a selective monoamine oxidase (MAO)-B inhibitor, with the cholinesterase (ChE) inhibitory activity of rivastigmine or iron chelating moiety such as M30.  In the case of M30 the pharmacophore of brain permeable iron chelator VK-28 plus the MAO inhibitor-neuroprotective propargylamine moiety of rasagiline are combined in a single mol. as a potential treatment for Alzheimer's disease, Lewy body disease, and Parkinson's disease with dementia.  Here, we discuss the activities of ladostigil in terms of its cholinesterase cognitive enhancing potential, antiParkinson, antidepressant, neuroprotection and APP (amyloid precursor protein) processing potential.  One major attribute of ladostigil is its neuroprotective activity in neuronal cell cultures and in vivo.  Employing an apoptotic model of neuroblastoma SK-N-SH cells, the mol. mechanism of its neuroprotective activity has been detd.  The current studies show that ladostigil significantly decreased apoptosis via inhibition of the cleavage and prevention of caspase-3 activation through a mechanism related to regulation of the Bcl-2 family proteins, resulting in reduced levels of Bad and Bax and induced levels of Bcl-2.  In addn., ladostigil elevated the levels of pPKC(pan).  We have also followed the regulation of APP processing and found that ladostigil markedly decreased apoptotic-induced levels of holo-APP, as well as stimulated the release of the non-amyloidogenic sol. APP (sAPPα) into the conditioned medium via a established protein kinsae c-MAPkinase dependent pathway.  Similar to ladostigil, its S-isomer, TV3279, which is a ChE inhibitor lacking MAO inhibitory activity, exerted similar neuroprotective properties and APP processing, suggesting that the mode of action is independent of MAO inhibition.  These effects were shown to reside in the propargylamine moiety.  These findings indicate that the dual actions of the anti-apoptotic-neuroprotective activity and the ability to modulate APP processing, could make ladostigil a potentially valuable drug for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpywM2IsMu1OLVg90H21EOLACvtfcHk0lgQhicpVjUGWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFekt70%253D&md5=58ba89f08e3eb4afdb5d602265baf060</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2FBF03033355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03033355%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DYogev-Falach%26aufirst%3DM.%26atitle%3DImplications%2520of%2520co-morbidity%2520for%2520etiology%2520and%2520treatment%2520of%2520neurodegenerative%2520diseases%2520with%2520multifunctional%2520neuroprotective-%2520neurorescue%2520drugs%253A%2520ladostigil%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2006%26volume%3D10%26spage%3D181%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2013&pages=893-902&author=I.+Boleaauthor=A.+Gellaauthor=M.+Unzeta&title=Propargylamine-derived+multitarget-directed+ligands%3A+fighting+Alzheimer%E2%80%99s+disease+with+monoamine+oxidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DGella%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DPropargylamine-derived%2520multitarget-directed%2520ligands%253A%2520fighting%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2013%26volume%3D120%26spage%3D893%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F092986711797379302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=21864289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4568-4587&author=L.+Pisaniauthor=M.+Cattoauthor=F.+Leonettiauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=F.+Campagnaauthor=A.+Carotti&title=Targeting+monoamine+oxidases+with+multipotent+ligands%3A+an+emerging+strategy+in+the+search+of+new+drugs+against+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases</span></div><div class="casAuthors">Pisani, L.; Catto, M.; Leonetti, F.; Nicolotti, O.; Stefanachi, A.; Campagna, F.; Carotti, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4568-4587</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The socioeconomic burden of multi-factorial pathologies, such as neurodegenerative diseases (NDs), is enormous worldwide.  Unfortunately, no proven disease-modifying therapy is available yet and in most cases (e.g., Alzheimer's and Parkinson's disease) the approved drugs exert only palliative and symptomatic effects.  Nowadays, an emerging strategy for the discovery of disease-modifying drugs is based on the multi-target directed ligand (MTDL) design, an innovative shift from the traditional approach one-drug-one-target to the more ambitious one-drug-more-targets goal.  Herein, we review the discovery strategy, the mechanism of action and the biopharmacol. evaluation of multipotent ligands exhibiting monoamine oxidase (MAO) inhibition as the core activity with a potential for the treatment of NDs.  In particular, MAO inhibitors exhibiting addnl. acetylcholinesterase (AChE) or nitric oxide synthase (NOS) inhibition, or ion chelation/antioxidant-radical scavenging/anti-inflammatory/A2A receptor antagonist/APP processing modulating activities have been thoroughly examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4N8fMdFNcwrVg90H21EOLACvtfcHk0lgQhicpVjUGWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O&md5=2463da84a1da0142e353ff9d3a354fe6</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F092986711797379302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797379302%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DTargeting%2520monoamine%2520oxidases%2520with%2520multipotent%2520ligands%253A%2520an%2520emerging%2520strategy%2520in%2520the%2520search%2520of%2520new%2520drugs%2520against%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4568%26epage%3D4587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Los Ríos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglietta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terencio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7607</span><span class="NLM_x">–</span> <span class="NLM_lpage">7610</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061047j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7607-7610&author=J.+Marco-Contellesauthor=R.+Le%C3%B3nauthor=C.+de+Los+R%C3%ADosauthor=A.+Gugliettaauthor=J.+Terencioauthor=M.+G.+L%C3%B3pezauthor=A.+G.+Garc%C3%ADaauthor=M.+Villarroya&title=Novel+multipotent+tacrine-dihydropyridine+hybrids+with+improved+acetylcholinesterase+inhibitory+and+neuroprotective+activities+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm061047j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061047j%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3Dde%2BLos%2BR%25C3%25ADos%26aufirst%3DC.%26aulast%3DGuglietta%26aufirst%3DA.%26aulast%3DTerencio%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNovel%2520multipotent%2520tacrine-dihydropyridine%2520hybrids%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520neuroprotective%2520activities%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7607%26epage%3D7610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistolozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gálvez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span> </span><span class="NLM_article-title">Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">ChemMedChem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1990</span><span class="NLM_x">–</span> <span class="NLM_lpage">1997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1990-1997&author=M.+Bartoliniauthor=M.+Pistolozziauthor=V.+Andrisanoauthor=J.+Egeaauthor=M.+G.+L%C3%B3pezauthor=I.+Iriepaauthor=I.+Moraledaauthor=E.+G%C3%A1lvezauthor=J.+Marco-Contellesauthor=A.+Samadi&title=Chemical+and+pharmacological+studies+on+enantiomerically+pure+p-methoxytacripyrines%2C+promising+multi-target-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPistolozzi%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DG%25C3%25A1lvez%26aufirst%3DE.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26atitle%3DChemical%2520and%2520pharmacological%2520studies%2520on%2520enantiomerically%2520pure%2520p-methoxytacripyrines%252C%2520promising%2520multi-target-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChemMedChem.%26date%3D2011%26volume%3D6%26spage%3D1990%26epage%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">A small molecule targeting the multifactorial nature of Alzheimer’s disease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3689-3692&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=S.+Capsoniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=E.+Margottiauthor=A.+Cattaneoauthor=M.+Recanatiniauthor=C.+Melchiorre&title=A+small+molecule+targeting+the+multifactorial+nature+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMargotti%26aufirst%3DE.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DA%2520small%2520molecule%2520targeting%2520the%2520multifactorial%2520nature%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2007%26volume%3D46%26spage%3D3689%26epage%3D3692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Lecoutey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hédou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Since, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaisier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malzert Fréon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cresteil, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span> </span><span class="NLM_article-title">Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer’s disease treatment</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">E3825</span><span class="NLM_x">–</span> <span class="NLM_lpage">E3830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E3825-E3830&author=C.+Lecouteyauthor=D.+H%C3%A9douauthor=T.+Freretauthor=P.+Giannoniauthor=F.+Gavenauthor=M.+Sinceauthor=V.+Bouetauthor=C.+Ballandonneauthor=S.+Corvaisierauthor=A.+Malzert+Fr%C3%A9onauthor=S.+Mignaniauthor=T.+Cresteilauthor=M.+Boulouardauthor=S.+Claeysenauthor=C.+Rochaisauthor=P.+Dallemagne&title=Design+of+donecopride%2C+a+dual+serotonin+subtype+4+receptor+agonist%2Facetylcholinesterase+inhibitor+with+potential+interest+for+Alzheimer%E2%80%99s+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3DSince%26aufirst%3DM.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCorvaisier%26aufirst%3DS.%26aulast%3DMalzert%2BFr%25C3%25A9on%26aufirst%3DA.%26aulast%3DMignani%26aufirst%3DS.%26aulast%3DCresteil%26aufirst%3DT.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DDallemagne%26aufirst%3DP.%26atitle%3DDesign%2520of%2520donecopride%252C%2520a%2520dual%2520serotonin%2520subtype%25204%2520receptor%2520agonist%252Facetylcholinesterase%2520inhibitor%2520with%2520potential%2520interest%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3DE3825%26epage%3DE3830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Eglen, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonhaus, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R. D.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of two novel and potent 5-HT<sub>4</sub> receptor agonists, RS67333 and RS67506, in vitro and in vivo</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">1387</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1111%2Fj.1476-5381.1995.tb16628.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=8564196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaK2MXns1Wgsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1995&pages=1387-1392&author=R.+M.+Eglenauthor=D.+W.+Bonhausauthor=L.+G.+Johnsonauthor=E.+Leungauthor=R.+D.+Clark&title=Pharmacological+characterization+of+two+novel+and+potent+5-HT4+receptor+agonists%2C+RS67333+and+RS67506%2C+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo</span></div><div class="casAuthors">Eglen, R. M.; Bonhaus, D. W.; Johnson, L. G.; Leung, E.; Clark, R. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1387-92</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">The pharmacol. of two novel 5-HT4 receptor agonists, RS 67333 (1-(4-amino-5-chloro-2-methoxy phenyl)-3-[1(n-butyl)-4-piperidinyl]-1-propanone HCl) and RS 67506 (1-(4-amino-5-chloro-2-methoxy-phenyl)-3-[1-(2-Me sulfonylamino)ethyl-4-piperidinyl]-1-propanone HCl) have been assessed in vitro and in vivo.  RS 67333 and RS 67506 exhibited affinities (pKi = 8.7 and 8.8, resp.) for the 5-HT4 binding sites, labeled with [3H]-GR 113808, in guinea-pig striatum.  The Hill coeffs. from these displacement curves were not significantly different from unity.  The compds. exhibited lower affinities (<6.0) at several other receptors including 5-HT1A, 5-HT1D, 5-HT2A, 5-HT2C, dopamine D1, D2 and muscarinic M1-M3 receptors.  However, RS 67333 and RS 67506 did exhibit affinities for the σ1 (pKi = 8.9 and 7.9, resp.) and σ2 (pKi = 8.0 and 7.3, resp.) binding sites.  At the 5-HT4 receptor mediating relaxation of the carbachol-precontracted esophagus, RS 67333 and RS 67506 acted as potent (pEC50 8.4 and 8.6, resp.) with respect to 5-HT.  Relaxant responses to RS 67333 or RS 67506 were surmountably antagonized by GR 113808 (10 nM), with apparent affinities (pKB) of 9.1 and 9.0, resp.  RS 67333 and RS 67506 induced dose-dependent increases in heart rate of the anesthetized micropig (ED50 4.9 and 5.4 μg kg-1, i.v.), with maximal increases of 35 and 47 beats min-1, resp.  RS 67333 and RS 67506, therefore, acted as potent, partial 5-HT4 receptor agonists in vitro and in vivo.  These compds., by virtue of their high potency and selectivity, may have some utility in elucidating the physiol. role of 5-HT4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzNOdCScURALVg90H21EOLACvtfcHk0lgxnpxnc3X8Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXns1Wgsrg%253D&md5=c35823f3865d177e00933fd35a779137</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb16628.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb16628.x%26sid%3Dliteratum%253Aachs%26aulast%3DEglen%26aufirst%3DR.%2BM.%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26aulast%3DJohnson%26aufirst%3DL.%2BG.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DClark%26aufirst%3DR.%2BD.%26atitle%3DPharmacological%2520characterization%2520of%2520two%2520novel%2520and%2520potent%25205-HT4%2520receptor%2520agonists%252C%2520RS67333%2520and%2520RS67506%252C%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D115%26spage%3D1387%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Lecoutey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt-Gueulle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaisier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepailleur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span> </span><span class="NLM_article-title">Synthesis of dual AChE/5-HT<sub>4</sub> receptor multi-target directed ligands</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=627-634&author=C.+Lecouteyauthor=C.+Rochaisauthor=D.+Genestauthor=S.+Butt-Gueulleauthor=C.+Ballandonneauthor=S.+Corvaisierauthor=F.+Dulinauthor=A.+Lepailleurauthor=J.+Sopkova-de+Oliveira+Santosauthor=P.+Dallemagne&title=Synthesis+of+dual+AChE%2F5-HT4+receptor+multi-target+directed+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DGenest%26aufirst%3DD.%26aulast%3DButt-Gueulle%26aufirst%3DS.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCorvaisier%26aufirst%3DS.%26aulast%3DDulin%26aufirst%3DF.%26aulast%3DLepailleur%26aufirst%3DA.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DDallemagne%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520dual%2520AChE%252F5-HT4%2520receptor%2520multi-target%2520directed%2520ligands%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D627%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Grossman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunc, K. T.</span><span> </span><span class="NLM_article-title">Development of a radioligand binding assay for 5HT<sub>4</sub> receptors in guinea pig and rat brain</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1111%2Fj.1476-5381.1993.tb13617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=8358562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFahsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1993&pages=618-624&author=C.+J.+Grossmanauthor=G.+J.+Kilpatrickauthor=K.+T.+Bunc&title=Development+of+a+radioligand+binding+assay+for+5HT4+receptors+in+guinea+pig+and+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a radioligand binding assay for 5-HT4 receptors in guinea pig and rat brain</span></div><div class="casAuthors">Grossman, C. J.; Kilpatrick, G. J.; Bunce, K. T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">618-24</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The 5-HT4 receptor antagonist, GR 113808, was radiolabeled to a high specific activity with tritium.  Characterization of specific [3H]GR 113808 binding in homogenates of guinea pig striatum and hippocampus revealed a single site of high affinity (Kd values 0.20 and 0.13 nM resp.).  [3H]GR 113808 binding was reversible and displayed rapid kinetics such that assocn. and dissocn. were complete within 3 min.  Specific [3H]GR 113808 binding was potently and stereoselectively inhibited by agonists and antagonists acting at the 5-HT4 receptor but not by compds. selective for other 5-HT receptors or other neurotransmitter receptors.  Autoradiog. anal. revealed a discrete localization in both guinea pig and rat brain with high concns. of binding in brain areas such as the striatum, substantia nigra and olfactory tubercle.  [3H]GR 113808 binding to homogenates of guinea pig striatum meets the criteria for labeling of the 5-HT4 receptor and, as such, represents the first characterization of this receptor in a radioligand binding assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1U7Xw7D_scrVg90H21EOLACvtfcHk0lhwCOejsLn2bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFahsLo%253D&md5=e56f6af24f3c2284620f86142af11e45</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1993.tb13617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1993.tb13617.x%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DC.%2BJ.%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26aulast%3DBunc%26aufirst%3DK.%2BT.%26atitle%3DDevelopment%2520of%2520a%2520radioligand%2520binding%2520assay%2520for%25205HT4%2520receptors%2520in%2520guinea%2520pig%2520and%2520rat%2520brain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D109%26spage%3D618%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Cheung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burshteyn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Height, J. J.</span><span> </span><span class="NLM_article-title">Structures of human acetylcholinesterase in complex with pharmacologically important ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10282</span><span class="NLM_x">–</span> <span class="NLM_lpage">10286</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300871x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10282-10286&author=J.+Cheungauthor=M.+J.+Rudolphauthor=F.+Burshteynauthor=M.+S.+Cassidyauthor=E.+N.+Garyauthor=J.+Loveauthor=M.+C.+Franklinauthor=J.+J.+Height&title=Structures+of+human+acetylcholinesterase+in+complex+with+pharmacologically+important+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands</span></div><div class="casAuthors">Cheung, Jonah; Rudolph, Michael J.; Burshteyn, Fiana; Cassidy, Michael S.; Gary, Ebony N.; Love, James; Franklin, Matthew C.; Height, Jude J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10282-10286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human acetylcholinesterase (AChE) is a significant target for therapeutic drugs.  Here we present high resoln. crystal structures of human AChE, alone and in complexes with drug ligands; donepezil, an Alzheimer's disease drug, binds differently to human AChE than it does to Torpedo AChE.  These crystals of human AChE provide a more accurate platform for further drug development than previously available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdjhYPmZBMf7Vg90H21EOLACvtfcHk0lhwCOejsLn2bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN&md5=c27461e0288f42ac96af354cbefd387e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm300871x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300871x%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DM.%2BJ.%26aulast%3DBurshteyn%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DM.%2BS.%26aulast%3DGary%26aufirst%3DE.%2BN.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DHeight%26aufirst%3DJ.%2BJ.%26atitle%3DStructures%2520of%2520human%2520acetylcholinesterase%2520in%2520complex%2520with%2520pharmacologically%2520important%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10282%26epage%3D10286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Dubost, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt-Gueulle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charnay, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cailly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabis, F.</span><span> </span><span class="NLM_article-title">Synthesis and structure-affinity relationships of selective high-affinity 5-HT<sub>4</sub> receptor antagonists: application to the design of new potential single photon emission computed tomography (SPECT) tracers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9693</span><span class="NLM_x">–</span> <span class="NLM_lpage">9707</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300943r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9693-9707&author=E.+Dubostauthor=N.+Dumasauthor=C.+Fosseyauthor=R.+Magnelliauthor=S.+Butt-Gueulleauthor=C.+Ballandonneauthor=D.+Caignardauthor=F.+Dulinauthor=J.+Sopkova-de+Oliveira+Santosauthor=P.+Milletauthor=Y.+Charnayauthor=S.+Raultauthor=T.+Caillyauthor=F.+Fabis&title=Synthesis+and+structure-affinity+relationships+of+selective+high-affinity+5-HT4+receptor+antagonists%3A+application+to+the+design+of+new+potential+single+photon+emission+computed+tomography+%28SPECT%29+tracers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm300943r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300943r%26sid%3Dliteratum%253Aachs%26aulast%3DDubost%26aufirst%3DE.%26aulast%3DDumas%26aufirst%3DN.%26aulast%3DFossey%26aufirst%3DC.%26aulast%3DMagnelli%26aufirst%3DR.%26aulast%3DButt-Gueulle%26aufirst%3DS.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCaignard%26aufirst%3DD.%26aulast%3DDulin%26aufirst%3DF.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DMillet%26aufirst%3DP.%26aulast%3DCharnay%26aufirst%3DY.%26aulast%3DRault%26aufirst%3DS.%26aulast%3DCailly%26aufirst%3DT.%26aulast%3DFabis%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520structure-affinity%2520relationships%2520of%2520selective%2520high-affinity%25205-HT4%2520receptor%2520antagonists%253A%2520application%2520to%2520the%2520design%2520of%2520new%2520potential%2520single%2520photon%2520emission%2520computed%2520tomography%2520%2528SPECT%2529%2520tracers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9693%26epage%3D9707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1258</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1126%2Fscience.1150577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=17962520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1258-1265&author=V.+Cherezovauthor=D.+M.+Rosenbaumauthor=M.+A.+Hansonauthor=S.+G.+Rasmussenauthor=F.+S.+Thianauthor=T.+S.+Kobilkaauthor=H.+J.+Choiauthor=P.+Kuhnauthor=W.+I.+Weisauthor=B.+K.+Kobilkaauthor=R.+C.+Stevens&title=High-resolution+crystal+structure+of+an+engineered+human+beta2-adrenergic+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein-Coupled Receptor</span></div><div class="casAuthors">Cherezov, Vadim; Rosenbaum, Daniel M.; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Kuhn, Peter; Weis, William I.; Kobilka, Brian K.; Stevens, Raymond C.; Takeda, S.; Kadowaki, S.; Haga, T.; Takaesu, H.; Mitaku, S.; Fredriksson, R.; Lagerstrom, M. C.; Lundin, L. G.; Schioth, H. B.; Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J.; Lefkowitz, R. J.; Shenoy, S. K.; Rosenbaum, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">5854</span>),
    <span class="NLM_cas:pages">1258-1265</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Second extracellular loop, which in the β2-adrenergic receptor contains an unusual pair of disulfide bonds and an extra helix.  This loop and the absence Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors constitute the largest family of eukaryotic signal transduction proteins that communicate across the membrane.  We report the crystal structure of a human β2-adrenergic receptor-T4 lysozyme fusion protein bound to the partial inverse agonist carazolol at 2.4 angstrom resoln.  The structure provides a high-resoln. view of a human G protein-coupled receptor bound to a diffusible ligand.  Ligand-binding site accessibility is enabled by the second extracellular loop, which is held out of the binding cavity by a pair of closely spaced disulfide bridges and a short helical segment within the loop.  Cholesterol, a necessary component for crystn., mediates an intriguing parallel assocn. of receptor mols. in the crystal lattice.  Although the location of carazolol in the β2-adrenergic receptor is very similar to that of retinal in rhodopsin, structural differences in the ligand-binding site and other regions highlight the challenges in using rhodopsin as a template model for this large receptor family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC-8wZ2k2GHLVg90H21EOLACvtfcHk0ljcoN5TFfmH5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I&md5=12c5bacb8464a4b243fe9341192b5b3b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1126%2Fscience.1150577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1150577%26sid%3Dliteratum%253Aachs%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DHigh-resolution%2520crystal%2520structure%2520of%2520an%2520engineered%2520human%2520beta2-adrenergic%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1258%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Vickery, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beattie, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulido-Rios, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, P. P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A. M.</span><span> </span><span class="NLM_article-title">A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT<sub>4</sub> receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1038%2Fsj.bjp.0707154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=17293885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFCqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2007&pages=782-791&author=R.+G.+Vickeryauthor=N.+Maiauthor=E.+Kaufmanauthor=D.+T.+Beattieauthor=T.+Pulido-Riosauthor=M.+O%E2%80%99Keefeauthor=P.+P.+A.+Humphreyauthor=J.+A.+M.+Smith&title=A+comparison+of+the+pharmacological+properties+of+guinea-pig+and+human+recombinant+5-HT4+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors</span></div><div class="casAuthors">Vickery, R. G.; Mai, N.; Kaufman, E.; Beattie, D. T.; Pulido-Rios, T.; O'Keefe, M.; Humphrey, P. P. A.; Smith, J. A. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">782-791</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">5-HT4 receptor agonists are used therapeutically to treat disorders of reduced gastrointestinal motility.  Since such compds. are evaluated in guinea-pigs, we cloned, expressed and pharmacol. characterized the guinea-pig 5-HT4 and human 5-HT4(b) splice variant, which share 95% homol.  The functional properties of guinea-pig 5-HT4(b) receptors were compared with native receptors in guinea-pig colon.  Membrane radioligand binding and whole cell cAMP accumulation assays were used to det. the affinities, potencies and intrinsic activities (IA).  Contraction of the guinea-pig distal colon longitudinal muscle myenteric plexus prepn. (LMMP) was monitored to evaluate functional activity.  PKi values for guinea-pig and human recombinant receptors, and guinea-pig striatum 5-HT4 receptors, were in agreement, as were the potency and IA values for guinea-pig and human 5-HT4 receptors expressed at a similar d. (∼0.2 pmol mg-1 protein).  Tegaserod was a potent (pEC50 = 8.4 and 8.7, resp.), full agonist at both guinea-pig and human 5-HT4 receptors.  In contrast, in the LMMP prepn., tegaserod was a potent, partial agonist (pEC50 = 8.2; IA = 66%).  Close agreement between the pharmacol. properties of guinea-pig and human 5-HT4 receptors support the use of guinea-pig model systems for the identification of 5-HT4 receptor therapeutics.  However, the mechanisms underlying the different agonist properties of tegaserod in recombinant and isolated tissue prepns., and the extent to which these impact the clin. efficacy of tegaserod as a prokinetic agent, remain to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq03Zcp7vtSSrVg90H21EOLACvtfcHk0ljcoN5TFfmH5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFCqtLk%253D&md5=e0e8293735f8a2faa4085374bc4e9ff9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707154%26sid%3Dliteratum%253Aachs%26aulast%3DVickery%26aufirst%3DR.%2BG.%26aulast%3DMai%26aufirst%3DN.%26aulast%3DKaufman%26aufirst%3DE.%26aulast%3DBeattie%26aufirst%3DD.%2BT.%26aulast%3DPulido-Rios%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DM.%26aulast%3DHumphrey%26aufirst%3DP.%2BP.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%2BM.%26atitle%3DA%2520comparison%2520of%2520the%2520pharmacological%2520properties%2520of%2520guinea-pig%2520and%2520human%2520recombinant%25205-HT4%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D150%26spage%3D782%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawant-Basak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waizumi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papanikolaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutzman-Engwall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubitski, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span> </span><span class="NLM_article-title">Identification of multiple 5-HT<sub>4</sub> partial agonist clinical candidates for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9240</span><span class="NLM_x">–</span> <span class="NLM_lpage">9254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300953p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9240-9254&author=M.+A.+Brodneyauthor=D.+E.+Johnsonauthor=A.+Sawant-Basakauthor=K.+J.+Coffmanauthor=E.+M.+Drummondauthor=E.+L.+Hudsonauthor=K.+E.+Fisherauthor=H.+Noguchiauthor=N.+Waizumiauthor=L.+L.+McDowellauthor=A.+Papanikolaouauthor=B.+A.+Pettersenauthor=A.+W.+Schmidtauthor=E.+Tsengauthor=K.+Stutzman-Engwallauthor=D.+M.+Rubitskiauthor=M.+A.+Vanase-Frawleyauthor=S.+Grimwood&title=Identification+of+multiple+5-HT4+partial+agonist+clinical+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm300953p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300953p%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DSawant-Basak%26aufirst%3DA.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DDrummond%26aufirst%3DE.%2BM.%26aulast%3DHudson%26aufirst%3DE.%2BL.%26aulast%3DFisher%26aufirst%3DK.%2BE.%26aulast%3DNoguchi%26aufirst%3DH.%26aulast%3DWaizumi%26aufirst%3DN.%26aulast%3DMcDowell%26aufirst%3DL.%2BL.%26aulast%3DPapanikolaou%26aufirst%3DA.%26aulast%3DPettersen%26aufirst%3DB.%2BA.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DStutzman-Engwall%26aufirst%3DK.%26aulast%3DRubitski%26aufirst%3DD.%2BM.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DGrimwood%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520multiple%25205-HT4%2520partial%2520agonist%2520clinical%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9240%26epage%3D9254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F1568007043482615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=14965243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=39-51&author=J.+Bockaertauthor=S.+Claeysenauthor=V.+Companauthor=A.+Dumuis&title=5-HT4+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptors</span></div><div class="casAuthors">Bockaert, J.; Claeysen, S.; Compan, V.; Dumuis, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-51</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin 4 receptors (5-HT4Rs) were discovered 15 yr ago.  They are coded by a very complex gene (700Kb, 38 exons) which generates 8 C-terminal variants (a, b, c, d, e, f, g, and n).  Their sequences differ after position L358.  Another variant is characterized by a 14 residue insertion within the extracellular loop 2.  Highly selective potent 5-HT4 receptor antagonists and partial agonists which cross the blood-brain barrier have been synthesized, but a specific full agonist for brain studies is still missing.  Based on physiol. and behavioral expts., 5-HT4Rs may be targets to treat cognitive deficits, abdominal pain, and feeding disorders.  One 5-HT4R-directed drug (SL65.0155) is already in phase II to treat patients suffering from memory deficits or dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemFXFD0xNLrVg90H21EOLACvtfcHk0ljcoN5TFfmH5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D&md5=b9139c95c9d832dd89b51d45fc3bde96</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.2174%2F1568007043482615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482615%26sid%3Dliteratum%253Aachs%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT4%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D39%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, J. H.</span><span> </span><span class="NLM_article-title">Very fast empirical prediction and rationalization of protein pKa values</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=704-721&author=H.+Liauthor=A.+D.+Robertsonauthor=J.+H.+Jensen&title=Very+fast+empirical+prediction+and+rationalization+of+protein+pKa+values"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DVery%2520fast%2520empirical%2520prediction%2520and%2520rationalization%2520of%2520protein%2520pKa%2520values%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2005%26volume%3D61%26spage%3D704%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Vagedes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Åqvist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marelius, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, E.-W.</span><span> </span><span class="NLM_article-title">The deacylation step of acetylcholinesterase: computer simulation studies</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">12254</span><span class="NLM_x">–</span> <span class="NLM_lpage">12262</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0004581" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=12254-12262&author=P.+Vagedesauthor=B.+Rabensteinauthor=J.+%C3%85qvistauthor=J.+Mareliusauthor=E.-W.+Knapp&title=The+deacylation+step+of+acetylcholinesterase%3A+computer+simulation+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fja0004581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0004581%26sid%3Dliteratum%253Aachs%26aulast%3DVagedes%26aufirst%3DP.%26aulast%3DRabenstein%26aufirst%3DB.%26aulast%3D%25C3%2585qvist%26aufirst%3DJ.%26aulast%3DMarelius%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DE.-W.%26atitle%3DThe%2520deacylation%2520step%2520of%2520acetylcholinesterase%253A%2520computer%2520simulation%2520studies%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D12254%26epage%3D12262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Fragkouli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papatheodoropoulos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamatakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stylianopoulou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsilibary, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzinia, A. K.</span><span> </span><span class="NLM_article-title">Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over-expressing MMP9</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1111%2Fj.1471-4159.2011.07637.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=22192143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVKlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2012&pages=239-251&author=A.+Fragkouliauthor=C.+Papatheodoropoulosauthor=S.+Georgopoulosauthor=A.+Stamatakisauthor=F.+Stylianopoulouauthor=E.+C.+Tsilibaryauthor=A.+K.+Tzinia&title=Enhanced+neuronal+plasticity+and+elevated+endogenous+sAPP%CE%B1+levels+in+mice+over-expressing+MMP9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over-expressing MMP9</span></div><div class="casAuthors">Fragkouli, Apostolia; Papatheodoropoulos, Costas; Georgopoulos, Spiros; Stamatakis, Antonios; Stylianopoulou, Fotini; Tsilibary, Effie C.; Tzinia, Athina K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">239-251</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Evidence accumulating during the past few years points to a significant role of matrix metalloproteinase 9 (MMP9) enzymic activity in synaptic plasticity and cognitive processes.  We have previously demonstrated that MMP9 is involved in receptor-mediated α-secretase-like cleavage of APP in vitro, resulting in increased secretion of sAPPα, the sol. N-terminal product of the non-amyloidogenic pathway known to be involved in neuronal plasticity and memory formation.  To study the in vivo role of MMP9, we have generated transgenic mice over-expressing MMP9 in the brain.  Herein, we demonstrate that MMP9 transgenic animals display enhanced performance in the non-spatial novel object recognition and the spatial water-maze task and that their enhanced performance was accompanied by increased dendritic spine d. in the hippocampus and cortex following behavioral testing.  Consistent with the above observations, the electrophysiol. anal. revealed prolonged maintenance of long-term synaptic potentiation in hippocampal slices from MMP9 transgenic mice.  Moreover, elevated sAPPα levels in the hippocampus and cortex of MPP9 transgenic animals were also obsd.  Overall, our results extend previous findings on the physiol. role of MMP9 in neuronal plasticity and furthermore reveal that, APP may be one of the physiol. proteolytic targets of MMP9 in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDc4s1RZXTSrVg90H21EOLACvtfcHk0lhewUJwPXdaLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVKlt7w%253D&md5=8aa95ff635c5b6342dba852c419d5238</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07637.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07637.x%26sid%3Dliteratum%253Aachs%26aulast%3DFragkouli%26aufirst%3DA.%26aulast%3DPapatheodoropoulos%26aufirst%3DC.%26aulast%3DGeorgopoulos%26aufirst%3DS.%26aulast%3DStamatakis%26aufirst%3DA.%26aulast%3DStylianopoulou%26aufirst%3DF.%26aulast%3DTsilibary%26aufirst%3DE.%2BC.%26aulast%3DTzinia%26aufirst%3DA.%2BK.%26atitle%3DEnhanced%2520neuronal%2520plasticity%2520and%2520elevated%2520endogenous%2520sAPP%25CE%25B1%2520levels%2520in%2520mice%2520over-expressing%2520MMP9%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D121%26spage%3D239%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Giannoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bundel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baranger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti-Gauthier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valjent, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span> </span><span class="NLM_article-title">Early administration of RS 67333, a specific 5-HT<sub>4</sub> receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Front. Aging Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.3389%2Ffnagi.2013.00096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=24399967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslamsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=96&author=P.+Giannoniauthor=F.+Gavenauthor=D.+de+Bundelauthor=K.+Barangerauthor=E.+Marchetti-Gauthierauthor=F.+S.+Romanauthor=E.+Valjentauthor=P.+Marinauthor=J.+Bockaertauthor=S.+Riveraauthor=S.+Claeysen&title=Early+administration+of+RS+67333%2C+a+specific+5-HT4+receptor+agonist%2C+prevents+amyloidogenesis+and+behavioral+deficits+in+the+5XFAD+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Early administration of RS67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease</span></div><div class="casAuthors">Giannoni, Patrizia; Gaven, Florence; Bundel, Dimitride; Baranger, Kevin; Marchetti-Gauthier, Evelyne; Roman, Francois S.; Valjent, Emmanuel; Marin, Philippe; Bockaert, Joeel; Rivera, Santiago; Claeysen, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Aging Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Dec.</span>),
    <span class="NLM_cas:pages">96/1-96/12</span>CODEN:
                <span class="NLM_cas:coden">FANRC5</span>;
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Amyloid β (Aβ) accumulation is considered the main culprit in the pathogenesis of Alzheimer's disease (AD).  Recent studies suggest that decreasing Aβ prodn. at very early stages of AD could be a promising strategy to slow down disease progression.  Serotonin 5-HT4 receptor activation stimulates α-cleavage of the amyloid precursor protein (APP), leading to the release of the sol. and neurotrophic sAPPα fragment and thus precluding Aβ formation.  Using the 5XFAD mouse model of AD that shows accelerated Aβ deposition, we investigated the effect of chronic treatments (treatment onset at different ages and different durations) with the 5-HT4 receptor agonist RS 67333 during the asymptomatic phase of the disease.  Chronic administration of RS 67333 decreased concomitantly the no. of amyloid plaques and the level of Aβ species.  Redn. of Aβ levels was accompanied by a striking decrease in hippocampal astrogliosis and microgliosis.  RS 67333 also transiently increased sAPPα concn. in the cerebrospinal fiuid and brain.  Moreover, a specific 5-HT4 receptor antagonist (RS 39604) prevented the RS 67333-mediated redn. of the amyloid pathol.  Finally, the novel object recognition test deficits of 5XFAD mice were reversed by chronic treatment with RS 67333.  Collectively, these results strongly highlight this 5-HT4 receptor agonist as a promising disease modifying-agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIgv-fla4yPLVg90H21EOLACvtfcHk0lhewUJwPXdaLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslamsbzJ&md5=3370afc60266e72919e21e8df93f17b4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2013.00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2013.00096%26sid%3Dliteratum%253Aachs%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3Dde%2BBundel%26aufirst%3DD.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DMarchetti-Gauthier%26aufirst%3DE.%26aulast%3DRoman%26aufirst%3DF.%2BS.%26aulast%3DValjent%26aufirst%3DE.%26aulast%3DMarin%26aufirst%3DP.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DClaeysen%26aufirst%3DS.%26atitle%3DEarly%2520administration%2520of%2520RS%252067333%252C%2520a%2520specific%25205-HT4%2520receptor%2520agonist%252C%2520prevents%2520amyloidogenesis%2520and%2520behavioral%2520deficits%2520in%2520the%25205XFAD%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2013%26volume%3D5%26spage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Tesseur, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimenova, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciesielska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Maeyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuurkes, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Hooge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Chronic 5-HT<sub>4</sub> receptor activation decreases Aβ production and deposition in hAPP/PS1 mice</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1779</span><span class="NLM_x">–</span> <span class="NLM_lpage">1789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2Fj.neurobiolaging.2013.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=23474291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFOqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1779-1789&author=I.+Tesseurauthor=A.+A.+Pimenovaauthor=A.+C.+Loauthor=M.+Ciesielskaauthor=S.+F.+Lichtenthalerauthor=J.+H.+De+Maeyerauthor=J.+A.+Schuurkesauthor=R.+D%E2%80%99Hoogeauthor=B.+De+Strooper&title=Chronic+5-HT4+receptor+activation+decreases+A%CE%B2+production+and+deposition+in+hAPP%2FPS1+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice</span></div><div class="casAuthors">Tesseur, Ina; Pimenova, Anna A.; Lo, Adrian C.; Ciesielska, Marta; Lichtenthaler, Stefan F.; De Maeyer, Joris H.; Schuurkes, Jan A. J.; D'Hooge, Rudi; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1779-1789</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Lowering the prodn. and accumulation of Aβ has been explored as treatment for Alzheimer's disease (AD), because Aβ is postulated to play an important role in the pathogenesis of AD.  5-HT4 receptors are an interesting drug target in this regard, as their activation might stimulate α-secretase processing, which increases sAPPα and reduces Aβ, at least according to the central dogma in APP processing.  Here we describe a novel high-affinity 5-HT4 receptor agonist SSP-002392 that, in cultured human neuroblastoma cells, potently increases the levels of cAMP and sAPPα at 100-fold lower concns. than the effective concns. of prucalopride, a known selective 5-HT4 receptor agonist.  Chronic administration of this compd. in a hAPP/PS1 mouse model of Alzheimer's disease decreased sol. and insol. Aβ in hippocampus, but the potential mechanisms underlying these observations seem to be complex.  We found no evidence for direct α-secretase stimulation in the brain in vivo, but obsd. decreased APP and BACE-1 expression and elevated astroglia and microglia responses.  Taken together these results provide support for a potential disease-modifying aspect when stimulating central 5-HT4 receptors; however, the complexity of the phenomena warrants further research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYF9gyZ-bbm7Vg90H21EOLACvtfcHk0lh43xrZ7VCh2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFOqsrk%253D&md5=c9d7e525100c9ef123b2c17cbd9759ba</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2013.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2013.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DTesseur%26aufirst%3DI.%26aulast%3DPimenova%26aufirst%3DA.%2BA.%26aulast%3DLo%26aufirst%3DA.%2BC.%26aulast%3DCiesielska%26aufirst%3DM.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DDe%2BMaeyer%26aufirst%3DJ.%2BH.%26aulast%3DSchuurkes%26aufirst%3DJ.%2BA.%26aulast%3DD%25E2%2580%2599Hooge%26aufirst%3DR.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DChronic%25205-HT4%2520receptor%2520activation%2520decreases%2520A%25CE%25B2%2520production%2520and%2520deposition%2520in%2520hAPP%252FPS1%2520mice%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D1779%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Clark, R. D.; Eglen, R.; Jahangir, A.; Miller, A. B.; Gardner, J. O.</span><span> </span><span class="NLM_article-title">Preparation of 1–4-aminophenyl)-ω-amino-1-alkanones as 5-HT<sub>4</sub> receptor ligands</span>.  WO 1994027965 A1, December 8,<span class="NLM_x"> </span><span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&author=R.+D.+Clark&author=R.+Eglen&author=A.+Jahangir&author=A.+B.+Miller&author=J.+O.+Gardner&title=Preparation+of+1%E2%80%934-aminophenyl%29-%CF%89-amino-1-alkanones+as+5-HT4+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BD.%26atitle%3DPreparation%2520of%25201%25E2%2580%25934-aminophenyl%2529-%25CF%2589-amino-1-alkanones%2520as%25205-HT4%2520receptor%2520ligands%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Kawakita, T.; Kuroita, T.; Murozono, T.; Hakira, H.; Haga, K.; Ito, K.; Sonda, S.; Kawahara, T.; Asano, K.</span>Benzoic acid compounds and use thereof as medicaments. US 5864039 A, January 26,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=T.+Kawakita&author=T.+Kuroita&author=T.+Murozono&author=H.+Hakira&author=K.+Haga&author=K.+Ito&author=S.+Sonda&author=T.+Kawahara&author=K.+Asano&title=Benzoic+acid+compounds+and+use+thereof+as+medicaments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKawakita%26aufirst%3DT.%26jtitle%3DBenzoic%2520acid%2520compounds%2520and%2520use%2520thereof%2520as%2520medicaments%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">A short history of SHELX</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">A64</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lh43xrZ7VCh2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%26date%3D2008%26volume%3DA64%26spage%3D112%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span>SHELXL2014; <span class="NLM_publisher-name">University of Göttingen</span>: <span class="NLM_publisher-loc">Göttingen, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=G.+M.+Sheldrick&title=SHELXL2014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26jtitle%3DSHELXL2014%26pub%3DUniversity%2520of%2520G%25C3%25B6ttingen%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Lowry, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosebrought, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farr, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, R. J.</span><span> </span><span class="NLM_article-title">Protein measurement with the folin phenol reagent</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FS0021-9258%2819%2952451-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=14907713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1951&pages=265-275&author=O.+H.+Lowryauthor=N.+J.+Rosebroughtauthor=A.+L.+Farrauthor=R.+J.+Randall&title=Protein+measurement+with+the+folin+phenol+reagent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Protein measurement with the Folin phenol reagent</span></div><div class="casAuthors">Lowry, Oliver H.; Rosebrough, Nira J.; Farr, A. Lewis; Randall, Rose J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-75</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">cf. C.A. 41, 1271h.  Proteins were detd. with the Folin phenol reagent after alk. Cu treatment.  The method is as sensitive as with Nessler reagent, yet requires no digestion.  It is 10-20 times more sensitive than detn. of the ultraviolet absorption at λ = 280 mμ and is more specific.  It is several fold more sensitive than the ninhydrin reaction and 100 times more sensitive than the biuret reaction.  Two major disadvantages are: the amt. of color varies with different proteins; the color is not strictly proportional to concn.  Few substances cause serious interference.  Uric acid, guanine, and xanthine react with Folin reagent.  The method is useful for following enzyme fractionation, detg. mixed tissue proteins, detn. of very small amts. of protein, or detg. highly dild. protein, or protein in colored solns. or in the presence of N-contg. material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHNRKGd34F8LVg90H21EOLACvtfcHk0lh43xrZ7VCh2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D&md5=19d36395fad7dd87661caa3d2b97640d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2952451-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252952451-6%26sid%3Dliteratum%253Aachs%26aulast%3DLowry%26aufirst%3DO.%2BH.%26aulast%3DRosebrought%26aufirst%3DN.%2BJ.%26aulast%3DFarr%26aufirst%3DA.%2BL.%26aulast%3DRandall%26aufirst%3DR.%2BJ.%26atitle%3DProtein%2520measurement%2520with%2520the%2520folin%2520phenol%2520reagent%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1951%26volume%3D193%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetyl-cholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=91-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetyl-cholinesterase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetyl-cholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D91%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallender, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szegletes, T.</span><span> </span><span class="NLM_article-title">A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate</span> <span class="citation_source-journal">Chem. Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">119–120</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FS0009-2797%2899%2900017-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10421442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaK1MXkvVKit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119%E2%80%93120&publication_year=1999&pages=85-97&author=T.+L.+Rosenberryauthor=W.+D.+Mallenderauthor=P.+J.+Thomasauthor=T.+Szegletes&title=A+steric+blockade+model+for+inhibition+of+acetylcholinesterase+by+peripheral+site+ligands+and+substrate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate</span></div><div class="casAuthors">Rosenberry, Terrone L.; Mallender, William D.; Thomas, Patrick J.; Szegletes, Tivadar</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">119-120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-97</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The active site gorge of acetylcholinesterase (AChE) contains two sites of ligand binding, an acylation site near the base of the gorge and a peripheral site at its mouth.  We recently introduced a steric blockade model which demonstrated that small peripheral site ligands like propidium can inhibit substrate hydrolysis simply by decreasing the substrate assocn. and dissocn. rate consts. without altering the equil. const. for substrate binding to the acylation site.  We now employ our nonequil. kinetic anal. to extend this model to include blockade of the dissocn. of substrate hydrolysis products by bound peripheral site ligand.  We also report here that acetylthiocholine can bind to the AChE peripheral site with an equil. dissocn. const. KS of about 1 mM.  This value was detd. from the effect of the acetylthiocholine concn. on the rate at which fasciculin assocs. with the peripheral site.  When substrate binding to the peripheral site is incorporated into our steric blockade model, hydrolysis rates at low substrate concn. appear to be accelerated while substrate inhibition of hydrolysis occurs at high substrate concn.  The model predicts that hydrolysis rates for substrates which equilibrate with the acylation site prior to the acylation step should not be inhibited by bound peripheral site ligand.  Organophosphates equilibrate with AChE prior to phosphorylating the active site serine residue, and as predicted propidium had little effect on the phosphorylation rate consts. for the fluorogenic organophosphate ethylmethyl-phosphonylcoumarin (EMPC).  The 2nd-order phosphorylation rate const. kOP/KOP was decreased 3-fold by a high concn. of propidium and the 1st-order rate const. kOP increased somewhat.  In contrast to propidium, when the neurotoxin fasciculin bound to the AChE peripheral site both a steric blockade and a conformational change in the acylation site appeared to occur.  With satg. fasciculin, kOP/KOP decreased by a factor of more than 750 and kOP decreased 300-fold.  These data suggest that new peripheral site ligands may be designed to have selective effects on AChE phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvzXlkBuOvcLVg90H21EOLACvtfcHk0lh0UO1yW7xCQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvVKit7Y%253D&md5=8731b3e4e833a42870412dbcffa71c25</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2899%2900017-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252899%252900017-4%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DMallender%26aufirst%3DW.%2BD.%26aulast%3DThomas%26aufirst%3DP.%2BJ.%26aulast%3DSzegletes%26aufirst%3DT.%26atitle%3DA%2520steric%2520blockade%2520model%2520for%2520inhibition%2520of%2520acetylcholinesterase%2520by%2520peripheral%2520site%2520ligands%2520and%2520substrate%26jtitle%3DChem.%2520Biol.%2520Interact.%26date%3D1999%26volume%3D119%25E2%2580%2593120%26spage%3D85%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Cheung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burshteyn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Height, J.</span><span> </span><span class="NLM_article-title">Structures of human acetylcholinesterase in complex with pharmacologically important ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10282</span><span class="NLM_x">–</span> <span class="NLM_lpage">10286</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300871x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10282-10286&author=J.+Cheungauthor=M.+J.+Rudolphauthor=F.+Burshteynauthor=M.+S.+Cassidyauthor=E.+N.+Garyauthor=J.+Loveauthor=M.+C.+Franklinauthor=J.+Height&title=Structures+of+human+acetylcholinesterase+in+complex+with+pharmacologically+important+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands</span></div><div class="casAuthors">Cheung, Jonah; Rudolph, Michael J.; Burshteyn, Fiana; Cassidy, Michael S.; Gary, Ebony N.; Love, James; Franklin, Matthew C.; Height, Jude J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10282-10286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human acetylcholinesterase (AChE) is a significant target for therapeutic drugs.  Here we present high resoln. crystal structures of human AChE, alone and in complexes with drug ligands; donepezil, an Alzheimer's disease drug, binds differently to human AChE than it does to Torpedo AChE.  These crystals of human AChE provide a more accurate platform for further drug development than previously available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdjhYPmZBMf7Vg90H21EOLACvtfcHk0lh0UO1yW7xCQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN&md5=c27461e0288f42ac96af354cbefd387e</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm300871x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300871x%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DM.%2BJ.%26aulast%3DBurshteyn%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DM.%2BS.%26aulast%3DGary%26aufirst%3DE.%2BN.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DHeight%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520human%2520acetylcholinesterase%2520in%2520complex%2520with%2520pharmacologically%2520important%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10282%26epage%3D10286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span> </span><span class="NLM_article-title">Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FS0022-2836%2895%2980037-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=7823319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1995&pages=43-53&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glen&title=Molecular+recognition+of+receptor+sites+using+a+genetic+algorithm+with+a+description+of+desolvation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of a receptor sites using a genetic algorithm with a description of desolvation</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Understanding the principles whereby macromol. biol. receptors can recognize small mol. substrates or inhibitors is the subject of a major effort.  This is of paramount importance in rational drug design where the receptor structure is known (the "docking" problem).  Current theor. approaches utilize models of the steric and electrostatic interaction of bound ligands and recently conformational flexibility has been incorporated.  The authors report results based on software using a genetic algorithm that uses an evolutionary strategy in exploring the full conformational flexibility of the ligand with partial flexibility of the protein, and which satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Results are reported on five test systems showing excellent agreement with exptl. data.  The design of the algorithm offers insight into the mol. recognition mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Xcn7nQyVRLVg90H21EOLACvtfcHk0lh0UO1yW7xCQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D&md5=bf45edafb986a73c7c1d0ac55e070f28</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2895%2980037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252895%252980037-9%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520recognition%2520of%2520receptor%2520sites%2520using%2520a%2520genetic%2520algorithm%2520with%2520a%2520description%2520of%2520desolvation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D245%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lgAgT1mC5A3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Morpugo, C.</span><span> </span><span class="NLM_article-title">A new design for the screening of CNS-active drugs in mice</span> <span class="citation_source-journal">Arzneim.-Forsch./Drug Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1727</span><span class="NLM_x">–</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1971&pages=1727-1734&author=C.+Morpugo&title=A+new+design+for+the+screening+of+CNS-active+drugs+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorpugo%26aufirst%3DC.%26atitle%3DA%2520new%2520design%2520for%2520the%2520screening%2520of%2520CNS-active%2520drugs%2520in%2520mice%26jtitle%3DArzneim.-Forsch.%252FDrug%2520Res.%26date%3D1971%26volume%3D11%26spage%3D1727%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiedeville, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span> </span><span class="NLM_article-title">Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT(4) receptor activation (RS67333) on object recognition in mice</span> <span class="citation_source-journal">Behav. Brain. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2012&pages=304-308&author=T.+Freretauthor=V.+Bouetauthor=A.+Quiedevilleauthor=G.+Neeauthor=P.+Dallemagneauthor=C.+Rochaisauthor=M.+Boulouard&title=Synergistic+effect+of+acetylcholinesterase+inhibition+%28donepezil%29+and+5-HT%284%29+receptor+activation+%28RS67333%29+on+object+recognition+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DQuiedeville%26aufirst%3DA.%26aulast%3DNee%26aufirst%3DG.%26aulast%3DDallemagne%26aufirst%3DP.%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DBoulouard%26aufirst%3DM.%26atitle%3DSynergistic%2520effect%2520of%2520acetylcholinesterase%2520inhibition%2520%2528donepezil%2529%2520and%25205-HT%25284%2529%2520receptor%2520activation%2520%2528RS67333%2529%2520on%2520object%2520recognition%2520in%2520mice%26jtitle%3DBehav.%2520Brain.%2520Res.%26date%3D2012%26volume%3D230%26spage%3D304%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Hooper, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, T.</span><span> </span><span class="NLM_article-title">Effect of purines analogues on spontaneous alternation in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1996&pages=250-257&author=N.+Hooperauthor=C.+Fraserauthor=T.+Stone&title=Effect+of+purines+analogues+on+spontaneous+alternation+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHooper%26aufirst%3DN.%26aulast%3DFraser%26aufirst%3DC.%26aulast%3DStone%26aufirst%3DT.%26atitle%3DEffect%2520of%2520purines%2520analogues%2520on%2520spontaneous%2520alternation%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D1996%26volume%3D123%26spage%3D250%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalfre, M.</span><span> </span><span class="NLM_article-title">Behavioral despair in mice: a primary screening test for antidepressants</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=596982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaE1cXktlKgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1977&pages=327-336&author=R.+D.+Porsoltauthor=A.+Bertinauthor=M.+Jalfre&title=Behavioral+despair+in+mice%3A+a+primary+screening+test+for+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral despair in mice:  a primary screening test for antidepressants</span></div><div class="casAuthors">Porsolt, R. D.; Bertin, A.; Jalfre, M.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-36</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">A depressed state can be induced in mice by forcing them to swim in a narrow cylinder from which they cannot escape.  After a brief period of vigorous activity the mice adopt a characteristic immobile posture which is readily identifiable.  Immobility was reduced by tricyclic antidepressants, monoamine oxidase inhibitors and atypical antidepressants, as well as by electroconvulsive shock.  Psychostimulants also reduced immobility but in contrast to antidepressants caused marked motor stimulation.  Immobility was not affected by minor or major tranquilizers.  These findings, closely parallel to those previously reported in rats, suggest that the procedure is selectively senstitive to antidepressant treatments.  The mouse procedure is, however, more rapid and less costly than that with rats and is thus more suitable for the primary screening of antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3THea0LRwE7Vg90H21EOLACvtfcHk0lgAgT1mC5A3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXktlKgsbs%253D&md5=70dd5706992ee8151a9801a2aeb42961</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DBertin%26aufirst%3DA.%26aulast%3DJalfre%26aufirst%3DM.%26atitle%3DBehavioral%2520despair%2520in%2520mice%253A%2520a%2520primary%2520screening%2520test%2520for%2520antidepressants%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1977%26volume%3D229%26spage%3D327%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Aguila, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulbault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léveillé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tóth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsodi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balboni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jauzac, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allouche, S.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">1312</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1038%2Fsj.bjp.0707497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=17982482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSlsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=1312-1324&author=B.+Aguilaauthor=L.+Coulbaultauthor=M.+Boulouardauthor=F.+L%C3%A9veill%C3%A9author=A.+Davisauthor=G.+T%C3%B3thauthor=A.+Borsodiauthor=G.+Balboniauthor=S.+Salvadoriauthor=P.+Jauzacauthor=S.+Allouche&title=In+vitro+and+in+vivo+pharmacological+profile+of+UFP-512%2C+a+novel+selective+delta-opioid+receptor+agonist%3B+correlations+between+desensitization+and+tolerance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo pharmacological profile of UFP-512, a novel selective δ-opioid receptor agonist; correlations between desensitization and tolerance</span></div><div class="casAuthors">Aguila, B.; Coulbault, L.; Boulouard, M.; Leveille, F.; Davis, A.; Toth, G.; Borsodi, A.; Balboni, G.; Salvadori, S.; Jauzac, P.; Allouche, S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1312-1324</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: δ-Opioid receptors (DOP receptors) could represent a novel target in the treatment of depressive disorders.  To explore this new field of interest, the development of highly selective DOP receptor agonists is essential.  UFP-512 [H-Dmt-Tic-NH-CH(CH2-COOH)-Bid], was recently shown to behave in vitro as a selective and potent DOP receptor agonist and to promote antidepressant- and anxiolytic-like effects in vivo.  Here, we have characterized the pharmacol. properties of UFP-512 and established a link between desensitization and tolerance.  Exptl. approach: Studies were performed in the human neuroblastoma SK-N-BE cells to establish (i) binding parameters for UFP-512 (ii) signaling pathways activated after acute and chronic treatment (iii) regulation (phosphorylation and trafficking) of human DOP (hDOP) receptors after sustained activation by UFP-512.  In vivo, we studied UFP-512-induced antidepressant-like effects after acute or chronic treatment in the mouse forced swimming test.  Key results: In vitro, UFP-512 was a high affinity agonist for DOP receptors.  While UFP-512 induced marked phosphorylation of DOP receptors on Ser363, we obsd. a low desensitization of the cAMP pathway, assocd. with receptor endocytosis and recycling without any redn. on extracellular signal-regulated protein kinase 1/2 activation.  In vivo, acute administration of UFP-512 produced an antidepressant-like effect, without any sign of tolerance after chronic administration.  Conclusions and implications: There was a correlation between weak desensitization, significant internalization and recycling of the human DOP receptors and lack of tolerance to UFP-512.  This suggests that this compd. would be a promising drug prototype for exploring innovative treatments for mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLmPrOFKIhBrVg90H21EOLACvtfcHk0lgAgT1mC5A3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSlsLrO&md5=5bd27e9271431f53880f037a8f8af394</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707497%26sid%3Dliteratum%253Aachs%26aulast%3DAguila%26aufirst%3DB.%26aulast%3DCoulbault%26aufirst%3DL.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DL%25C3%25A9veill%25C3%25A9%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DT%25C3%25B3th%26aufirst%3DG.%26aulast%3DBorsodi%26aufirst%3DA.%26aulast%3DBalboni%26aufirst%3DG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DJauzac%26aufirst%3DP.%26aulast%3DAllouche%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520profile%2520of%2520UFP-512%252C%2520a%2520novel%2520selective%2520delta-opioid%2520receptor%2520agonist%253B%2520correlations%2520between%2520desensitization%2520and%2520tolerance%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D1312%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duff, K.</span><span> </span><span class="NLM_article-title">A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse</span> <span class="citation_source-journal">J. Visualized Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">960</span><span class="refDoi"> DOI: 10.3791/960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.3791%2F960" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=960&author=L.+Liuauthor=K.+Duff&title=A+technique+for+serial+collection+of+cerebrospinal+fluid+from+the+cisterna+magna+in+mouse&doi=10.3791%2F960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.3791%2F960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F960%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDuff%26aufirst%3DK.%26atitle%3DA%2520technique%2520for%2520serial%2520collection%2520of%2520cerebrospinal%2520fluid%2520from%2520the%2520cisterna%2520magna%2520in%2520mouse%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2008%26volume%3D21%26spage%3D960%26doi%3D10.3791%2F960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Bourdin, J.; Desire, L.; Schweighoffer, F.</span><span> </span><span class="NLM_article-title">Methods and tools for the therapy of neurodegenerative pathologies</span>. WO2008009868, May 8,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Bourdin&author=L.+Desire&author=F.+Schweighoffer&title=Methods+and+tools+for+the+therapy+of+neurodegenerative+pathologies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBourdin%26aufirst%3DJ.%26atitle%3DMethods%2520and%2520tools%2520for%2520the%2520therapy%2520of%2520neurodegenerative%2520pathologies%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 75 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Piyoosh Sharma, Avanish Tripathi, Prabhash Nath Tripathi, Saumitra Sen Singh, Surya Pratap Singh, <span class="NLM_string-name hlFld-ContribAuthor">Sushant Kumar Shrivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (10)
                                     , 4361-4384. <a href="https://doi.org/10.1021/acschemneuro.9b00430" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00430%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BMolecular%252BHybrids%252Bof%252BN-Benzylpiperidine%252Band%252B1%25252C3%25252C4-Oxadiazole%252Bas%252BMultitargeted%252BTherapeutics%252Bto%252BTreat%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DSharma%26aufirst%3DPiyoosh%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D03082019%26date%3D06092019%26date%3D19092019%26date%3D06092019%26volume%3D10%26issue%3D10%26spage%3D4361%26epage%3D4384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinhui Hu, Ya-Dan Huang, Tingting Pan, Tianhua Zhang, Tao Su, Xingshu Li, Hai-Bin Luo, <span class="NLM_string-name hlFld-ContribAuthor">Ling Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 537-551. <a href="https://doi.org/10.1021/acschemneuro.8b00376" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00376</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00376%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BDual-Target%252BInhibitors%252Bof%252BAcetylcholinesterase%252B%252528AChE%252529%252Band%252BPhosphodiesterase%252B9A%252B%252528PDE9A%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHu%26aufirst%3DJinhui%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10082018%26date%3D25092018%26date%3D12102018%26date%3D25092018%26volume%3D10%26issue%3D1%26spage%3D537%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Ni, Huan Wang, Xiaokang Li, Xinyu Zheng, Manjiong Wang, Jian Zhang, Qi Gong, Dazheng Ling, Fei Mao, Haiyan Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jian Li</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Tadalafil Derivatives Ameliorates Scopolamine-Induced Cognitive Impairment in Mice via Inhibition of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5). </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 1625-1636. <a href="https://doi.org/10.1021/acschemneuro.8b00014" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00014%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BTadalafil%252BDerivatives%252BAmeliorates%252BScopolamine-Induced%252BCognitive%252BImpairment%252Bin%252BMice%252Bvia%252BInhibition%252Bof%252BAcetylcholinesterase%252B%252528AChE%252529%252Band%252BPhosphodiesterase%252B5%252B%252528PDE5%252529%26aulast%3DNi%26aufirst%3DWei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13012018%26date%3D04042018%26date%3D17042018%26date%3D04042018%26volume%3D9%26issue%3D7%26spage%3D1625%26epage%3D1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Ni</span>, <span class="hlFld-ContribAuthor ">Xinyu  Zheng</span>, <span class="hlFld-ContribAuthor ">Manjiong  Wang</span>, <span class="hlFld-ContribAuthor ">Keting  Bao</span>, <span class="hlFld-ContribAuthor ">Dazheng  Ling</span>, <span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Yixiang  Xu</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhang</span>, and <span class="hlFld-ContribAuthor ">Jian  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 328-345. <a href="https://doi.org/10.1021/acschemneuro.7b00345" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00345%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BOrally%252BAvailable%252BFirst-Generation%252BDual-Target%252BSelective%252BInhibitors%252Bof%252BAcetylcholinesterase%252B%252528AChE%252529%252Band%252BPhosphodiesterase%252B5%252B%252528PDE5%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMao%26aufirst%3DFei%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07092017%26date%3D25102017%26date%3D09112017%26date%3D21022018%26date%3D25102017%26volume%3D9%26issue%3D2%26spage%3D328%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Lu</span>, <span class="hlFld-ContribAuthor ">Xinyu  Zheng</span>, <span class="hlFld-ContribAuthor ">Wei  Ni</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Yan  Fu</span>, <span class="hlFld-ContribAuthor ">Fulin  Lian</span>, <span class="hlFld-ContribAuthor ">Naixia  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhang</span>, and <span class="hlFld-ContribAuthor ">Fei  Mao</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8326-8344. <a href="https://doi.org/10.1021/acs.jmedchem.6b00636" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00636%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BMultifunctional%252BPyrimidinylthiourea%252BDerivatives%252Bas%252BPotential%252BAnti-Alzheimer%252BAgents%26aulast%3DLi%26aufirst%3DXiaokang%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25042016%26date%3D06092016%26date%3D22092016%26date%3D23082016%26volume%3D59%26issue%3D18%26spage%3D8326%26epage%3D8344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Roberta  Farina</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Iacobazzi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Ramon  Soto-Otero</span>, <span class="hlFld-ContribAuthor ">Lydia  Siragusa</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>, and <span class="hlFld-ContribAuthor ">Angelo  Carotti</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (14)
                                     , 6791-6806. <a href="https://doi.org/10.1021/acs.jmedchem.6b00562" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00562%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploring%252BBasic%252BTail%252BModifications%252Bof%252BCoumarin-Based%252BDual%252BAcetylcholinesterase-Monoamine%252BOxidase%252BB%252BInhibitors%25253A%252BIdentification%252Bof%252BWater-Soluble%25252C%252BBrain-Permeant%252BNeuroprotective%252BMultitarget%252BAgents%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D13042016%26date%3D07072016%26date%3D28072016%26date%3D27062016%26volume%3D59%26issue%3D14%26spage%3D6791%26epage%3D6806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Sola</span>, <span class="hlFld-ContribAuthor ">Ester  Aso</span>, <span class="hlFld-ContribAuthor ">Daniela  Frattini</span>, <span class="hlFld-ContribAuthor ">Irene  López-González</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabaté</span>, <span class="hlFld-ContribAuthor ">Ornella  Di Pietro</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">M. Victòria  Clos</span>, <span class="hlFld-ContribAuthor ">Isidro  Ferrer</span>, and <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (15)
                                     , 6018-6032. <a href="https://doi.org/10.1021/acs.jmedchem.5b00624" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00624%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BLevetiracetam%252BDerivatives%252BThat%252BAre%252BEffective%252Bagainst%252Bthe%252BAlzheimer-like%252BPhenotype%252Bin%252BMice%25253A%252BSynthesis%25252C%252Bin%252BVitro%25252C%252Bex%252BVivo%25252C%252Band%252Bin%252BVivo%252BEfficacy%252BStudies%26aulast%3DSola%26aufirst%3DIrene%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D23042015%26date%3D27072015%26date%3D13082015%26date%3D16072015%26volume%3D58%26issue%3D15%26spage%3D6018%26epage%3D6032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Lu</span>, <span class="hlFld-ContribAuthor ">Yijun  Liu</span>, <span class="hlFld-ContribAuthor ">Nan  Qin</span>, <span class="hlFld-ContribAuthor ">Hongyu  Yang</span>, <span class="hlFld-ContribAuthor ">Yuting  Qiao</span>, <span class="hlFld-ContribAuthor ">Xueyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">You  Zhou</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and activity of miconazole derivatives as dual BChE/IDO1 inhibitors for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (13)
                                     , 1105-1125. <a href="https://doi.org/10.4155/fmc-2021-0039" title="DOI URL">https://doi.org/10.4155/fmc-2021-0039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2021-0039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2021-0039%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bactivity%252Bof%252Bmiconazole%252Bderivatives%252Bas%252Bdual%252BBChE%25252FIDO1%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLu%26aufirst%3DXin%26date%3D2021%26volume%3D13%26issue%3D13%26spage%3D1105%26epage%3D1125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca Serena  Abatematteo</span>, <span class="hlFld-ContribAuthor ">Mauro  Niso</span>, <span class="hlFld-ContribAuthor ">Marialessandra  Contino</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Carmen  Abate</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (12)
                                     , 6359. <a href="https://doi.org/10.3390/ijms22126359" title="DOI URL">https://doi.org/10.3390/ijms22126359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22126359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22126359%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMulti-Target%252BDirected%252BLigands%252B%252528MTDLs%252529%252BBinding%252Bthe%252B%2525CF%2525831%252BReceptor%252Bas%252BPromising%252BTherapeutics%25253A%252BState%252Bof%252Bthe%252BArt%252Band%252BPerspectives%26aulast%3DAbatematteo%26aufirst%3DFrancesca%2BSerena%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D12%26spage%3D6359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanay  Dalvi</span>, <span class="hlFld-ContribAuthor ">Bhaskar  Dewangan</span>, <span class="hlFld-ContribAuthor ">Gopal  Agarwal</span>, <span class="hlFld-ContribAuthor ">Dattatray  Shinde Suchita</span>, <span class="hlFld-ContribAuthor ">Alok  Jain</span>, <span class="hlFld-ContribAuthor ">Akshay  Srivastava</span>, <span class="hlFld-ContribAuthor ">Bichismita  Sahu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in-vitro evaluation of fluorinated triazoles as multi-target directed ligands for Alzheimer disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>42 </em>, 127999. <a href="https://doi.org/10.1016/j.bmcl.2021.127999" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127999%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin-vitro%252Bevaluation%252Bof%252Bfluorinated%252Btriazoles%252Bas%252Bmulti-target%252Bdirected%252Bligands%252Bfor%252BAlzheimer%252Bdisease%26aulast%3DDalvi%26aufirst%3DTanay%26date%3D2021%26volume%3D42%26spage%3D127999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Jakub  Jończyk</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Natalia  Szałaj</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Julia  Tabor</span>, <span class="hlFld-ContribAuthor ">Eva  Mezeiova</span>, <span class="hlFld-ContribAuthor ">Fabien  Chantegreil</span>, <span class="hlFld-ContribAuthor ">José  Dias</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Junfeng  Lu</span>, <span class="hlFld-ContribAuthor ">Rongbiao  Pi</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Xavier  Brazzolotto</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Georg  Höfner</span>, <span class="hlFld-ContribAuthor ">Klaus  Wanner</span>, <span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of multifunctional anti-Alzheimer’s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113397. <a href="https://doi.org/10.1016/j.ejmech.2021.113397" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113397%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bmultifunctional%252Banti-Alzheimer%2525E2%252580%252599s%252Bagents%252Bwith%252Ba%252Bunique%252Bmechanism%252Bof%252Baction%252Bincluding%252Binhibition%252Bof%252Bthe%252Benzyme%252Bbutyrylcholinesterase%252Band%252B%2525CE%2525B3-aminobutyric%252Bacid%252Btransporters%26aulast%3DPasieka%26aufirst%3DAnna%26date%3D2021%26volume%3D218%26spage%3D113397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martina  Bortolami</span>, <span class="hlFld-ContribAuthor ">Daniele  Rocco</span>, <span class="hlFld-ContribAuthor ">Antonella  Messore</span>, <span class="hlFld-ContribAuthor ">Roberto  Di Santo</span>, <span class="hlFld-ContribAuthor ">Roberta  Costi</span>, <span class="hlFld-ContribAuthor ">Valentina Noemi  Madia</span>, <span class="hlFld-ContribAuthor ">Luigi  Scipione</span>, <span class="hlFld-ContribAuthor ">Fabiana  Pandolfi</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease – a patent review (2016–present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (5)
                                     , 399-420. <a href="https://doi.org/10.1080/13543776.2021.1874344" title="DOI URL">https://doi.org/10.1080/13543776.2021.1874344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1874344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1874344%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DAcetylcholinesterase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252B%2525E2%252580%252593%252Ba%252Bpatent%252Breview%252B%2525282016%2525E2%252580%252593present%252529%26aulast%3DBortolami%26aufirst%3DMartina%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D5%26spage%3D399%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Rémi  Legay</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Jana  Sopková-de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2536. <a href="https://doi.org/10.3390/molecules26092536" title="DOI URL">https://doi.org/10.3390/molecules26092536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092536%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDevelopment%252Bof%252BNovel%252BPotential%252BPleiotropic%252BCompounds%252Bof%252BInterest%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTreatment%252Bthrough%252BRigidification%252BStrategy%26aulast%3DLecoutey%26aufirst%3DC%25C3%25A9dric%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anchala  Kumari</span>, <span class="hlFld-ContribAuthor ">Nidhi  Shrivastava</span>, <span class="hlFld-ContribAuthor ">Mohit  Mishra</span>, <span class="hlFld-ContribAuthor ">Pallavi  Somvanshi</span>, <span class="hlFld-ContribAuthor ">Abhinav  Grover</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory mechanism of an antifungal drug, caspofungin against amyloid β peptide aggregation: Repurposing via neuroinformatics and an experimental approach. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Neuroscience</span><span> <strong>2021,</strong> <em>112 </em>, 103612. <a href="https://doi.org/10.1016/j.mcn.2021.103612" title="DOI URL">https://doi.org/10.1016/j.mcn.2021.103612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mcn.2021.103612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mcn.2021.103612%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Neuroscience%26atitle%3DInhibitory%252Bmechanism%252Bof%252Ban%252Bantifungal%252Bdrug%25252C%252Bcaspofungin%252Bagainst%252Bamyloid%252B%2525CE%2525B2%252Bpeptide%252Baggregation%25253A%252BRepurposing%252Bvia%252Bneuroinformatics%252Band%252Ban%252Bexperimental%252Bapproach%26aulast%3DKumari%26aufirst%3DAnchala%26date%3D2021%26volume%3D112%26spage%3D103612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md. Sahab  Uddin</span>, <span class="hlFld-ContribAuthor ">Abdullah  Al Mamun</span>, <span class="hlFld-ContribAuthor ">Md. Tanvir  Kabir</span>, <span class="hlFld-ContribAuthor ">Ghulam Md  Ashraf</span>, <span class="hlFld-ContribAuthor ">May N.  Bin-Jumah</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Abdel-Daim</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurobiology</span><span> <strong>2021,</strong> <em>58 </em>
                                    (1)
                                     , 281-303. <a href="https://doi.org/10.1007/s12035-020-02116-9" title="DOI URL">https://doi.org/10.1007/s12035-020-02116-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12035-020-02116-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12035-020-02116-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurobiology%26atitle%3DMulti-Target%252BDrug%252BCandidates%252Bfor%252BMultifactorial%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BAChE%252Band%252BNMDAR%252Bas%252BMolecular%252BTargets%26aulast%3DUddin%26aufirst%3DMd.%2BSahab%26date%3D2021%26date%3D2020%26volume%3D58%26issue%3D1%26spage%3D281%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas M.  Barnes</span>, <span class="hlFld-ContribAuthor ">Gerard P.  Ahern</span>, <span class="hlFld-ContribAuthor ">Carine  Becamel</span>, <span class="hlFld-ContribAuthor ">Joël  Bockaert</span>, <span class="hlFld-ContribAuthor ">Michael  Camilleri</span>, <span class="hlFld-ContribAuthor ">Severine  Chaumont-Dubel</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Kevin C.  Fone</span>, <span class="hlFld-ContribAuthor ">Michael  Gershon</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Di Giovanni</span>, <span class="hlFld-ContribAuthor ">Nathalie M.  Goodfellow</span>, <span class="hlFld-ContribAuthor ">Adam L.  Halberstadt</span>, <span class="hlFld-ContribAuthor ">Rachel M.  Hartley</span>, <span class="hlFld-ContribAuthor ">Ghérici  Hassaine</span>, <span class="hlFld-ContribAuthor ">Katharine  Herrick-Davis</span>, <span class="hlFld-ContribAuthor ">Ruud  Hovius</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Evelyn K.  Lambe</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Finn Olav  Levy</span>, <span class="hlFld-ContribAuthor ">Sarah C. R.  Lummis</span>, <span class="hlFld-ContribAuthor ">Philippe  Marin</span>, <span class="hlFld-ContribAuthor ">Luc  Maroteaux</span>, <span class="hlFld-ContribAuthor ">Andrew C.  McCreary</span>, <span class="hlFld-ContribAuthor ">David L.  Nelson</span>, <span class="hlFld-ContribAuthor ">John F.  Neumaier</span>, <span class="hlFld-ContribAuthor ">Adrian  Newman-Tancredi</span>, <span class="hlFld-ContribAuthor ">Hugues  Nury</span>, <span class="hlFld-ContribAuthor ">Alexander  Roberts</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, <span class="hlFld-ContribAuthor ">Anne  Roumier</span>, <span class="hlFld-ContribAuthor ">Gareth J.  Sanger</span>, <span class="hlFld-ContribAuthor ">Milt  Teitler</span>, <span class="hlFld-ContribAuthor ">Trevor  Sharp</span>, <span class="hlFld-ContribAuthor ">Carlos M.  Villalón</span>, <span class="hlFld-ContribAuthor ">Horst  Vogel</span>, <span class="hlFld-ContribAuthor ">Stephanie W.  Watts</span>, <span class="hlFld-ContribAuthor ">Daniel  Hoyer</span>, . </span><span class="cited-content_cbyCitation_article-title">International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2021,</strong> <em>73 </em>
                                    (1)
                                     , 310-520. <a href="https://doi.org/10.1124/pr.118.015552" title="DOI URL">https://doi.org/10.1124/pr.118.015552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.118.015552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.118.015552%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DInternational%252BUnion%252Bof%252BBasic%252Band%252BClinical%252BPharmacology.%252BCX.%252BClassification%252Bof%252BReceptors%252Bfor%252B5-hydroxytryptamine%25253B%252BPharmacology%252Band%252BFunction%26aulast%3DBarnes%26aufirst%3DNicholas%2BM.%26date%3D2021%26date%3D2020%26volume%3D73%26issue%3D1%26spage%3D310%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Guieu</span>, <span class="hlFld-ContribAuthor ">Cedric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Rémi  Legay</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Jana  Sopkova de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (1)
                                     , 80. <a href="https://doi.org/10.3390/molecules26010080" title="DOI URL">https://doi.org/10.3390/molecules26010080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26010080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26010080%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DFirst%252BSynthesis%252Bof%252BRacemic%252BTrans%252BPropargylamino-Donepezil%25252C%252Ba%252BPleiotrope%252BAgent%252BAble%252Bto%252BBoth%252BInhibit%252BAChE%252Band%252BMAO-B%25252C%252Bwith%252BPotential%252BInterest%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGuieu%26aufirst%3DBenjamin%26date%3D2021%26date%3D2020%26volume%3D26%26issue%3D1%26spage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François-Xavier  Toublet</span>, <span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Bérénice  Hatat</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Jana  Sopková-de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 113059. <a href="https://doi.org/10.1016/j.ejmech.2020.113059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPleiotropic%252Bprodrugs%25253A%252BDesign%252Bof%252Ba%252Bdual%252Bbutyrylcholinesterase%252Binhibitor%252Band%252B5-HT6%252Breceptor%252Bantagonist%252Bwith%252Btherapeutic%252Binterest%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DToublet%26aufirst%3DFran%25C3%25A7ois-Xavier%26date%3D2021%26volume%3D210%26spage%3D113059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, , <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, , <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>, . </span><span class="cited-content_cbyCitation_article-title">Multifunctional Ligand Approach: Search for Effective Therapy Against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 181-203. <a href="https://doi.org/10.36255/exonpublications.alzheimersdisease.2020.ch11" title="DOI URL">https://doi.org/10.36255/exonpublications.alzheimersdisease.2020.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.36255/exonpublications.alzheimersdisease.2020.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.36255%2Fexonpublications.alzheimersdisease.2020.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DMultifunctional%252BLigand%252BApproach%25253A%252BSearch%252Bfor%252BEffective%252BTherapy%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPasieka%26aufirst%3DAnna%26date%3D2020%26date%3D2020%26spage%3D181%26epage%3D203%26pub%3DExon%2520Publications%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDrug%252BDiscovery%26aulast%3DHuang%26aufirst%3DXudong%26date%3D2020%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Hugo  Payan</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Rémi  Legay</span>, <span class="hlFld-ContribAuthor ">Jana  Sopkova-de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-59805-7" title="DOI URL">https://doi.org/10.1038/s41598-020-59805-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-59805-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-59805-7%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DRational%252Bdesign%252Bof%252Bnovel%252Bbenzisoxazole%252Bderivatives%252Bwith%252Bacetylcholinesterase%252Binhibitory%252Band%252Bserotoninergic%252B5-HT4%252Breceptors%252Bactivities%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DLalut%26aufirst%3DJulien%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark J.  Millan</span>, <span class="hlFld-ContribAuthor ">Anne  Dekeyne</span>, <span class="hlFld-ContribAuthor ">Alain  Gobert</span>, <span class="hlFld-ContribAuthor ">Mauricette  Brocco</span>, <span class="hlFld-ContribAuthor ">Clotilde  Mannoury la Cour</span>, <span class="hlFld-ContribAuthor ">Jean-Claude  Ortuno</span>, <span class="hlFld-ContribAuthor ">David  Watson</span>, <span class="hlFld-ContribAuthor ">Kevin C.F.  Fone</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>177 </em>, 108099. <a href="https://doi.org/10.1016/j.neuropharm.2020.108099" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.108099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.108099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.108099%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DDual-acting%252Bagents%252Bfor%252Bimproving%252Bcognition%252Band%252Breal-world%252Bfunction%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BFocus%252Bon%252B5-HT6%252Band%252BD3%252Breceptors%252Bas%252Bhubs%26aulast%3DMillan%26aufirst%3DMark%2BJ.%26date%3D2020%26volume%3D177%26spage%3D108099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Jankowska</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Grażyna  Chłoń-Rzepa</span>. </span><span class="cited-content_cbyCitation_article-title">Multifunctional Ligands Targeting Phosphodiesterase as the Future Strategy for the Symptomatic and Disease-Modifying Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (32)
                                     , 5351-5373. <a href="https://doi.org/10.2174/0929867326666190620095623" title="DOI URL">https://doi.org/10.2174/0929867326666190620095623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190620095623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190620095623%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DMultifunctional%252BLigands%252BTargeting%252BPhosphodiesterase%252Bas%252Bthe%252BFuture%252BStrategy%252Bfor%252Bthe%252BSymptomatic%252Band%252BDisease-Modifying%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DJankowska%26aufirst%3DAgnieszka%26date%3D2020%26volume%3D27%26issue%3D32%26spage%3D5351%26epage%3D5373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Zagórska</span>, <span class="hlFld-ContribAuthor ">Anna  Jaromin</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3337. <a href="https://doi.org/10.3390/molecules25153337" title="DOI URL">https://doi.org/10.3390/molecules25153337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153337%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPerspectives%252Bfor%252BNew%252Band%252BMore%252BEfficient%252BMultifunctional%252BLigands%252Bfor%252BAlzheimer%2525E2%252580%2525B2s%252BDisease%252BTherapy%26aulast%3DZag%25C3%25B3rska%26aufirst%3DAgnieszka%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijay  Kumar</span>, <span class="hlFld-ContribAuthor ">Bhupinder  Kumar</span>, <span class="hlFld-ContribAuthor ">Ashish  Ranjan Dwivedi</span>, <span class="hlFld-ContribAuthor ">Devashish  Mehta</span>, <span class="hlFld-ContribAuthor ">Naveen  Kumar</span>, <span class="hlFld-ContribAuthor ">Beenu  Bajaj</span>, <span class="hlFld-ContribAuthor ">Tania  Arora</span>, <span class="hlFld-ContribAuthor ">Vikash  Prashar</span>, <span class="hlFld-ContribAuthor ">Jyoti  Parkash</span>, <span class="hlFld-ContribAuthor ">Vinod  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Evaluation of
              O
              ‐Pentyne Substituted Diphenylpyrimidines as Monoamine Oxidase and Acetylcholinesterase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (27)
                                     , 8021-8032. <a href="https://doi.org/10.1002/slct.202002425" title="DOI URL">https://doi.org/10.1002/slct.202002425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202002425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202002425%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BEvaluation%252Bof%252BO%252B%2525E2%252580%252590Pentyne%252BSubstituted%252BDiphenylpyrimidines%252Bas%252BMonoamine%252BOxidase%252Band%252BAcetylcholinesterase%252BInhibitors%26aulast%3DKumar%26aufirst%3DVijay%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D27%26spage%3D8021%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuele  Maramai</span>, <span class="hlFld-ContribAuthor ">Mohamed  Benchekroun</span>, <span class="hlFld-ContribAuthor ">Moustafa T.  Gabr</span>, <span class="hlFld-ContribAuthor ">Samir  Yahiaoui</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2020,</strong> <em>2020 </em>, 1-27. <a href="https://doi.org/10.1155/2020/5120230" title="DOI URL">https://doi.org/10.1155/2020/5120230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/5120230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F5120230%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DMultitarget%252BTherapeutic%252BStrategies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BReview%252Bon%252BEmerging%252BTarget%252BCombinations%26aulast%3DMaramai%26aufirst%3DSamuele%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julio  Rodríguez-Lavado</span>, <span class="hlFld-ContribAuthor ">Carlos  Gallardo-Garrido</span>, <span class="hlFld-ContribAuthor ">Michael  Mallea</span>, <span class="hlFld-ContribAuthor ">Victor  Bustos</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Osorio</span>, <span class="hlFld-ContribAuthor ">Martín  Hödar-Salazar</span>, <span class="hlFld-ContribAuthor ">Hery  Chung</span>, <span class="hlFld-ContribAuthor ">Ramiro  Araya-Maturana</span>, <span class="hlFld-ContribAuthor ">Marcos  Lorca</span>, <span class="hlFld-ContribAuthor ">C. David  Pessoa-Mahana</span>, <span class="hlFld-ContribAuthor ">Jaime  Mella-Raipán</span>, <span class="hlFld-ContribAuthor ">Claudio  Saitz</span>, <span class="hlFld-ContribAuthor ">Pablo  Jaque</span>, <span class="hlFld-ContribAuthor ">Miguel  Reyes-Parada</span>, <span class="hlFld-ContribAuthor ">Patricio  Iturriaga-Vásquez</span>, <span class="hlFld-ContribAuthor ">Hernán  Pessoa-Mahana</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>198 </em>, 112368. <a href="https://doi.org/10.1016/j.ejmech.2020.112368" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112368%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bin%2525C2%2525A0vitro%252Bevaluation%252Band%252Bmolecular%252Bdocking%252Bof%252Ba%252Bnew%252Bclass%252Bof%252Bindolylpropyl%252Bbenzamidopiperazines%252Bas%252Bdual%252BAChE%252Band%252BSERT%252Bligands%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DRodr%25C3%25ADguez-Lavado%26aufirst%3DJulio%26date%3D2020%26volume%3D198%26spage%3D112368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Cieslikiewicz-Bouet</span>, <span class="hlFld-ContribAuthor ">Marina  Naldi</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">Denis  Servent</span>, <span class="hlFld-ContribAuthor ">Ludovic  Jean</span>, <span class="hlFld-ContribAuthor ">Rómulo  Aráoz</span>, <span class="hlFld-ContribAuthor ">Pierre-Yves  Renard</span>. </span><span class="cited-content_cbyCitation_article-title">Functional characterization of multifunctional ligands targeting acetylcholinesterase and alpha 7 nicotinic acetylcholine receptor. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>, 114010. <a href="https://doi.org/10.1016/j.bcp.2020.114010" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114010%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DFunctional%252Bcharacterization%252Bof%252Bmultifunctional%252Bligands%252Btargeting%252Bacetylcholinesterase%252Band%252Balpha%252B7%252Bnicotinic%252Bacetylcholine%252Breceptor%26aulast%3DCieslikiewicz-Bouet%26aufirst%3DMonika%26date%3D2020%26volume%3D177%26spage%3D114010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Albertini</span>, <span class="hlFld-ContribAuthor ">Alessandra  Salerno</span>, <span class="hlFld-ContribAuthor ">Pedro  Sena Murteira Pinheiro</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.1002/med.21699" title="DOI URL">https://doi.org/10.1002/med.21699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21699%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DFrom%252Bcombinations%252Bto%252Bmultitarget%2525E2%252580%252590directed%252Bligands%25253A%252BA%252Bcontinuum%252Bin%252BAlzheimer%252527s%252Bdisease%252Bpolypharmacology%26aulast%3DAlbertini%26aufirst%3DClaudia%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Katia  Hamidouche</span>, <span class="hlFld-ContribAuthor ">Patrizia  Giannoni</span>, <span class="hlFld-ContribAuthor ">Florence  Gaven</span>, <span class="hlFld-ContribAuthor ">Eleazere  Cem</span>, <span class="hlFld-ContribAuthor ">Serge  Mignani</span>, <span class="hlFld-ContribAuthor ">Kevin  Baranger</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Joël  Bockaert</span>, <span class="hlFld-ContribAuthor ">Santiago  Rivera</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>. </span><span class="cited-content_cbyCitation_article-title">Donecopride, a Swiss army knife with potential against Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (9)
                                     , 1988-2005. <a href="https://doi.org/10.1111/bph.14964" title="DOI URL">https://doi.org/10.1111/bph.14964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14964%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DDonecopride%25252C%252Ba%252BSwiss%252Barmy%252Bknife%252Bwith%252Bpotential%252Bagainst%252BAlzheimer%252527s%252Bdisease%26aulast%3DRochais%26aufirst%3DChristophe%26date%3D2020%26date%3D2020%26volume%3D177%26issue%3D9%26spage%3D1988%26epage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harapriya  Chakravarty</span>, <span class="hlFld-ContribAuthor ">Yaojun  Ju</span>, <span class="hlFld-ContribAuthor ">Wen‐Hua  Chen</span>, <span class="hlFld-ContribAuthor ">Kin Y.  Tam</span>. </span><span class="cited-content_cbyCitation_article-title">Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2020,</strong> <em>81 </em>
                                    (2)
                                     , 242-255. <a href="https://doi.org/10.1002/ddr.21631" title="DOI URL">https://doi.org/10.1002/ddr.21631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21631%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DDual%252Btargeting%252Bof%252Bcholinesterase%252Band%252Bamyloid%252Bbeta%252Bwith%252Bpyridinium%25252Fisoquinolium%252Bderivatives%26aulast%3DChakravarty%26aufirst%3DHarapriya%26date%3D2020%26volume%3D81%26issue%3D2%26spage%3D242%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Adnet</span>, <span class="hlFld-ContribAuthor ">Anne-Claire  Groo</span>, <span class="hlFld-ContribAuthor ">Céline  Picard</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Frédéric  Bounoure</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Loïc  Le Pluart</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Aurélie  Malzert-Fréon</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2020,</strong> <em>12 </em>
                                    (3)
                                     , 251. <a href="https://doi.org/10.3390/pharmaceutics12030251" title="DOI URL">https://doi.org/10.3390/pharmaceutics12030251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics12030251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics12030251%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DPharmacotechnical%252BDevelopment%252Bof%252Ba%252BNasal%252BDrug%252BDelivery%252BComposite%252BNanosystem%252BIntended%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTreatment%26aulast%3DAdnet%26aufirst%3DThomas%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D3%26spage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philippe  Marin</span>, <span class="hlFld-ContribAuthor ">Carine  Bécamel</span>, <span class="hlFld-ContribAuthor ">Séverine  Chaumont-Dubel</span>, <span class="hlFld-ContribAuthor ">Franck  Vandermoere</span>, <span class="hlFld-ContribAuthor ">Joël  Bockaert</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>. </span><span class="cited-content_cbyCitation_article-title">Classification and signaling characteristics of 5-HT receptors: toward the concept of 5-HT receptosomes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 91-120. <a href="https://doi.org/10.1016/B978-0-444-64125-0.00005-0" title="DOI URL">https://doi.org/10.1016/B978-0-444-64125-0.00005-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-64125-0.00005-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-64125-0.00005-0%26sid%3Dliteratum%253Aachs%26atitle%3DClassification%252Band%252Bsignaling%252Bcharacteristics%252Bof%252B5-HT%252Breceptors%25253A%252Btoward%252Bthe%252Bconcept%252Bof%252B5-HT%252Breceptosomes%26aulast%3DMarin%26aufirst%3DPhilippe%26date%3D2020%26spage%3D91%26epage%3D120%26pub%3DElsevier%26atitle%3DHandbook%252Bof%252Bthe%252BBehavioral%252BNeurobiology%252Bof%252BSerotonin%26date%3D2020%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. V.  Bobkova</span>, <span class="hlFld-ContribAuthor ">R. A.  Poltavtseva</span>, <span class="hlFld-ContribAuthor ">S. V.  Leonov</span>, <span class="hlFld-ContribAuthor ">G. T.  Sukhikh</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroregeneration: Regulation in Neurodegenerative Diseases and Aging. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry (Moscow)</span><span> <strong>2020,</strong> <em>85 </em>
                                    (S1)
                                     , 108-130. <a href="https://doi.org/10.1134/S0006297920140060" title="DOI URL">https://doi.org/10.1134/S0006297920140060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S0006297920140060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS0006297920140060%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%2520%2528Moscow%2529%26atitle%3DNeuroregeneration%25253A%252BRegulation%252Bin%252BNeurodegenerative%252BDiseases%252Band%252BAging%26aulast%3DBobkova%26aufirst%3DN.%2BV.%26date%3D2020%26date%3D2020%26volume%3D85%26issue%3DS1%26spage%3D108%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcella  Catania</span>, <span class="hlFld-ContribAuthor ">Giorgio  Giaccone</span>, <span class="hlFld-ContribAuthor ">Mario  Salmona</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Tagliavini</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Di Fede</span>. </span><span class="cited-content_cbyCitation_article-title">Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2019,</strong> <em>11 </em><a href="https://doi.org/10.3389/fnagi.2019.00317" title="DOI URL">https://doi.org/10.3389/fnagi.2019.00317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2019.00317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2019.00317%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DDreaming%252Bof%252Ba%252BNew%252BWorld%252BWhere%252BAlzheimer%2525E2%252580%252599s%252BIs%252Ba%252BTreatable%252BDisorder%26aulast%3DCatania%26aufirst%3DMarcella%26date%3D2019%26date%3D2019%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Huang  Xu</span>, <span class="hlFld-ContribAuthor ">Shumin  Ding</span>, <span class="hlFld-ContribAuthor ">Dongyan  Wang</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Song</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase 5 inhibitors as novel agents for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2019,</strong> <em>153 </em>, 223-231. <a href="https://doi.org/10.1016/j.brainresbull.2019.09.001" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2019.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2019.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2019.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DPhosphodiesterase%252B5%252Binhibitors%252Bas%252Bnovel%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DLiu%26aufirst%3DLi%26date%3D2019%26volume%3D153%26spage%3D223%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline  Lanthier</span>, <span class="hlFld-ContribAuthor ">Hugo  Payan</span>, <span class="hlFld-ContribAuthor ">Irene  Liparulo</span>, <span class="hlFld-ContribAuthor ">Bérénice  Hatat</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Christian  Bergamini</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Maria-Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111596. <a href="https://doi.org/10.1016/j.ejmech.2019.111596" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111596%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bmulti%252Btarget-directed%252Bligands%252Btargeting%252B5-HT4%252Breceptors%252Bwith%252Bin%252Bcellulo%252Bantioxidant%252Bproperties%252Bas%252Bpromising%252Bleads%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DLanthier%26aufirst%3DCaroline%26date%3D2019%26volume%3D182%26spage%3D111596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yusi  Chen</span>, <span class="hlFld-ContribAuthor ">Chunlin  Su</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Jingfang  Qin</span>, <span class="hlFld-ContribAuthor ">Shenqi  Wei</span>, <span class="hlFld-ContribAuthor ">Huang  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrids of oxoisoaporphine–tetrahydroisoquinoline: novel multi-target inhibitors of inflammation and amyloid-β aggregation in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2019,</strong> <em>23 </em>
                                    (3)
                                     , 709-722. <a href="https://doi.org/10.1007/s11030-018-9905-5" title="DOI URL">https://doi.org/10.1007/s11030-018-9905-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-018-9905-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-018-9905-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DHybrids%252Bof%252Boxoisoaporphine%2525E2%252580%252593tetrahydroisoquinoline%25253A%252Bnovel%252Bmulti-target%252Binhibitors%252Bof%252Binflammation%252Band%252Bamyloid-%2525CE%2525B2%252Baggregation%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DChen%26aufirst%3DYusi%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D3%26spage%3D709%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-target design strategies for the improved treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 228-247. <a href="https://doi.org/10.1016/j.ejmech.2019.05.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMulti-target%252Bdesign%252Bstrategies%252Bfor%252Bthe%252Bimproved%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DZhang%26aufirst%3DPengfei%26date%3D2019%26volume%3D176%26spage%3D228%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François-Xavier  Toublet</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Bérénice  Hatat</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Jana  Sopkova de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (15)
                                     , 2786. <a href="https://doi.org/10.3390/molecules24152786" title="DOI URL">https://doi.org/10.3390/molecules24152786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24152786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24152786%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DInhibiting%252BAcetylcholinesterase%252Bto%252BActivate%252BPleiotropic%252BProdrugs%252Bwith%252BTherapeutic%252BInterest%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DToublet%26aufirst%3DFran%25C3%25A7ois-Xavier%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D15%26spage%3D2786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sneha R.  Sagar</span>, <span class="hlFld-ContribAuthor ">Devendra Pratap  Singh</span>, <span class="hlFld-ContribAuthor ">Rajesh D.  Das</span>, <span class="hlFld-ContribAuthor ">Nirupa B.  Panchal</span>, <span class="hlFld-ContribAuthor ">Vasudevan  Sudarsanam</span>, <span class="hlFld-ContribAuthor ">Manish  Nivsarkar</span>, <span class="hlFld-ContribAuthor ">Kamala K.  Vasu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological investigation of quinoxaline-bisthiazoles as multitarget-directed ligands for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>89 </em>, 102992. <a href="https://doi.org/10.1016/j.bioorg.2019.102992" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.102992</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.102992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.102992%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPharmacological%252Binvestigation%252Bof%252Bquinoxaline-bisthiazoles%252Bas%252Bmultitarget-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSagar%26aufirst%3DSneha%2BR.%26date%3D2019%26volume%3D89%26spage%3D102992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bérénice  Hatat</span>, <span class="hlFld-ContribAuthor ">Samir  Yahiaoui</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2019,</strong> <em>11 </em><a href="https://doi.org/10.3389/fnagi.2019.00148" title="DOI URL">https://doi.org/10.3389/fnagi.2019.00148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2019.00148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2019.00148%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DA%252BNovel%252Bin%252Bvivo%252BAnti-amnesic%252BAgent%25252C%252BSpecially%252BDesigned%252Bto%252BExpress%252BBoth%252BAcetylcholinesterase%252B%252528AChE%252529%252BInhibitory%25252C%252BSerotonergic%252BSubtype%252B4%252BReceptor%252B%2525285-HT4R%252529%252BAgonist%252Band%252BSerotonergic%252BSubtype%252B6%252BReceptor%252B%2525285-HT6R%252529%252BInverse%252BAgonist%252BActivities%25252C%252BWith%252Ba%252BPotential%252BInterest%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHatat%26aufirst%3DB%25C3%25A9r%25C3%25A9nice%26date%3D2019%26date%3D2019%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helia  Abdshahzadeh</span>, <span class="hlFld-ContribAuthor ">Mostafa  Golshani</span>, <span class="hlFld-ContribAuthor ">Hamid  Nadri</span>, <span class="hlFld-ContribAuthor ">Iraj  Saberi Kia</span>, <span class="hlFld-ContribAuthor ">Zahra  Abdolahi</span>, <span class="hlFld-ContribAuthor ">Hamid  Forootanfar</span>, <span class="hlFld-ContribAuthor ">Alieh  Ameri</span>, <span class="hlFld-ContribAuthor ">Tuba  Tüylü Küçükkılınç</span>, <span class="hlFld-ContribAuthor ">Beyza  Ayazgok</span>, <span class="hlFld-ContribAuthor ">Leili  Jalili‐Baleh</span>, <span class="hlFld-ContribAuthor ">Seyed Esmaeil  Sadat Ebrahimi</span>, <span class="hlFld-ContribAuthor ">Setareh  Moghimi</span>, <span class="hlFld-ContribAuthor ">Ismaeil  Haririan</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoobi</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>. </span><span class="cited-content_cbyCitation_article-title">3‐Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi‐Target‐Directed Ligands against Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (5)
                                     , e1800436. <a href="https://doi.org/10.1002/cbdv.201800436" title="DOI URL">https://doi.org/10.1002/cbdv.201800436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201800436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201800436%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3D3%2525E2%252580%252590Aryl%252BCoumarin%252BDerivatives%252BBearing%252BAminoalkoxy%252BMoiety%252Bas%252BMulti%2525E2%252580%252590Target%2525E2%252580%252590Directed%252BLigands%252Bagainst%252BAlzheimer%252527s%252BDisease%26aulast%3DAbdshahzadeh%26aufirst%3DHelia%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D5%26spage%3De1800436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piyoosh  Sharma</span>, <span class="hlFld-ContribAuthor ">Pavan  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ankit  Seth</span>, <span class="hlFld-ContribAuthor ">Prabhash Nath  Tripathi</span>, <span class="hlFld-ContribAuthor ">Anupam G.  Banerjee</span>, <span class="hlFld-ContribAuthor ">Sushant K.  Shrivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neurobiology</span><span> <strong>2019,</strong> <em>174 </em>, 53-89. <a href="https://doi.org/10.1016/j.pneurobio.2018.12.006" title="DOI URL">https://doi.org/10.1016/j.pneurobio.2018.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pneurobio.2018.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pneurobio.2018.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neurobiology%26atitle%3DComprehensive%252Breview%252Bof%252Bmechanisms%252Bof%252Bpathogenesis%252Binvolved%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bpotential%252Btherapeutic%252Bstrategies%26aulast%3DSharma%26aufirst%3DPiyoosh%26date%3D2019%26volume%3D174%26spage%3D53%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhui  Hu</span>, <span class="hlFld-ContribAuthor ">Tingting  Pan</span>, <span class="hlFld-ContribAuthor ">Baijiao  An</span>, <span class="hlFld-ContribAuthor ">Zhengcunxiao  Li</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 512-526. <a href="https://doi.org/10.1016/j.ejmech.2018.12.013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bclioquinol-rolipram%25252Froflumilast%252Bhybrids%252Bas%252Bmultitarget-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DHu%26aufirst%3DJinhui%26date%3D2019%26volume%3D163%26spage%3D512%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Gianluca  Santoni</span>, <span class="hlFld-ContribAuthor ">Delphine  Karila</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Florian  Nachon</span>, <span class="hlFld-ContribAuthor ">Israel  Silman</span>, <span class="hlFld-ContribAuthor ">Joel  Sussman</span>, <span class="hlFld-ContribAuthor ">Martin  Weik</span>, <span class="hlFld-ContribAuthor ">Tangui  Maurice</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 234-248. <a href="https://doi.org/10.1016/j.ejmech.2018.10.064" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.064%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bmultitarget-directed%252Bligands%252Btargeting%252Bacetylcholinesterase%252Band%252B%2525CF%2525831%252Breceptors%252Bas%252Blead%252Bcompounds%252Bfor%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%25253A%252BSynthesis%25252C%252Bevaluation%25252C%252Band%252Bstructural%252Bcharacterization%252Bof%252Btheir%252Bcomplexes%252Bwith%252Bacetylcholinesterase%26aulast%3DLalut%26aufirst%3DJulien%26date%3D2019%26volume%3D162%26spage%3D234%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxime  Meyer</span>, <span class="hlFld-ContribAuthor ">Sébastien  Foulquier</span>, <span class="hlFld-ContribAuthor ">François  Dupuis</span>, <span class="hlFld-ContribAuthor ">Stéphane  Flament</span>, <span class="hlFld-ContribAuthor ">Linda  Grimaud</span>, <span class="hlFld-ContribAuthor ">Daniel  Henrion</span>, <span class="hlFld-ContribAuthor ">Isabelle  Lartaud</span>, <span class="hlFld-ContribAuthor ">Gérald  Monard</span>, <span class="hlFld-ContribAuthor ">Isabelle  Grillier-Vuissoz</span>, <span class="hlFld-ContribAuthor ">Michel  Boisbrun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of new designed multiple ligands directed towards both peroxisome proliferator-activated receptor-γ and angiotensin II type 1 receptor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 334-352. <a href="https://doi.org/10.1016/j.ejmech.2018.08.082" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.082%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnew%252Bdesigned%252Bmultiple%252Bligands%252Bdirected%252Btowards%252Bboth%252Bperoxisome%252Bproliferator-activated%252Breceptor-%2525CE%2525B3%252Band%252Bangiotensin%252BII%252Btype%252B1%252Breceptor%26aulast%3DMeyer%26aufirst%3DMaxime%26date%3D2018%26volume%3D158%26spage%3D334%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Siyu  He</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 463-477. <a href="https://doi.org/10.1016/j.ejmech.2018.09.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDonepezil-based%252Bmulti-functional%252Bcholinesterase%252Binhibitors%252Bfor%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLi%26aufirst%3DQi%26date%3D2018%26volume%3D158%26spage%3D463%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng-Xin  Gong</span>, <span class="hlFld-ContribAuthor ">Fei  Liu</span>, <span class="hlFld-ContribAuthor ">Khalid  Iqbal</span>, , , , , . </span><span class="cited-content_cbyCitation_article-title">Multifactorial Hypothesis and Multi-Targets for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2018,</strong> <em>64 </em>
                                    (s1)
                                     , S107-S117. <a href="https://doi.org/10.3233/JAD-179921" title="DOI URL">https://doi.org/10.3233/JAD-179921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-179921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-179921%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DMultifactorial%252BHypothesis%252Band%252BMulti-Targets%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGong%26aufirst%3DCheng-Xin%26date%3D2018%26volume%3D64%26issue%3Ds1%26spage%3DS107%26epage%3DS117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lindon W. K.  Moodie</span>, <span class="hlFld-ContribAuthor ">Gunnar  Cervin</span>, <span class="hlFld-ContribAuthor ">Rozenn  Trepos</span>, <span class="hlFld-ContribAuthor ">Christophe  Labriere</span>, <span class="hlFld-ContribAuthor ">Claire  Hellio</span>, <span class="hlFld-ContribAuthor ">Henrik  Pavia</span>, <span class="hlFld-ContribAuthor ">Johan  Svenson</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Biological Evaluation of Antifouling Dihydrostilbene Oxime Hybrids. </span><span class="cited-content_cbyCitation_journal-name">Marine Biotechnology</span><span> <strong>2018,</strong> <em>20 </em>
                                    (2)
                                     , 257-267. <a href="https://doi.org/10.1007/s10126-018-9802-z" title="DOI URL">https://doi.org/10.1007/s10126-018-9802-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10126-018-9802-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10126-018-9802-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Biotechnology%26atitle%3DDesign%252Band%252BBiological%252BEvaluation%252Bof%252BAntifouling%252BDihydrostilbene%252BOxime%252BHybrids%26aulast%3DMoodie%26aufirst%3DLindon%2BW.%2BK.%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D2%26spage%3D257%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoliang  Li</span>, <span class="hlFld-ContribAuthor ">Ge  Hong</span>, <span class="hlFld-ContribAuthor ">Xinyu  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Zengping  Xu</span>, <span class="hlFld-ContribAuthor ">Lina  Mao</span>, <span class="hlFld-ContribAuthor ">Xizeng  Feng</span>, <span class="hlFld-ContribAuthor ">Tianjun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and activity towards Alzheimer's disease in vitro: Tacrine, phenolic acid and ligustrazine hybrids. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>148 </em>, 238-254. <a href="https://doi.org/10.1016/j.ejmech.2018.01.028" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.028%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bactivity%252Btowards%252BAlzheimer%252527s%252Bdisease%252Bin%2525C2%2525A0vitro%25253A%252BTacrine%25252C%252Bphenolic%252Bacid%252Band%252Bligustrazine%252Bhybrids%26aulast%3DLi%26aufirst%3DGuoliang%26date%3D2018%26volume%3D148%26spage%3D238%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cindy Juliet Cristancho  Ortiz</span>, <span class="hlFld-ContribAuthor ">Matheus  de Freitas Silva</span>, <span class="hlFld-ContribAuthor ">Vanessa Silva  Gontijo</span>, <span class="hlFld-ContribAuthor ">Flávia Pereira Dias  Viegas</span>, <span class="hlFld-ContribAuthor ">Kris Simone Tranches  Dias</span>, <span class="hlFld-ContribAuthor ">Claudio  Viegas</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 255-351. <a href="https://doi.org/10.1007/7653_2018_2" title="DOI URL">https://doi.org/10.1007/7653_2018_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2018_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2018_2%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BMulti-target%252BDirected%252BLigands%252Bas%252Ba%252BModern%252BApproach%252Bfor%252Bthe%252BDevelopment%252Bof%252BInnovative%252BDrug%252BCandidates%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DOrtiz%26aufirst%3DCindy%2BJuliet%2BCristancho%26date%3D2018%26date%3D2018%26spage%3D255%26epage%3D351%26pub%3DSpringer%2520New%2520York%26atitle%3DMulti-Target%252BDrug%252BDesign%252BUsing%252BChem-Bioinformatic%252BApproaches%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2019%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentine  Bouet</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Pascale  Schumann-Bard</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Object Recognition Test in Rodents:. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 391-402. <a href="https://doi.org/10.1016/B978-0-12-812012-5.00027-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-812012-5.00027-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-812012-5.00027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-812012-5.00027-6%26sid%3Dliteratum%253Aachs%26atitle%3DNovel%252BObject%252BRecognition%252BTest%252Bin%252BRodents%25253A%26aulast%3DBouet%26aufirst%3DValentine%26date%3D2018%26spage%3D391%26epage%3D402%26pub%3DElsevier%26atitle%3DHandbook%252Bof%252BObject%252BNovelty%252BRecognition%26date%3D2018%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple Ligands in Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 477-508. <a href="https://doi.org/10.1002/9783527674381.ch16" title="DOI URL">https://doi.org/10.1002/9783527674381.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch16%26sid%3Dliteratum%253Aachs%26atitle%3DMultiple%252BLigands%252Bin%252BNeurodegenerative%252BDiseases%26aulast%3DLalut%26aufirst%3DJulien%26date%3D2017%26date%3D2017%26spage%3D477%26epage%3D508%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivani  Kumar</span>, <span class="hlFld-ContribAuthor ">Suman  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Suresh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">In silico repurposing of antipsychotic drugs for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">BMC Neuroscience</span><span> <strong>2017,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12868-017-0394-8" title="DOI URL">https://doi.org/10.1186/s12868-017-0394-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12868-017-0394-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12868-017-0394-8%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Neuroscience%26atitle%3DIn%252Bsilico%252Brepurposing%252Bof%252Bantipsychotic%252Bdrugs%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKumar%26aufirst%3DShivani%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin  Baranger</span>, <span class="hlFld-ContribAuthor ">Patrizia  Giannoni</span>, <span class="hlFld-ContribAuthor ">Stéphane D.  Girard</span>, <span class="hlFld-ContribAuthor ">Sarah  Girot</span>, <span class="hlFld-ContribAuthor ">Florence  Gaven</span>, <span class="hlFld-ContribAuthor ">Delphine  Stephan</span>, <span class="hlFld-ContribAuthor ">Martine  Migliorati</span>, <span class="hlFld-ContribAuthor ">Michel  Khrestchatisky</span>, <span class="hlFld-ContribAuthor ">Joël  Bockaert</span>, <span class="hlFld-ContribAuthor ">Evelyne  Marchetti-Gauthier</span>, <span class="hlFld-ContribAuthor ">Santiago  Rivera</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">François S.  Roman</span>. </span><span class="cited-content_cbyCitation_article-title">Chronic treatments with a 5-HT 4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>126 </em>, 128-141. <a href="https://doi.org/10.1016/j.neuropharm.2017.08.031" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.08.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.08.031%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DChronic%252Btreatments%252Bwith%252Ba%252B5-HT%252B4%252Breceptor%252Bagonist%252Bdecrease%252Bamyloid%252Bpathology%252Bin%252Bthe%252Bentorhinal%252Bcortex%252Band%252Blearning%252Band%252Bmemory%252Bdeficits%252Bin%252Bthe%252B5xFAD%252Bmouse%252Bmodel%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DBaranger%26aufirst%3DKevin%26date%3D2017%26volume%3D126%26spage%3D128%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Véronique  Lelong-Boulouard</span>, <span class="hlFld-ContribAuthor ">Pierre  Lecouflet</span>, <span class="hlFld-ContribAuthor ">Katia  Hamidouche</span>, <span class="hlFld-ContribAuthor ">François  Dauphin</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>. </span><span class="cited-content_cbyCitation_article-title">Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2017,</strong> <em>234 </em>
                                    (15)
                                     , 2365-2374. <a href="https://doi.org/10.1007/s00213-017-4664-z" title="DOI URL">https://doi.org/10.1007/s00213-017-4664-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-017-4664-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-017-4664-z%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DCo-modulation%252Bof%252Ban%252Ballosteric%252Bmodulator%252Bof%252Bnicotinic%252Breceptor-cholinesterase%252Binhibitor%252B%252528galantamine%252529%252Band%252Ba%252B5-HT4%252Breceptor%252Bagonist%252B%252528RS-67333%252529%25253A%252Beffect%252Bon%252Bscopolamine-induced%252Bmemory%252Bdeficit%252Bin%252Bthe%252Bmouse%26aulast%3DFreret%26aufirst%3DThomas%26date%3D2017%26date%3D2017%26volume%3D234%26issue%3D15%26spage%3D2365%26epage%3D2374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Pierre  Jourdan</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Laïla  El Kihel</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Rémi  Legay</span>, <span class="hlFld-ContribAuthor ">Jana  Sopková-de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Thierry  Cresteil</span>, <span class="hlFld-ContribAuthor ">Aurélie  Malzert-Fréon</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Benzylphenylpyrrolizinones with Anti-amyloid and Radical Scavenging Effects, Potentially Useful in Alzheimer's Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (12)
                                     , 913-916. <a href="https://doi.org/10.1002/cmdc.201700102" title="DOI URL">https://doi.org/10.1002/cmdc.201700102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700102%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DBenzylphenylpyrrolizinones%252Bwith%252BAnti-amyloid%252Band%252BRadical%252BScavenging%252BEffects%25252C%252BPotentially%252BUseful%252Bin%252BAlzheimer%252527s%252BDisease%252BTreatment%26aulast%3DJourdan%26aufirst%3DJean-Pierre%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D12%26spage%3D913%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francisco Javier  Pérez-Areales</span>, <span class="hlFld-ContribAuthor ">Nibal  Betari</span>, <span class="hlFld-ContribAuthor ">Antonio  Viayna</span>, <span class="hlFld-ContribAuthor ">Caterina  Pont</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">José Fernando  Rinaldi Alvarenga</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Lamuela-Raventós</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Francisco Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein–huprine hybrids. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (10)
                                     , 965-981. <a href="https://doi.org/10.4155/fmc-2017-0049" title="DOI URL">https://doi.org/10.4155/fmc-2017-0049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0049%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bmultitarget%252Bbiological%252Bprofiling%252Bof%252Bsecond-generation%252Banti-Alzheimer%252Brhein%2525E2%252580%252593huprine%252Bhybrids%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DFrancisco%2BJavier%26date%3D2017%26volume%3D9%26issue%3D10%26spage%3D965%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Delphine  Karila</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating 5-HT
              4
              and 5-HT
              6
              receptors in Alzheimer’s disease treatment. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (8)
                                     , 781-795. <a href="https://doi.org/10.4155/fmc-2017-0031" title="DOI URL">https://doi.org/10.4155/fmc-2017-0031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0031%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DModulating%252B5-HT%252B4%252Band%252B5-HT%252B6%252Breceptors%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Btreatment%26aulast%3DLalut%26aufirst%3DJulien%26date%3D2017%26volume%3D9%26issue%3D8%26spage%3D781%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent  Douchamps</span>, <span class="hlFld-ContribAuthor ">Chantal  Mathis</span>. </span><span class="cited-content_cbyCitation_article-title">A second wind for the cholinergic system in Alzheimer’s therapy. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Pharmacology</span><span> <strong>2017,</strong> <em>28 </em>
                                    (2 and 3)
                                     , 112-123. <a href="https://doi.org/10.1097/FBP.0000000000000300" title="DOI URL">https://doi.org/10.1097/FBP.0000000000000300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/FBP.0000000000000300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FFBP.0000000000000300%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Pharmacology%26atitle%3DA%252Bsecond%252Bwind%252Bfor%252Bthe%252Bcholinergic%252Bsystem%252Bin%252BAlzheimer%2525E2%252580%252599s%252Btherapy%26aulast%3DDouchamps%26aufirst%3DVincent%26date%3D2017%26volume%3D28%26issue%3D2%2520and%25203%26spage%3D112%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Anti-Alzheimer Hybrid Compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 167-192. <a href="https://doi.org/10.1016/B978-0-08-101011-2.00006-4" title="DOI URL">https://doi.org/10.1016/B978-0-08-101011-2.00006-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-101011-2.00006-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-101011-2.00006-4%26sid%3Dliteratum%253Aachs%26atitle%3DMultitarget%252BAnti-Alzheimer%252BHybrid%252BCompounds%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DDiego%26date%3D2017%26spage%3D167%26epage%3D192%26pub%3DElsevier%26atitle%3DDesign%252Bof%252BHybrid%252BMolecules%252Bfor%252BDrug%252BDevelopment%26date%3D2017%26volume%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Wallach</span>, <span class="hlFld-ContribAuthor ">T.  Colestock</span>, <span class="hlFld-ContribAuthor ">A.  Adejare</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor Targets in Alzheimer’s Disease Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 83-107. <a href="https://doi.org/10.1016/B978-0-12-802810-0.00006-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-802810-0.00006-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-802810-0.00006-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-802810-0.00006-4%26sid%3Dliteratum%253Aachs%26atitle%3DReceptor%252BTargets%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BDrug%252BDiscovery%26aulast%3DWallach%26aufirst%3DJ.%26date%3D2017%26spage%3D83%26epage%3D107%26pub%3DElsevier%26atitle%3DDrug%252BDiscovery%252BApproaches%252Bfor%252Bthe%252BTreatment%252Bof%252BNeurodegenerative%252BDisorders%26date%3D2017%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asha  Hiremathad</span>, <span class="hlFld-ContribAuthor ">Luca  Piemontese</span>. </span><span class="cited-content_cbyCitation_article-title">Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy. </span><span class="cited-content_cbyCitation_journal-name">Neural Regeneration Research</span><span> <strong>2017,</strong> <em>12 </em>
                                    (8)
                                     , 1256. <a href="https://doi.org/10.4103/1673-5374.213541" title="DOI URL">https://doi.org/10.4103/1673-5374.213541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/1673-5374.213541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2F1673-5374.213541%26sid%3Dliteratum%253Aachs%26jtitle%3DNeural%2520Regeneration%2520Research%26atitle%3DHeterocyclic%252Bcompounds%252Bas%252Bkey%252Bstructures%252Bfor%252Bthe%252Binteraction%252Bwith%252Bold%252Band%252Bnew%252Btargets%252Bin%252BAlzheimer%252527s%252Bdisease%252Btherapy%26aulast%3DHiremathad%26aufirst%3DAsha%26date%3D2017%26volume%3D12%26issue%3D8%26spage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M Amélia  Santos</span>, <span class="hlFld-ContribAuthor ">Karam  Chand</span>, <span class="hlFld-ContribAuthor ">Sílvia  Chaves</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (17)
                                     , 2113-2142. <a href="https://doi.org/10.4155/fmc-2016-0103" title="DOI URL">https://doi.org/10.4155/fmc-2016-0103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0103%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252Brepositioning%252BAlzheimer%252527s%252Bdisease%252Bdrugs%252Bbased%252Bon%252Ba%252Bmultitarget%252Bstrategy%26aulast%3DSantos%26aufirst%3DM%2BAm%25C3%25A9lia%26date%3D2016%26volume%3D8%26issue%3D17%26spage%3D2113%26epage%3D2142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samir  Yahiaoui</span>, <span class="hlFld-ContribAuthor ">Katia  Hamidouche</span>, <span class="hlFld-ContribAuthor ">Céline  Ballandonne</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Jana Sopkova  de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>121 </em>, 283-293. <a href="https://doi.org/10.1016/j.ejmech.2016.05.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.05.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.05.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.05.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bmultitarget-directed%252Bligands%252Bwith%252Bboth%252Bserotonergic%252Bsubtype%252B4%252Breceptor%252B%2525285-HT4R%252529%252Bpartial%252Bagonist%252Band%252B5-HT6R%252Bantagonist%252Bactivities%25252C%252Bas%252Bpotential%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DYahiaoui%26aufirst%3DSamir%26date%3D2016%26volume%3D121%26spage%3D283%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gustavo Petri  Guerra</span>, <span class="hlFld-ContribAuthor ">Maribel Antonello  Rubin</span>, <span class="hlFld-ContribAuthor ">Carlos Fernando  Mello</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of learning and memory by natural polyamines. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2016,</strong> <em>112 </em>, 99-118. <a href="https://doi.org/10.1016/j.phrs.2016.03.023" title="DOI URL">https://doi.org/10.1016/j.phrs.2016.03.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2016.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2016.03.023%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DModulation%252Bof%252Blearning%252Band%252Bmemory%252Bby%252Bnatural%252Bpolyamines%26aulast%3DGuerra%26aufirst%3DGustavo%2BPetri%26date%3D2016%26volume%3D112%26spage%3D99%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">Magdalena  Majekova</span>, <span class="hlFld-ContribAuthor ">Milagros  Medina</span>, <span class="hlFld-ContribAuthor ">Massimo  Valoti</span>. </span><span class="cited-content_cbyCitation_article-title">Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2016,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnins.2016.00375" title="DOI URL">https://doi.org/10.3389/fnins.2016.00375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2016.00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2016.00375%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DKey%252BTargets%252Bfor%252BMulti-Target%252BLigands%252BDesigned%252Bto%252BCombat%252BNeurodegeneration%26aulast%3DRamsay%26aufirst%3DRona%2BR.%26date%3D2016%26date%3D2016%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martín  Estrada</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Elena  Soriano</span>, <span class="hlFld-ContribAuthor ">Erik  Laurini</span>, <span class="hlFld-ContribAuthor ">Maurizio  Romano</span>, <span class="hlFld-ContribAuthor ">Sabrina  Pricl</span>, <span class="hlFld-ContribAuthor ">José A  Morales-García</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (11)
                                     , 1191-1207. <a href="https://doi.org/10.4155/fmc-2016-0036" title="DOI URL">https://doi.org/10.4155/fmc-2016-0036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0036%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bneurogenic%252Blipoic-based%252Bhybrids%252Bas%252Binnovative%252BAlzheimer%252527s%252Bdrugs%252Bwith%252B%2525CF%252583-1%252Bagonism%252Band%252B%2525CE%2525B2-secretase%252Binhibition%26aulast%3DEstrada%26aufirst%3DMart%25C3%25ADn%26date%3D2016%26volume%3D8%26issue%3D11%26spage%3D1191%26epage%3D1207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Benjamin B.  Tournier</span>, <span class="hlFld-ContribAuthor ">Thomas  Cailly</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Céline  Ballandonne</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Philippe  Millet</span>, <span class="hlFld-ContribAuthor ">Frédéric  Fabis</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel serotonin 4 receptor radiotracers for single photon emission computed tomography. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>116 </em>, 90-101. <a href="https://doi.org/10.1016/j.ejmech.2016.03.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252Bserotonin%252B4%252Breceptor%252Bradiotracers%252Bfor%252Bsingle%252Bphoton%252Bemission%252Bcomputed%252Btomography%26aulast%3DLalut%26aufirst%3DJulien%26date%3D2016%26volume%3D116%26spage%3D90%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Pierre  Jourdan</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Laïla  El Kihel</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Rémi  Legay</span>, <span class="hlFld-ContribAuthor ">Jana  Sopkova-de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Thierry  Cresteil</span>, <span class="hlFld-ContribAuthor ">Aurélie  Malzert-Fréon</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>114 </em>, 365-379. <a href="https://doi.org/10.1016/j.ejmech.2016.03.023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bbenzylidenephenylpyrrolizinones%252Bwith%252Bpleiotropic%252Bactivities%252Bpotentially%252Buseful%252Bin%252BAlzheimer%252527s%252Bdisease%252Btreatment%26aulast%3DJourdan%26aufirst%3DJean-Pierre%26date%3D2016%26volume%3D114%26spage%3D365%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rebecca E.  Hughes</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>. </span><span class="cited-content_cbyCitation_article-title">One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2016,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnins.2016.00177" title="DOI URL">https://doi.org/10.3389/fnins.2016.00177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2016.00177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2016.00177%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DOne%252Bfor%252BAll%25253F%252BHitting%252BMultiple%252BAlzheimer%252527s%252BDisease%252BTargets%252Bwith%252BOne%252BDrug%26aulast%3DHughes%26aufirst%3DRebecca%2BE.%26date%3D2016%26date%3D2016%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michalina  Hebda</span>, <span class="hlFld-ContribAuthor ">Marek  Bajda</span>, <span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Natalia  Szałaj</span>, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Tomasz  Wichur</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (4)
                                     , 410. <a href="https://doi.org/10.3390/molecules21040410" title="DOI URL">https://doi.org/10.3390/molecules21040410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21040410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21040410%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BMolecular%252BModelling%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BHeterodimeric%25252C%252BMultiple%252BLigands%252BTargeting%252BCholinesterases%252Band%252BAmyloid%252BBeta%26aulast%3DHebda%26aufirst%3DMichalina%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michela  Rosini</span>, <span class="hlFld-ContribAuthor ">Elena  Simoni</span>, <span class="hlFld-ContribAuthor ">Roberta  Caporaso</span>, <span class="hlFld-ContribAuthor ">Anna  Minarini</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (6)
                                     , 697-711. <a href="https://doi.org/10.4155/fmc-2016-0003" title="DOI URL">https://doi.org/10.4155/fmc-2016-0003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0003%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMultitarget%252Bstrategies%252Bin%252BAlzheimer%252527s%252Bdisease%25253A%252Bbenefits%252Band%252Bchallenges%252Bon%252Bthe%252Broad%252Bto%252Btherapeutics%26aulast%3DRosini%26aufirst%3DMichela%26date%3D2016%26volume%3D8%26issue%3D6%26spage%3D697%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabeth K.  Olsen</span>, <span class="hlFld-ContribAuthor ">Espen  Hansen</span>, <span class="hlFld-ContribAuthor ">Lindon  W. K. Moodie</span>, <span class="hlFld-ContribAuthor ">Johan  Isaksson</span>, <span class="hlFld-ContribAuthor ">Kristina  Sepčić</span>, <span class="hlFld-ContribAuthor ">Marija  Cergolj</span>, <span class="hlFld-ContribAuthor ">Johan  Svenson</span>, <span class="hlFld-ContribAuthor ">Jeanette H.  Andersen</span>. </span><span class="cited-content_cbyCitation_article-title">Marine AChE inhibitors isolated from Geodia barretti: natural compounds and their synthetic analogs. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (5)
                                     , 1629-1640. <a href="https://doi.org/10.1039/C5OB02416A" title="DOI URL">https://doi.org/10.1039/C5OB02416A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02416A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02416A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMarine%252BAChE%252Binhibitors%252Bisolated%252Bfrom%252BGeodia%252Bbarretti%25253A%252Bnatural%252Bcompounds%252Band%252Btheir%252Bsynthetic%252Banalogs%26aulast%3DOlsen%26aufirst%3DElisabeth%2BK.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D5%26spage%3D1629%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">New paradigms in GPCR drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2015,</strong> <em>98 </em>
                                    (4)
                                     , 541-555. <a href="https://doi.org/10.1016/j.bcp.2015.08.085" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.08.085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.08.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.08.085%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DNew%252Bparadigms%252Bin%252BGPCR%252Bdrug%252Bdiscovery%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2015%26volume%3D98%26issue%3D4%26spage%3D541%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of donecopride, DPZ, and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pleiotropic interest of DBS AChEI/5-HT<sub>4</sub>R agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic pathways for access to compounds <b>1</b> and <b>6</b>–<b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions and reagents: (a) CDI, THF; (b) KO<sub>2</sub>CCH<sub>2</sub>CO<sub>2</sub>Et, MgCl<sub>2</sub>, THF; (c) <i>N</i>-Boc 4-iodomethylpiperidine, K<sub>2</sub>CO<sub>3</sub>, DMF; (d) KOH, EtOH/H<sub>2</sub>O; (e) TFA, DCM; (f) RBr, K<sub>2</sub>CO<sub>3</sub>, DMF; (g) HCl/EtOH; (h) H<sub>2</sub>NOR’, HCl, pyridine; (i) NaBH<sub>4</sub>, MeOH; (j) TEA, DMF; (k) HOBT, EDCI·HCl, <i>N</i>-Boc 4-aminomethylpiperidine, DMF; (l) CyHexCH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF; (m) <i>N</i>-CyHexCH<sub>2</sub>-4-hydroxymethylpiperidine, NaH, THF.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ORTEP diagram of donecopride (A) and superposition of its four conformations in the crystal (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Donecopride positioned in the (<i>h</i>)5-HT<sub>4</sub>R (A) and (<i>h</i>)AChE (B) binding sites from docking studies. The compound and the side chains of the binding site residues are represented by the stick-like shapes, and the protein is represented in ribbon. This figure was made with PYMOL (DeLano Scientific, 2002, San Carlo, U.S.A.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of donecopride on spontaneous locomotor activity. Data are expressed as the mean ± standard deviation (<i>n</i> = 9–10). Drugs were administered intraperitoneally (IP) 30 min before placing mice in the actimeter, except for DPZ which was administered subcutaneously (SC) 20 min before the test. Donecopride: 0.1–1–10 mg/kg; AMP: amphetamine 2 mg/kg; CPZ: chlorpromazine 10 mg/kg; RS + DPZ: <b>2</b> 0.1 mg/kg + DPZ 0.3 mg/kg (*<i>p</i> < 0.05 NaCl, SNK test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of donecopride on scopolamine-induced impairment during the spontaneous alternation test. Data are expressed as the mean ± standard deviation (<i>n</i> = 10–12). Drugs were administered IP 30 min before the test, except for DPZ, and scopolamine was administered SC 30 and 20 min, respectively. DC (donecopride): 0.1, 0.3, 3, and 10 mg/kg; DPZ: 1 mg/kg; RS + DPZ: <b>2</b> 0.1 mg/kg + DPZ 0.3 mg/kg; scopolamine: 0.5 mg/kg (*<i>p</i> < 0.05 versus 50%; univariate <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of donecopride on time immobility during the forced swimming test. Data are expressed as the mean ± standard deviation (<i>n</i> = 10–12). Drugs were administered IP 30 min before the test. Donecopride: 0.3, 3 mg/kg; imipramine (IMI) 16 mg/kg (* <i>p</i> < 0.05 NaCl, Student–Newman–Keuls [SNK] test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Acute in vivo treatment with donecopride shows a tendency to increase sAPPα release in the CSF of 2-month-old C57BL/6 mice. sAPPα was quantified via enzyme-linked immunosorbent assay (ELISA). Each dot represents an individual mouse; the horizontal lines show the means of each group. The <i>p</i> value is indicated (unpaired Student’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Two representative docking poses of compound <b>19</b> into (<i>h</i>)AChE. The compounds and the side chains of the binding site residues are in stick and the protein in ribbon representation. This figure was made with PYMOL (DeLano Scientific, 2002, San Carlo, U.S.A.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/medium/jm-2015-00115a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Two representative docking poses of compound <b>10</b> into (<i>h</i>)AChE. The compounds and the side chains of the binding site residues are represented by the stick-like shapes and the protein is represented by ribbon. This figure was made with PYMOL (DeLano Scientific, 2002, San Carlo, U.S.A.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-7/acs.jmedchem.5b00115/20150403/images/large/jm-2015-00115a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00115&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78601" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78601" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 89 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Stelzmann, R.</span><span> </span><span class="NLM_article-title">An English translation of Alzheimer’s 1907 paper, “Über eine eigenartige erkankung der hirnrinde</span> <span class="citation_source-journal">Clinical Anat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1002%2Fca.980080612" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=429-431&author=R.+Stelzmann&title=An+English+translation+of+Alzheimer%E2%80%99s+1907+paper%2C+%E2%80%9C%C3%9Cber+eine+eigenartige+erkankung+der+hirnrinde"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fca.980080612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fca.980080612%26sid%3Dliteratum%253Aachs%26aulast%3DStelzmann%26aufirst%3DR.%26atitle%3DAn%2520English%2520translation%2520of%2520Alzheimer%25E2%2580%2599s%25201907%2520paper%252C%2520%25E2%2580%259C%25C3%259Cber%2520eine%2520eigenartige%2520erkankung%2520der%2520hirnrinde%26jtitle%3DClinical%2520Anat.%26date%3D1995%26volume%3D1%26spage%3D429%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span> </span><span class="NLM_article-title">World Alzheimer Report 2013: the global economic impact of dementia</span>. Alzheimer’s Disease International Home Page. <a href="http://www.alz.co.uk" class="extLink">http://www.alz.co.uk</a> (accessed December 12,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Alzheimer+Report+2013%3A+the+global+economic+impact+of+dementia.+Alzheimer%E2%80%99s+Disease+International+Home+Page.+http%3A%2F%2Fwww.alz.co.uk+%28accessed+December+12%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DWorld%2520Alzheimer%2520Report%25202013%253A%2520the%2520global%2520economic%2520impact%2520of%2520dementia%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%2520Home%2520Page%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Mount, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downton, C.</span><span> </span><span class="NLM_article-title">Alzheimer disease: progress or profit?</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1038%2Fnm0706-780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=16829947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1eks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=780-784&author=C.+Mountauthor=C.+Downton&title=Alzheimer+disease%3A+progress+or+profit%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease: progress or profit?</span></div><div class="casAuthors">Mount, Claire; Downton, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">780-784</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp458aEz9g7-rVg90H21EOLACvtfcHk0linCLI02twITw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1eks7s%253D&md5=53e9af938ef93beee99bc9a7feb7eeea</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm0706-780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0706-780%26sid%3Dliteratum%253Aachs%26aulast%3DMount%26aufirst%3DC.%26aulast%3DDownton%26aufirst%3DC.%26atitle%3DAlzheimer%2520disease%253A%2520progress%2520or%2520profit%253F%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D780%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Melnikova, I.</span><span> </span><span class="NLM_article-title">Therapies for Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=341-342&author=I.+Melnikova&title=Therapies+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelnikova%26aufirst%3DI.%26atitle%3DTherapies%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D341%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target design strategies in the context of Alzheimer’s disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the diving forces</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1914</span><span class="NLM_x">–</span> <span class="NLM_lpage">1923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1007%2Fs11064-014-1250-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=24493627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=1914-1923&author=M.+Rosiniauthor=E.+Simoniauthor=A.+Minariniauthor=C.+Melchiorre&title=Multi-target+design+strategies+in+the+context+of+Alzheimer%E2%80%99s+disease%3A+acetylcholinesterase+inhibition+and+NMDA+receptor+antagonism+as+the+diving+forces"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target Design Strategies in the Context of Alzheimer's Disease: Acetylcholinesterase Inhibition and NMDA Receptor Antagonism as the Driving Forces</span></div><div class="casAuthors">Rosini, Michela; Simoni, Elena; Minarini, Anna; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1914-1923</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In recent years, the multi-target-directed ligand concept has been used to design a variety of mols. hitting different biol. targets for Alzheimer's disease.  We have sought to combine, in the same mol., the neuroprotective action of N-methyl-D-aspartate receptor antagonism with the symptomatic relief offered by cholinergic activity through acetylcholinesterase inhibition.  This strategy could potentially maintain the pos. outcomes of memantine-acetylcholinesterase inhibitor combinations, but with the benefits of a single mol. therapy.  Herein, we discuss selected examples of multifunctional compds., which we rationally designed to simultaneously modulate these targets.  We also examine the intertwined relationship between acetylcholinesterase, N-methyl-D-aspartate receptors, and other active players in the neurotoxic cascade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1nvk7HjF3w7Vg90H21EOLACvtfcHk0linCLI02twITw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2mtb4%253D&md5=00aaa680058bb58d9aec21c0648e60ee</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs11064-014-1250-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-014-1250-1%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target%2520design%2520strategies%2520in%2520the%2520context%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520acetylcholinesterase%2520inhibition%2520and%2520NMDA%2520receptor%2520antagonism%2520as%2520the%2520diving%2520forces%26jtitle%3DNeurochem.%2520Res.%26date%3D2014%26volume%3D39%26spage%3D1914%26epage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, J.</span><span> </span><span class="NLM_article-title">Can the pharmaceutical industry reduce attrition rates?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=711-715&author=I.+Kolaauthor=J.+Landis&title=Can+the+pharmaceutical+industry+reduce+attrition+rates%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKola%26aufirst%3DI.%26aulast%3DLandis%26aufirst%3DJ.%26atitle%3DCan%2520the%2520pharmaceutical%2520industry%2520reduce%2520attrition%2520rates%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D711%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uliassi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Two diseases, one approach: multitarget drug discovery in Alzheimer’s and neglected tropical diseases</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=853-861&author=F.+Pratiauthor=E.+Uliassiauthor=M.+L.+Bolognesi&title=Two+diseases%2C+one+approach%3A+multitarget+drug+discovery+in+Alzheimer%E2%80%99s+and+neglected+tropical+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DUliassi%26aufirst%3DE.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DTwo%2520diseases%252C%2520one%2520approach%253A%2520multitarget%2520drug%2520discovery%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520neglected%2520tropical%2520diseases%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D853%26epage%3D861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">From magic bullets to designed multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FS1359-6446%2804%2903163-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=15279847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=641-651&author=R.+Morphyauthor=C.+Kayauthor=Z.+Rankovic&title=From+magic+bullets+to+designed+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">From magic bullets to designed multiple ligands</span></div><div class="casAuthors">Morphy, Richard; Kay, Corinne; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">641-651</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  A major trend in medicinal chem. in the coming years will be the rational design of ligands that are capable of modulating multiple disease-relevant targets in a specific manner.  Increasingly, it is being recognized that a balanced modulation of several targets can provide a superior therapeutic effect and side effect profile compared to the action of a selective ligand.  Rational approaches in which structural features from selective ligands are combined have produced designed multiple ligands that span a wide variety of targets and target classes.  A key challenge in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile.  An anal. of literature examples reveals trends and insights that might help medicinal chemists discover the next generation of these types of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcsGpfzZok5rVg90H21EOLACvtfcHk0ljUOyE92aeIDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D&md5=cd2491baad707043dbee4f59ccad9e1d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903163-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903163-0%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DKay%26aufirst%3DC.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFrom%2520magic%2520bullets%2520to%2520designed%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D641%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0ljUOyE92aeIDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Espinoza-Fonseca, L. M.</span><span> </span><span class="NLM_article-title">The benefits of the multi-target approach in drug design and discovery</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">896</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2Fj.bmc.2005.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=16203151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=896-897&author=L.+M.+Espinoza-Fonseca&title=The+benefits+of+the+multi-target+approach+in+drug+design+and+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The benefits of the multi-target approach in drug design and discovery</span></div><div class="casAuthors">Espinoza-Fonseca, L. Michel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">896-897</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Promiscuous binding has been considered to be a problem in the design and development of new drugs against a given disease.  However, promiscuity in mol. recognition is not all bad news, and scientists are currently taking advantage of the emerging promiscuous binding' or multi-target approach' in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocGqPWnEVzk7Vg90H21EOLACvtfcHk0lgzqoJD344amg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOjuw%253D%253D&md5=3daf3304b9bc2c60575b5e3003e89897</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DEspinoza-Fonseca%26aufirst%3DL.%2BM.%26atitle%3DThe%2520benefits%2520of%2520the%2520multi-target%2520approach%2520in%2520drug%2520design%2520and%2520discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D896%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Fragments, network biology and designing multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=156-160&author=R.+Morphyauthor=Z.+Rankovic&title=Fragments%2C+network+biology+and+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFragments%252C%2520network%2520biology%2520and%2520designing%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D156%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Korcsmáros, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalay, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böde, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovács, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csermely, P.</span><span> </span><span class="NLM_article-title">How to design multi-target drugs</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=799-808&author=T.+Korcsm%C3%A1rosauthor=M.+S.+Szalayauthor=C.+B%C3%B6deauthor=I.+A.+Kov%C3%A1csauthor=P.+Csermely&title=How+to+design+multi-target+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKorcsm%25C3%25A1ros%26aufirst%3DT.%26aulast%3DSzalay%26aufirst%3DM.%2BS.%26aulast%3DB%25C3%25B6de%26aufirst%3DC.%26aulast%3DKov%25C3%25A1cs%26aufirst%3DI.%2BA.%26aulast%3DCsermely%26aufirst%3DP.%26atitle%3DHow%2520to%2520design%2520multi-target%2520drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D799%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Bolognesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzi, R.</span><span> </span><span class="NLM_article-title">Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4882</span><span class="NLM_x">–</span> <span class="NLM_lpage">4897</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=4882-4897&author=M.+Bolognesiauthor=R.+Banzi&title=Novel+class+of+quinone-bearing+polyamines+as+multi-target-directed+ligands+to+combat+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%26aulast%3DBanzi%26aufirst%3DR.%26atitle%3DNovel%2520class%2520of%2520quinone-bearing%2520polyamines%2520as%2520multi-target-directed%2520ligands%2520to%2520combat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D10%26spage%3D4882%26epage%3D4897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Meunier, B.</span><span> </span><span class="NLM_article-title">Hybrid molecules with a dual mode of action: dream or reality?</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar7000843" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=69-77&author=B.+Meunier&title=Hybrid+molecules+with+a+dual+mode+of+action%3A+dream+or+reality%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Far7000843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far7000843%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DB.%26atitle%3DHybrid%2520molecules%2520with%2520a%2520dual%2520mode%2520of%2520action%253A%2520dream%2520or%2520reality%253F%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D69%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+Bolognesi&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lgzqoJD344amg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Morphy, R.; Rankovic, Z.</span><span> </span><span class="NLM_article-title">Multi-Target Drugs. Strategies and challenges for medicinal chemists</span>. In  <span class="citation_source-book">The Practice of Medicinal Chemistry</span>, <span class="NLM_edition">3</span>rd ed; <span class="NLM_contrib-group">Wermuth, C. G.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FB978-0-12-374194-3.00027-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=549-571&author=R.+Morphy&author=Z.+Rankovicauthor=C.+G.+Wermuth&title=The+Practice+of+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-374194-3.00027-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-374194-3.00027-5%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DMulti-Target%2520Drugs.%2520Strategies%2520and%2520challenges%2520for%2520medicinal%2520chemists%26btitle%3DThe%2520Practice%2520of%2520Medicinal%2520Chemistry%26aulast%3DWermuth%26aufirst%3DC.%2BG.%26pub%3DElsevier%26date%3D2008%26spage%3D549%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designing multiple ligands - medicinal chemistry strategies and challenges</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F138161209787315594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=19199984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=587-600&author=R.+Morphyauthor=Z.+Rankovic&title=Designing+multiple+ligands+-+medicinal+chemistry+strategies+and+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Designing multiple ligands - medicinal chemistry strategies and challenges</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">587-600</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It has been widely recognized over the recent years that parallel modulation of multiple biol. targets can be beneficial for treatment of diseases with complex etiologies such as cancer asthma, and psychiatric disease.  In this article, current strategies for the generation of ligands with a specific multi-target profile (designed multiple ligands or DMLs) are described and a no. of illustrative example are given.  Designing multiple ligands is frequently a challenging endeavor for medicinal chemists, with the need to appropriately balance affinity for 2 or more targets while obtaining physicochem. and pharmacokinetic properties that are consistent with the administration of an oral drug.  Given that the properties of DMLs are influenced to a large extent by the proteomic superfamily to which the targets belong and the lead generation strategy that is pursued, an early assessment of the feasibility of any given DML project is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUo6NjoK5D-LVg90H21EOLACvtfcHk0li491-xIK62Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D&md5=fa34039be6e9c3b489f530fc74fd0346</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F138161209787315594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787315594%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigning%2520multiple%2520ligands%2520-%2520medicinal%2520chemistry%2520strategies%2520and%2520challenges%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D587%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span> </span><span class="NLM_article-title">Polyamines in drug discovery: from the universal template approach to the multitarget-directed ligand design strategy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5906</span><span class="NLM_x">–</span> <span class="NLM_lpage">5914</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100293f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5906-5914&author=C.+Melchiorreauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiatti&title=Polyamines+in+drug+discovery%3A+from+the+universal+template+approach+to+the+multitarget-directed+ligand+design+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm100293f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100293f%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26atitle%3DPolyamines%2520in%2520drug%2520discovery%253A%2520from%2520the%2520universal%2520template%2520approach%2520to%2520the%2520multitarget-directed%2520ligand%2520design%2520strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5906%26epage%3D5914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Why design multi-target drugs?</span> In  <span class="citation_source-book">Designing Multi-Target Drugs</span>; <span class="NLM_contrib-group">Morphy, J. R.; Harris, C. J.</span>, Eds.; <span class="NLM_publisher-name">RCS Publishing</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">394</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=394&author=A.+L.+Hopkinsauthor=J.+R.+Morphy&author=C.+J.+Harris&title=Designing+Multi-Target+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DWhy%2520design%2520multi-target%2520drugs%253F%26btitle%3DDesigning%2520Multi-Target%2520Drugs%26aulast%3DMorphy%26aufirst%3DJ.%2BR.%26pub%3DRCS%2520Publishing%26date%3D2012%26spage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. T.</span><span> </span><span class="NLM_article-title">Multi-target drugs: The trend of drug research and development</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e40262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1371%2Fjournal.pone.0040262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=22768266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVaisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e40262&author=J.+J.+Luauthor=W.+Panauthor=Y.+J.+Huauthor=Y.+T.+Wang&title=Multi-target+drugs%3A+The+trend+of+drug+research+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target drugs: the trend of drug research and development</span></div><div class="casAuthors">Lu, Jin-Jian; Pan, Wei; Hu, Yuan-Jia; Wang, Yi-Tao</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e40262</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Summarizing the status of drugs in the market and examg. the trend of drug research and development is important in drug discovery.  In this study, we compared the drug targets and the market sales of the new mol. entities approved by the U.S. Food and Drug Administration from Jan. 2000 to Dec. 2009.  Two networks, namely, the target-target and drug-drug networks, have been set up using the network anal. tools.  The multi-target drugs have much more potential, as shown by the network visualization and the market trends.  We discussed the possible reasons and proposed the rational strategies for drug research and development in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrapZATY1GnWbVg90H21EOLACvtfcHk0liOBu9ETcqREA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVaisr8%253D&md5=79489aaf7a36ee9c30287621a7244a6a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0040262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0040262%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%2BJ.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DY.%2BJ.%26aulast%3DWang%26aufirst%3DY.%2BT.%26atitle%3DMulti-target%2520drugs%253A%2520The%2520trend%2520of%2520drug%2520research%2520and%2520development%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De40262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">The physicochemical challenges of designing multiple ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4961</span><span class="NLM_x">–</span> <span class="NLM_lpage">4970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4961-4970&author=R.+Morphyauthor=Z.+Rankovic&title=The+physicochemical+challenges+of+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The Physicochemical Challenges of Designing Multiple Ligands</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4961-4970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. designed to bind more than one target can provide a therapeutic benefit relative to highly target-selective ligands.  The physicochem. properties of designed multiple ligands were found to be less druglike than those for preclin. compds. in general.  These properties are controlled by the superfamily to which the targets belong and the lead discovery strategy that was followed.  The properties for peptide G-protein-coupled receptor (GPCR) ligands were the least favorable for oral delivery, whereas transporter, monoamine GPCR, and oxidase ligands were the most druglike.  The lead discovery strategy, framework combination or screening, exerts a profound influence on the property values.  Combining the frameworks from two selective ligands often results in large, complex dual ligands, but druglike ligands can be achieved if the degree of framework overlap is maximized and the size of the selective ligands minimized.  For some target combinations, a screening approach may provide a route to smaller, less complex leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonGHbXyxgv4LVg90H21EOLACvtfcHk0liOBu9ETcqREA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D&md5=c7a227848516d0aa58ed037a582943fe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0603015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603015%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DThe%2520physicochemical%2520challenges%2520of%2520designing%2520multiple%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4961%26epage%3D4970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Schmitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhardt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeller, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuser, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolich, L.</span><span> </span><span class="NLM_article-title">Combination therapy in Alzheimer’s disease: a review of current evidence</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=827-844&author=B.+Schmittauthor=T.+Bernhardtauthor=H.+J.+Moellerauthor=I.+Heuserauthor=L.+Frolich&title=Combination+therapy+in+Alzheimer%E2%80%99s+disease%3A+a+review+of+current+evidence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DB.%26aulast%3DBernhardt%26aufirst%3DT.%26aulast%3DMoeller%26aufirst%3DH.%2BJ.%26aulast%3DHeuser%26aufirst%3DI.%26aulast%3DFrolich%26aufirst%3DL.%26atitle%3DCombination%2520therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520review%2520of%2520current%2520evidence%26jtitle%3DCNS%2520Drugs%26date%3D2004%26volume%3D18%26spage%3D827%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Progress in acetylcholinesterase inhibitors for Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1517%2F13543776.16.6.811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVOhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=811-823&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=Progress+in+acetylcholinesterase+inhibitors+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in acetylcholinesterase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Bolognesi, Maria Laura; Minarini, Anna; Tumiatti, Vincenzo; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">811-823</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Current pharmacotherapy of Alzheimer's disease (AD) involves drugs that are known as acetylcholinesterase inhibitors (AChEIs), which increase the acetylcholine concn. in the brain.  Although effective in improving cognitive, behavioral and functional impairments, these drugs are not able to alter disease progression.  In this review, the recent patent literature on AChEIs from 2002 to early 2005 will be discussed, focusing attention on the novel analogs of the approved drugs, as well as on the most important AD therapeutic advances.  The clin. efficacy of AChEIs will probably be enhanced by their combination with other drugs acting through different pharmacol. mechanisms.  As the neuronal loss comprises more than the forebrain cholinergic system, the weak effectiveness of AChEIs is not surprising.  Besides the cholinergic hypothesis' approaches, new treatments are emerging based on multipotent compds. able to target the underlying pathogenic mechanisms of AD; these treatments are summarized herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptSL4AfWXbaLVg90H21EOLACvtfcHk0liOBu9ETcqREA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVOhu7g%253D&md5=1094dc53e60353b61a4ac6fe0cbbfee8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F13543776.16.6.811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.16.6.811%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DProgress%2520in%2520acetylcholinesterase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D811%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zhang, H.-Y.</span><span> </span><span class="NLM_article-title">One-compound-multiple-targets strategy to combat Alzheimer’s disease</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=5260-5264&author=H.-Y.+Zhang&title=One-compound-multiple-targets+strategy+to+combat+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Y.%26atitle%3DOne-compound-multiple-targets%2520strategy%2520to%2520combat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D5260%26epage%3D5264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F156720506779025288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=17168653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=541-550&author=M.+B.+Youdim&title=The+path+from+anti+Parkinson+drug+selegiline+and+rasagiline+to+multifunctional+neuroprotective+anti+Alzheimer+drugs+ladostigil+and+m30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and M30</span></div><div class="casAuthors">Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">541-550</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The therapeutic use of enzyme inhibitors in treatment of neurodegenerative diseases has its origin in the anti Parkinson action of the selective monoamine oxidase (MAO) B inhibitor, 1-deprenyl (selegiline), a failed anti depressant in 1975.  This led to further development of MAO- A and B, catechol-O-methyltansferase and cholinestrerase inhibitors as anti Parkinson and Alzheimer drugs.  One of the main reasons for the cognitive deficit in dementia of the Alzheimer' type (AD) and in dementia with Lewy bodies (DLB) is degeneration of cholinergic cortical neurons and synaptic plasticity.  This led to a correlation that similar to Parkinson's Disease (PD), cholinesterase inhibitors (ChEI) may also have therapeutic activity in AD.  Significant percentage of AD and DLB subjects also nigrostriatal dopaminergic, locus ceruleous noradrenergic and raphe nucleus serotoninergic neurons.  The present ChEI anti AD drugs have limited symptomatic activity and devoid of neuroprotective property that is needed for disease modifying action.  It is becoming clear that there are no magic bullets for neurodegenerative disorders and shut gun approach is needed either as polypharmacol. or drugs with multiple activity at different target sites in the CNS.  The complex pathol. of AD as well as cascade of events that leads to the neurodegenerative process has led us to develop several multifunctional neuroprotective drugs with several CNS targets with possible disease modifying activity.  Employing the pharmacophore of our antiparkinson drug rasagiline (Azilect, Agilect, N-propagrgyl-1R-aminoindan) we have developed a novel multifunctional neuroprotective drug, ladostigil [TV-3326 (N-propargyl-3R-aminoindan-5yl)-Et methylcarbamate], with both cholinesterase-butyrylesterase (Ch-BuE) and brain selective monoamine-oxidase (MAO) AB inhibitory activities possessing the neuroprotective-neurescue propargyl moiety, as potential treatment of AD and DLB and PD with dementias.  Since brain MAO and iron increase in AD, PD and aging, that could lead to iron dependent oxidative stress neurodegeneration, we have developed another series of multifunctional drugs (M30 HLA-20 series) which are brain permeable iron chelators- brain selective MAO inhibitors and possess the propargyl neuroprotective moiety.  These series of drugs have the ability of regulating and processing APP (amyloid precursor protein) and reducing Aβ peptide, since APP is a metaloprotein, with an iron responsive element 5''UTR similar to transferring and ferritin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUf6C6njrCALVg90H21EOLACvtfcHk0liOBu9ETcqREA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrF&md5=33be9cc15d120660265a0927b176d0dd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F156720506779025288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506779025288%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DThe%2520path%2520from%2520anti%2520Parkinson%2520drug%2520selegiline%2520and%2520rasagiline%2520to%2520multifunctional%2520neuroprotective%2520anti%2520Alzheimer%2520drugs%2520ladostigil%2520and%2520m30%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D541%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Multifunctional neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimer’s and Parkinson’s diseases</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1358%2Fdof.2006.031.05.985904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFyntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=447-460&author=C.+J.+Van+der+Schyfauthor=W.+J.+Geldenhuysauthor=M.+B.+Youdim&title=Multifunctional+neuroprotective+drugs+for+the+treatment+of+cognitive+and+movement+impairment+disorders%2C+including+Alzheimer%E2%80%99s+and+Parkinson%E2%80%99s+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimer's and Parkinson's diseases</span></div><div class="casAuthors">Van der Schyf, Cornelis J.; Geldenhuys, Werner J.; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">447-460</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The concept of targeting multiple disease etiologies that lead to cognitive and movement impairment in neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and stroke, is challenging the widely held assumption that "silver bullet" agents are superior to "dirty drugs" in the pharmacol. treatment of these diseases.  Accumulating evidence in the literature suggests that a drug with two or more mechanisms of action targeted at multiple etiologies of the same disease may offer greater therapeutic benefit in certain disorders than a drug that targets only one disease etiol.  In addn., the use of a single such multifunctional drug possessing several pharmacol. active moieties may yield a more favorable side effect profile than a combination of several drugs that individually target the same disease etiologies.  In this review, we offer a synopsis of therapeutic strategies and novel investigative drugs developed in our own and other labs. that modulate multiple disease targets assocd. with cognitive and movement impairment disorders, including cognitive decline assocd. with Alzheimer's disease, Parkinson's disease with dementia and movement deficits in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXfldsPAa7krVg90H21EOLACvtfcHk0liFe5K0Jz6eNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFyntbk%253D&md5=4899ea8eef04811b55f1c4638898dc42</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.05.985904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.05.985904%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMultifunctional%2520neuroprotective%2520drugs%2520for%2520the%2520treatment%2520of%2520cognitive%2520and%2520movement%2520impairment%2520disorders%252C%2520including%2520Alzheimer%25E2%2580%2599s%2520and%2520Parkinson%25E2%2580%2599s%2520diseases%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D447%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bajda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzior, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignasik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malawska, B.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands in Alzheimer’s disease treatment</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4949</span><span class="NLM_x">–</span> <span class="NLM_lpage">4975</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F092986711797535245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=22050745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4949-4975&author=M.+Bajdaauthor=N.+Guziorauthor=M.+Ignasikauthor=B.+Malawska&title=Multi-target-directed+ligands+in+Alzheimer%E2%80%99s+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-directed ligands in Alzheimer's disease treatment</span></div><div class="casAuthors">Bajda, M.; Guzior, N.; Ignasik, M.; Malawska, B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">4949-4975</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Among the various drug discovery methods, a very promising modern approach consists in designing multi-target-directed ligands (MTDLs).  This methodol. has been specifically developed for treatment of disorders with complex pathol. mechanisms.  One such disorder is Alzheimer's disease (AD), currently the most common multifactorial neurodegenerative disease.  AD is related to increased levels of the amyloid β peptide (Aβ) and the hyperphosphorylated tau protein, along with loss of neurons and synapses.  Moreover, there is some evidence pointing to the role of oxidative stress, metal ion deregulation, inflammation and cell cycle regulatory failure in its pathogenesis.  There are many attractive targets for the development of anti-AD drugs, and the multi-factor nature of this disease calls for multi-target-directed compds. which can be beneficial for AD treatment.  This review presents the discovery of dual- and multi-acting anti-AD drug candidates, focusing on the novel design strategy and the compds. it yields - particularly hybrids obtained by linking structurally active moieties interacting with different targets.  The first group of compds. includes cholinesterase inhibitors acting as dual binding site inhibitors and/or inhibitors with addnl. properties.  These compds. are characterized by increased potency against acetylcholinesterase (AChE) and Aβ plaque formation with addnl. properties such as antioxidant activity, neuroprotective, and metal-complexing property, voltage-dependent calcium channel antagonistic activity, inhibitory activity against glutamate-induced excitotoxicity, histamine H3 receptor antagonism, cannabinoid CB1 receptor antagonism and β-secretase (BACE1) inhibition.  A novel class of compds. represents the combination of dual BACE1 inhibitors with metal chelators, and dual modulators of γ-secretase with peroxisome proliferator-activated receptor γ (PPARγ).  We have reviewed the latest reports (2008-2011) presenting new multi-target-directed compds. in Alzheimer's disease treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZHSluHvxy4bVg90H21EOLACvtfcHk0liFe5K0Jz6eNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOrtL3F&md5=c8f35f849c399d43c90570f71ca10e13</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F092986711797535245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797535245%26sid%3Dliteratum%253Aachs%26aulast%3DBajda%26aufirst%3DM.%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DIgnasik%26aufirst%3DM.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DMulti-target-directed%2520ligands%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4949%26epage%3D4975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Carmo Carreiras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesus Perry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paula Francisco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, A.</span><span> </span><span class="NLM_article-title">The multifactorial nature of Alzheimer’s disease for developing potential therapeutics</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1745</span><span class="NLM_x">–</span> <span class="NLM_lpage">1770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F15680266113139990135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=23931435" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1745-1770&author=M.+Carmo+Carreirasauthor=E.+Mendesauthor=M.+Jesus+Perryauthor=A.+Paula+Franciscoauthor=J.+Marco-Contellesauthor=M.+Carreirasauthor=M.+Perryauthor=A.+Francisco&title=The+multifactorial+nature+of+Alzheimer%E2%80%99s+disease+for+developing+potential+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990135%26sid%3Dliteratum%253Aachs%26aulast%3DCarmo%2BCarreiras%26aufirst%3DM.%26aulast%3DMendes%26aufirst%3DE.%26aulast%3DJesus%2BPerry%26aufirst%3DM.%26aulast%3DPaula%2BFrancisco%26aufirst%3DA.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DCarreiras%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DM.%26aulast%3DFrancisco%26aufirst%3DA.%26atitle%3DThe%2520multifactorial%2520nature%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520for%2520developing%2520potential%2520therapeutics%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1745%26epage%3D1770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=115-129&author=W.+J.+Geldenhuysauthor=C.+J.+Van+der+Schyf&title=Designing+drugs+with+multi-target+activity%3A+the+next+step+in+the+treatment+of+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DDesigning%2520drugs%2520with%2520multi-target%2520activity%253A%2520the%2520next%2520step%2520in%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D115%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">León, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Le%C3%B3nauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0lgc-5_uZEumig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span> </span><span class="NLM_article-title">New multi-target-directed small molecules against Alzheimer’s disease: a combination of resveratrol and clioquinol</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5936</span><span class="NLM_x">–</span> <span class="NLM_lpage">5944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=5936-5944&author=F.+Maoauthor=J.+Yanauthor=J.+Liauthor=X.+Jiaauthor=H.+Miaoauthor=Y.+Sunauthor=L.+Huangauthor=X.+Li&title=New+multi-target-directed+small+molecules+against+Alzheimer%E2%80%99s+disease%3A+a+combination+of+resveratrol+and+clioquinol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DNew%2520multi-target-directed%2520small%2520molecules%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520combination%2520of%2520resveratrol%2520and%2520clioquinol%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2014%26volume%3D12%26spage%3D5936%26epage%3D5944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Tacrine derivatives and Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1825</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F092986710791111206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=20345341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFCnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1825-1838&author=V.+Tumiattiauthor=A.+Minariniauthor=M.+L.+Bolognesiauthor=A.+Milelliauthor=M.+Rosiniauthor=C.+Melchiorre&title=Tacrine+derivatives+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine derivatives and Alzheimer's disease</span></div><div class="casAuthors">Tumiatti, V.; Minarini, A.; Bolognesi, M. L.; Milelli, A.; Rosini, M.; Melchiorre, C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1825-1838</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  To date, the pharmacotherapy of Alzheimer's disease (AD) has relied on acetylcholinesterase (AChE) inhibitors (AChEIs) and, more recently, an N-methyl-D-aspartate receptor (NMDAR) antagonist.  AD is a multifactorial syndrome with several target proteins contributing to its etiol.  "Multi-target-directed ligands" (MTDLs) have great potential for treating complex diseases such as AD because they can interact with multiple targets.  The design of compds. that can hit more than one specific AD target thus represents an innovative strategy for AD treatment.  Tacrine was the first AChEI introduced in therapy.  Recent studies have demonstrated its ability to interact with different AD targets.  Furthermore, numerous tacrine homo- and heterodimers were developed with the aim of improving and enlarging its biol. profile beyond its ability to act as an AChEI.  Several tacrine hybrid derivs. were designed and synthesized with the same goal.  This review will focus on and summarize the last 2 years of research into the development of tacrine derivs. able to hit AD targets beyond simple AChE inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoAUhZIxP33LVg90H21EOLACvtfcHk0lgc-5_uZEumig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFCnu78%253D&md5=0506197d9fdaa47d5a76bdf2099cf483</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F092986710791111206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791111206%26sid%3Dliteratum%253Aachs%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DTacrine%2520derivatives%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D1825%26epage%3D1838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Agis-Torres, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söllhuber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Montero, J. M.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F1570159X113116660047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=24533013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksFSnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=2-36&author=A.+Agis-Torresauthor=M.+S%C3%B6llhuberauthor=M.+Fernandezauthor=J.+M.+Sanchez-Montero&title=Multi-target-directed+ligands+and+other+therapeutic+strategies+in+the+search+of+a+real+solution+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease</span></div><div class="casAuthors">Agis-Torres, Angel; Sollhuber, Monica; Fernandez, Maria; Sanchez-Montero, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-36</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The lack of an adequate therapy for Alzheimer's Disease (AD) contributes greatly to the continuous growing amt. of papers and reviews, reflecting the important efforts made by scientists in this field.  It is well known that AD is the most common cause of dementia, and up-to-date there is no prevention therapy and no cure for the disease, which contrasts with the enormous efforts put on the task.  On the other hand many aspects of AD are currently debated or even unknown.  This review offers a view of the current state of knowledge about AD which includes more relevant findings and processes that take part in the disease; it also shows more relevant past, present and future research on therapeutic drugs taking into account the new paradigm "Multi-Target-Directed Ligands" (MTDLs).  In our opinion, this paradigm will lead from now on the research toward the discovery of better therapeutic solns., not only in the case of AD but also in other complex diseases.  This review highlights the strategies followed by now, and focuses other emerging targets that should be taken into account for the future development of new MTDLs.  Thus, the path followed in this review goes from the pathol. and the processes involved in AD to the strategies to consider in on-going and future researches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocAfdyZkil7LVg90H21EOLACvtfcHk0lgc-5_uZEumig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksFSnsb8%253D&md5=ddb64c9aea98b442eef32bd03e050fb2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F1570159X113116660047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X113116660047%26sid%3Dliteratum%253Aachs%26aulast%3DAgis-Torres%26aufirst%3DA.%26aulast%3DS%25C3%25B6llhuber%26aufirst%3DM.%26aulast%3DFernandez%26aufirst%3DM.%26aulast%3DSanchez-Montero%26aufirst%3DJ.%2BM.%26atitle%3DMulti-target-directed%2520ligands%2520and%2520other%2520therapeutic%2520strategies%2520in%2520the%2520search%2520of%2520a%2520real%2520solution%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2014%26volume%3D12%26spage%3D2%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budriesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors based on a polyamine backbone for potential use against Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4186</span><span class="NLM_x">–</span> <span class="NLM_lpage">4189</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9810452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4186-4189&author=C.+Melchiorreauthor=V.+Andrisanoauthor=M.+L.+Bolognesiauthor=R.+Budriesiauthor=A.+Cavalliauthor=V.+Cavriniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatini&title=Acetylcholinesterase+inhibitors+based+on+a+polyamine+backbone+for+potential+use+against+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm9810452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9810452%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520based%2520on%2520a%2520polyamine%2520backbone%2520for%2520potential%2520use%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4186%26epage%3D4189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">3-(4-{[Benzyl(methyl)amino]methyl}-phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation: A dual function lead for Alzheimer’s disease therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2282</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0340602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2279-2282&author=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Cavalli&title=3-%284-%7B%5BBenzyl%28methyl%29amino%5Dmethyl%7D-phenyl%29-6%2C7-dimethoxy-2H-2-chromenone+%28AP2238%29+inhibits+both+acetylcholinesterase+and+acetylcholinesterase-induced+%CE%B2-amyloid+aggregation%3A+A+dual+function+lead+for+Alzheimer%E2%80%99s+disease+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0340602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0340602%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3D3-%25284-%257B%255BBenzyl%2528methyl%2529amino%255Dmethyl%257D-phenyl%2529-6%252C7-dimethoxy-2H-2-chromenone%2520%2528AP2238%2529%2520inhibits%2520both%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520%25CE%25B2-amyloid%2520aggregation%253A%2520A%2520dual%2520function%2520lead%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2279%26epage%3D2282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FS0006-2952%2802%2901514-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=12527333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=407-416&author=M.+Bartoliniauthor=C.+Bertucciauthor=V.+Cariniauthor=V.+Andrisano&title=beta-Amyloid+aggregation+induced+by+human+acetylcholinesterase%3A+inhibition+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span></div><div class="casAuthors">Bartolini, Manuela; Bertucci, Carlo; Cavrini, Vanni; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The aggregation of β-amyloid (1-40) (Aβ) induced by human recombinant acetylcholinesterase (HuAChE) was studied by means of CD (CD) and by thioflavin T fluorescence spectroscopy.  Aβ was incubated alone and with HuAChE.  The kinetic of fibrils formation was followed for 48 h.  The increasing β-conformation content induced by HuAChE, preliminary to the formation of Aβ fibrils, was detd. by CD.  This phenomenon was found to be related to the thioflavin T emission of fluorescence at 490 nm.  Incubation expts. were performed in the presence of known AChE inhibitors (physostigmine, edrophonium, decamethonium, propidium) and drugs used for Alzheimer's disease (AD) (tacrine, donepezil), to test their capability of preventing the HuAChE-induced Aβ aggregation.  The non-competitive or mixed mode of AChE inhibition was confirmed to be an essential feature.  At 100 μM propidium, decamethonium, donepezil and physostigmine were found to inhibit the HuAChE-induced Aβ aggregation by 82, 25, 22 and 30%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2eDGIBesVCbVg90H21EOLACvtfcHk0liwolFa28yWRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D&md5=51d1021e8be93014f0b15a61db241392</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901514-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901514-9%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DCarini%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3Dbeta-Amyloid%2520aggregation%2520induced%2520by%2520human%2520acetylcholinesterase%253A%2520inhibition%2520studies%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D65%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Bolognesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-β aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049156q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=24-27&author=M.+Bolognesiauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=R.+Banziauthor=C.+Melchiorre&title=Propidium-based+polyamine+ligands+as+potent+inhibitors+of+acetylcholinesterase+and+acetylcholinesterase-induced+amyloid-%CE%B2+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm049156q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049156q%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBanzi%26aufirst%3DR.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DPropidium-based%2520polyamine%2520ligands%2520as%2520potent%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520amyloid-%25CE%25B2%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D24%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span> </span><span class="NLM_article-title">Searching for the multi-target-directed ligands against Alzheimer’s disease: discovery of quinoxaline-based hybrid compounds with AChE, H<sub>3</sub>R and BACE 1 inhibitory activities</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7158</span><span class="NLM_x">–</span> <span class="NLM_lpage">7167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=7158-7167&author=W.+Huangauthor=L.+Tangauthor=Y.+Shiauthor=S.+Huangauthor=L.+Xuauthor=R.+Shengauthor=P.+Wuauthor=J.+Liauthor=N.+Zhouauthor=Y.+Hu&title=Searching+for+the+multi-target-directed+ligands+against+Alzheimer%E2%80%99s+disease%3A+discovery+of+quinoxaline-based+hybrid+compounds+with+AChE%2C+H3R+and+BACE+1+inhibitory+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DSearching%2520for%2520the%2520multi-target-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520discovery%2520of%2520quinoxaline-based%2520hybrid%2520compounds%2520with%2520AChE%252C%2520H3R%2520and%2520BACE%25201%2520inhibitory%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D7158%26epage%3D7167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, R.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer’s disease therapy</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4717</span><span class="NLM_x">–</span> <span class="NLM_lpage">4725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4717-4725&author=Y.+Liauthor=P.+Pengauthor=L.+Tangauthor=Y.+Huauthor=Y.+Huauthor=R.+Sheng&title=Design%2C+synthesis+and+evaluation+of+rivastigmine+and+curcumin+hybrids+as+site-activated+multitarget-directed+ligands+for+Alzheimer%E2%80%99s+disease+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520rivastigmine%2520and%2520curcumin%2520hybrids%2520as%2520site-activated%2520multitarget-directed%2520ligands%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4717%26epage%3D4725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcclymont, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Inhibition of acetylcholinesterase, β-amyloid aggregation, and NMDA receptors in Alzheimer’s disease: a promising direction for the multi-target-directed ligands gold rush</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4381</span><span class="NLM_x">–</span> <span class="NLM_lpage">4384</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800577j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4381-4384&author=M.+Rosiniauthor=E.+Simoniauthor=M.+Bartoliniauthor=A.+Cavalliauthor=L.+Ceccariniauthor=N.+Pascuauthor=D.+W.+Mcclymontauthor=A.+Tarozziauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=V.+Tumiattiauthor=V.+Andrisanoauthor=I.+R.+Mellorauthor=C.+Melchiorre&title=Inhibition+of+acetylcholinesterase%2C+%CE%B2-amyloid+aggregation%2C+and+NMDA+receptors+in+Alzheimer%E2%80%99s+disease%3A+a+promising+direction+for+the+multi-target-directed+ligands+gold+rush"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm800577j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800577j%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DCeccarini%26aufirst%3DL.%26aulast%3DPascu%26aufirst%3DN.%26aulast%3DMcclymont%26aufirst%3DD.%2BW.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DMellor%26aufirst%3DI.%2BR.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DInhibition%2520of%2520acetylcholinesterase%252C%2520%25CE%25B2-amyloid%2520aggregation%252C%2520and%2520NMDA%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520promising%2520direction%2520for%2520the%2520multi-target-directed%2520ligands%2520gold%2520rush%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4381%26epage%3D4384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Muñoz-Ruiz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Palomero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorronsoro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Monte-Millán, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenzuela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usán, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Austria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7223</span><span class="NLM_x">–</span> <span class="NLM_lpage">7233</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7223-7233&author=P.+Mu%C3%B1oz-Ruizauthor=L.+Rubioauthor=E.+Garc%C3%ADa-Palomeroauthor=I.+Dorronsoroauthor=M.+del+Monte-Mill%C3%A1nauthor=R.+Valenzuelaauthor=P.+Us%C3%A1nauthor=C.+de+Austriaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=A.+Bidon-Chanalauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=M.+Medinaauthor=A.+Mart%C3%ADnez&title=Design%2C+synthesis%2C+and+biological+evaluation+of+dual+binding+site+acetylcholinesterase+inhibitors%3A+new+disease-modifying+agents+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm0503289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503289%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Ruiz%26aufirst%3DP.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3Ddel%2BMonte-Mill%25C3%25A1n%26aufirst%3DM.%26aulast%3DValenzuela%26aufirst%3DR.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3Dde%2BAustria%26aufirst%3DC.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitors%253A%2520new%2520disease-modifying%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7223%26epage%3D7233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valgimigli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compounds against Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6446</span><span class="NLM_x">–</span> <span class="NLM_lpage">6449</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701225u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6446-6449&author=M.+L.+Bolognesiauthor=A.+Cavalliauthor=L.+Valgimigliauthor=M.+Bartoliniauthor=M.+Rosiniauthor=V.+Andrisanoauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+drug+design+strategy%3A+from+a+dual+binding+site+acetylcholinesterase+inhibitor+to+a+trifunctional+compounds+against+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm701225u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701225u%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DValgimigli%26aufirst%3DL.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520drug%2520design%2520strategy%253A%2520from%2520a%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitor%2520to%2520a%2520trifunctional%2520compounds%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6446%26epage%3D6449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">960</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=960-967&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=From+dual+binding+site+acetylcholinesterase+inhibitors+to+multi-target-directed+ligands+%28MTDLs%29%3A+a+step+forward+in+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DFrom%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitors%2520to%2520multi-target-directed%2520ligands%2520%2528MTDLs%2529%253A%2520a%2520step%2520forward%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D960%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Z.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.-Z.</span><span> </span><span class="NLM_article-title">Bis(9)-(−)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2013&pages=138-143&author=T.+Liuauthor=Z.+Xiaauthor=W.-W.+Zhangauthor=J.+Xuauthor=X.-X.+Geauthor=J.+Liauthor=Y.+Cuiauthor=Z.-B.+Qiuauthor=J.+Xuauthor=Q.+Xieauthor=H.+Wangauthor=H.-Z.+Chen&title=Bis%289%29-%28%E2%88%92%29-nor-meptazinol+as+a+novel+dual-binding+AChEI+potently+ameliorates+scopolamine-induced+cognitive+deficits+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.-W.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DX.-X.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DZ.-B.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.-Z.%26atitle%3DBis%25289%2529-%2528%25E2%2588%2592%2529-nor-meptazinol%2520as%2520a%2520novel%2520dual-binding%2520AChEI%2520potently%2520ameliorates%2520scopolamine-induced%2520cognitive%2520deficits%2520in%2520mice%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2013%26volume%3D104%26spage%3D138%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeloni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrelia, S.</span><span> </span><span class="NLM_article-title">Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1003</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=997-1003&author=A.+Minariniauthor=A.+Milelliauthor=V.+Tumiattiauthor=M.+Rosiniauthor=E.+Simoniauthor=M.+L.+Bolognesiauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=E.+Motoriauthor=C.+Angeloniauthor=S.+Hrelia&title=Cystamine-tacrine+dimer%3A+a+new+multi-target-directed+ligand+as+potential+therapeutic+agent+for+Alzheimer%E2%80%99s+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMotori%26aufirst%3DE.%26aulast%3DAngeloni%26aufirst%3DC.%26aulast%3DHrelia%26aufirst%3DS.%26atitle%3DCystamine-tacrine%2520dimer%253A%2520a%2520new%2520multi-target-directed%2520ligand%2520as%2520potential%2520therapeutic%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D997%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Holmquist, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuchbury, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berbaum, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muscat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hager, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Münch, G.</span><span> </span><span class="NLM_article-title">Lipoic acid as a novel treatment for Alzheimer’s disease and related dementias</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2Fj.pharmthera.2006.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=16989905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFCkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2007&pages=154-164&author=L.+Holmquistauthor=G.+Stuchburyauthor=K.+Berbaumauthor=S.+Muscatauthor=S.+Youngauthor=K.+Hagerauthor=J.+Engelauthor=G.+M%C3%BCnch&title=Lipoic+acid+as+a+novel+treatment+for+Alzheimer%E2%80%99s+disease+and+related+dementias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Lipoic acid as a novel treatment for Alzheimer's disease and related dementias</span></div><div class="casAuthors">Holmquist, Lina; Stuchbury, Grant; Berbaum, Katrin; Muscat, Sonja; Young, Simon; Hager, Klaus; Engel, Juergen; Muench, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154-164</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder that destroys patient memory and cognition, communication ability with the social environment and the ability to carry out daily activities.  Despite extensive research into the pathogenesis of AD, a neuroprotective treatment - particularly for the early stages of disease - remains unavailable for clin. use.  In this review, we advance the suggestion that lipoic acid (LA) may fulfil this therapeutic need.  A naturally occurring precursor of an essential cofactor for mitochondrial enzymes, including pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH), LA has been shown to have a variety of properties which can interfere with pathogenic principles of AD.  For example, LA increases acetylcholine (ACh) prodn. by activation of choline acetyltransferase and increases glucose uptake, thus supplying more acetyl-CoA for the prodn. of ACh.  LA chelates redox-active transition metals, thus inhibiting the formation of hydroxyl radicals and also scavenges reactive oxygen species (ROS), thereby increasing the levels of reduced glutathione.  Via the same mechanisms, downregulation redox-sensitive inflammatory processes is also achieved.  Furthermore, LA can scavenge lipid peroxidn. products such as hydroxynonenal and acrolein.  The reduced form of LA, dihydrolipoic acid (DHLA), is the active compd. responsible for most of these beneficial effects.  R-α-LA can be applied instead of DHLA, as it is reduced by mitochondrial lipoamide dehydrogenase, a part of the PDH complex.  In this review, the properties of LA are explored with particular emphasis on how this agent, particularly the R-α-enantiomer, may be effective to treat AD and related dementias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcoiEDmF4ru7Vg90H21EOLACvtfcHk0ljhPKcUEpX6-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFCkug%253D%253D&md5=9de980ce1a7f7c2b1c13ed92e36d9b5f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DHolmquist%26aufirst%3DL.%26aulast%3DStuchbury%26aufirst%3DG.%26aulast%3DBerbaum%26aufirst%3DK.%26aulast%3DMuscat%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DHager%26aufirst%3DK.%26aulast%3DEngel%26aufirst%3DJ.%26aulast%3DM%25C3%25BCnch%26aufirst%3DG.%26atitle%3DLipoic%2520acid%2520as%2520a%2520novel%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520dementias%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D113%26spage%3D154%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1269-1274&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=Lipoic+acid%2C+a+lead+structure+for+multi-target-directed+drugs+for+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DLipoic%2520acid%252C%2520a%2520lead%2520structure%2520for%2520multi-target-directed%2520drugs%2520for%2520neurodegeneration%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1269%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">MTDL design strategy in the context of Alzheimer’s disease: from lipocrine to memoquin and beyond</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F138161209787315585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=19199985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=601-613&author=M.+L.+Bolognesiauthor=M.+Rosiniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=A.+Minariniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=MTDL+design+strategy+in+the+context+of+Alzheimer%E2%80%99s+disease%3A+from+lipocrine+to+memoquin+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond</span></div><div class="casAuthors">Bolognesi, M. L.; Rosini, M.; Andrisano, V.; Bartolini, M.; Minarini, A.; Tumiatti, V.; Melchiorre, C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">601-613</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The multifunctional nature of Alzheimer's disease (AD) provides the logical foundation for the development of an innovative drug design strategy centered on multi-target-directed-ligands (MTDLs).  In recent years, the MTDL concept has been exploited to design different ligands hitting different biol. targets.  Our first rationally designed MTDL was the polyamine caproctamine (1), which provided a synergistic cholinergic action against AD by antagonizing muscarinic M2 autoreceptors and inhibiting acetylcholinesterase (AChE).  Lipocrine (7) represented the next step in our research.  Due to its ability to inhibit AChE catalytic and non-catalytic functions together with oxidative stress, 7 emerged as an interesting pharmacol. tool for investigating the neurodegenerative mechanism underlying AD.  Memoquin (9) is a quinone-bearing polyamine endowed with a unique multifunctional profile.  With its development, we arrived at the proof of concept of the MTDL drug discovery approach.  Expts. in vitro and in vivo confirmed its multimodal mechanisms of action and its interaction with different end-points of the neurotoxic cascade leading to AD.  More recently, the MTDL approach led to carbacrine (12).  In addn. to the multiple activities displayed by 7, 12 displayed an interesting modulation of NMDA receptor activity.  The pivotal role played by this target in AD pathogenesis suggests that 12 may be a promising new chem. entity in the MTDL gold rush.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3C4yyVzh8SrVg90H21EOLACvtfcHk0ljhPKcUEpX6-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSns7o%253D&md5=28c160f9fa0b9cbb16403d14aab2cf3d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.2174%2F138161209787315585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787315585%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMTDL%2520design%2520strategy%2520in%2520the%2520context%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520from%2520lipocrine%2520to%2520memoquin%2520and%2520beyond%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D601%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Memoquin: A multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer’s disease</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=152-162&author=M.+L.+Bolognesiauthor=A.+Cavalliauthor=C.+Melchiorre&title=Memoquin%3A+A+multi-target-directed+ligand+as+an+innovative+therapeutic+opportunity+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMemoquin%253A%2520A%2520multi-target-directed%2520ligand%2520as%2520an%2520innovative%2520therapeutic%2520opportunity%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D152%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020120c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Miskolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+Youdimauthor=M.+Weinstock&title=Novel+dual+inhibitors+of+AChE+and+MAO+derived+from+hydroxy+aminoindan+and+phenethylamine+as+potential+treatment+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm020120c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020120c%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520dual%2520inhibitors%2520of%2520AChE%2520and%2520MAO%2520derived%2520from%2520hydroxy%2520aminoindan%2520and%2520phenethylamine%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5260%26epage%3D5279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yogev-Falach, M.</span><span> </span><span class="NLM_article-title">Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective- neurorescue drugs: ladostigil</span> <span class="citation_source-journal">Neurotoxic. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1007%2FBF03033355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=17197368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFekt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=181-192&author=M.+B.+Youdimauthor=T.+Amitauthor=O.+Bar-Amauthor=O.+Weinrebauthor=M.+Yogev-Falach&title=Implications+of+co-morbidity+for+etiology+and+treatment+of+neurodegenerative+diseases+with+multifunctional+neuroprotective-+neurorescue+drugs%3A+ladostigil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil</span></div><div class="casAuthors">Youdim, Moussa B. H.; Amit, Tamar; Bar-Am, Orit; Weinreb, Orly; Yogev-Falach, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3,4</span>),
    <span class="NLM_cas:pages">181-192</span>CODEN:
                <span class="NLM_cas:coden">NURRFI</span>;
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    
            (<span class="NLM_cas:orgname">F. P. Graham Publishing Co.</span>)
        </div><div class="casAbstract">A review.  The recent therapeutic approach in which drug candidates are designed to possess diverse pharmacol. properties and act on multiple targets has stimulated the development of several multifunction drugs.  These include ladostigil (TV3326) [(N-propargyl-(3R) aminoindan-5yl)-Et Me carbamate], which combines the pharmacophore-neuroprotective effects of rasagiline, a selective monoamine oxidase (MAO)-B inhibitor, with the cholinesterase (ChE) inhibitory activity of rivastigmine or iron chelating moiety such as M30.  In the case of M30 the pharmacophore of brain permeable iron chelator VK-28 plus the MAO inhibitor-neuroprotective propargylamine moiety of rasagiline are combined in a single mol. as a potential treatment for Alzheimer's disease, Lewy body disease, and Parkinson's disease with dementia.  Here, we discuss the activities of ladostigil in terms of its cholinesterase cognitive enhancing potential, antiParkinson, antidepressant, neuroprotection and APP (amyloid precursor protein) processing potential.  One major attribute of ladostigil is its neuroprotective activity in neuronal cell cultures and in vivo.  Employing an apoptotic model of neuroblastoma SK-N-SH cells, the mol. mechanism of its neuroprotective activity has been detd.  The current studies show that ladostigil significantly decreased apoptosis via inhibition of the cleavage and prevention of caspase-3 activation through a mechanism related to regulation of the Bcl-2 family proteins, resulting in reduced levels of Bad and Bax and induced levels of Bcl-2.  In addn., ladostigil elevated the levels of pPKC(pan).  We have also followed the regulation of APP processing and found that ladostigil markedly decreased apoptotic-induced levels of holo-APP, as well as stimulated the release of the non-amyloidogenic sol. APP (sAPPα) into the conditioned medium via a established protein kinsae c-MAPkinase dependent pathway.  Similar to ladostigil, its S-isomer, TV3279, which is a ChE inhibitor lacking MAO inhibitory activity, exerted similar neuroprotective properties and APP processing, suggesting that the mode of action is independent of MAO inhibition.  These effects were shown to reside in the propargylamine moiety.  These findings indicate that the dual actions of the anti-apoptotic-neuroprotective activity and the ability to modulate APP processing, could make ladostigil a potentially valuable drug for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpywM2IsMu1OLVg90H21EOLACvtfcHk0lgcFU1xiCTyMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFekt70%253D&md5=58ba89f08e3eb4afdb5d602265baf060</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2FBF03033355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03033355%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DYogev-Falach%26aufirst%3DM.%26atitle%3DImplications%2520of%2520co-morbidity%2520for%2520etiology%2520and%2520treatment%2520of%2520neurodegenerative%2520diseases%2520with%2520multifunctional%2520neuroprotective-%2520neurorescue%2520drugs%253A%2520ladostigil%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2006%26volume%3D10%26spage%3D181%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2013&pages=893-902&author=I.+Boleaauthor=A.+Gellaauthor=M.+Unzeta&title=Propargylamine-derived+multitarget-directed+ligands%3A+fighting+Alzheimer%E2%80%99s+disease+with+monoamine+oxidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DGella%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DPropargylamine-derived%2520multitarget-directed%2520ligands%253A%2520fighting%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2013%26volume%3D120%26spage%3D893%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F092986711797379302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=21864289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4568-4587&author=L.+Pisaniauthor=M.+Cattoauthor=F.+Leonettiauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=F.+Campagnaauthor=A.+Carotti&title=Targeting+monoamine+oxidases+with+multipotent+ligands%3A+an+emerging+strategy+in+the+search+of+new+drugs+against+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases</span></div><div class="casAuthors">Pisani, L.; Catto, M.; Leonetti, F.; Nicolotti, O.; Stefanachi, A.; Campagna, F.; Carotti, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4568-4587</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The socioeconomic burden of multi-factorial pathologies, such as neurodegenerative diseases (NDs), is enormous worldwide.  Unfortunately, no proven disease-modifying therapy is available yet and in most cases (e.g., Alzheimer's and Parkinson's disease) the approved drugs exert only palliative and symptomatic effects.  Nowadays, an emerging strategy for the discovery of disease-modifying drugs is based on the multi-target directed ligand (MTDL) design, an innovative shift from the traditional approach one-drug-one-target to the more ambitious one-drug-more-targets goal.  Herein, we review the discovery strategy, the mechanism of action and the biopharmacol. evaluation of multipotent ligands exhibiting monoamine oxidase (MAO) inhibition as the core activity with a potential for the treatment of NDs.  In particular, MAO inhibitors exhibiting addnl. acetylcholinesterase (AChE) or nitric oxide synthase (NOS) inhibition, or ion chelation/antioxidant-radical scavenging/anti-inflammatory/A2A receptor antagonist/APP processing modulating activities have been thoroughly examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4N8fMdFNcwrVg90H21EOLACvtfcHk0lhVzJ5RBFiVZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O&md5=2463da84a1da0142e353ff9d3a354fe6</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F092986711797379302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797379302%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DTargeting%2520monoamine%2520oxidases%2520with%2520multipotent%2520ligands%253A%2520an%2520emerging%2520strategy%2520in%2520the%2520search%2520of%2520new%2520drugs%2520against%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4568%26epage%3D4587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Los Ríos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglietta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terencio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7607</span><span class="NLM_x">–</span> <span class="NLM_lpage">7610</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061047j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7607-7610&author=J.+Marco-Contellesauthor=R.+Le%C3%B3nauthor=C.+de+Los+R%C3%ADosauthor=A.+Gugliettaauthor=J.+Terencioauthor=M.+G.+L%C3%B3pezauthor=A.+G.+Garc%C3%ADaauthor=M.+Villarroya&title=Novel+multipotent+tacrine-dihydropyridine+hybrids+with+improved+acetylcholinesterase+inhibitory+and+neuroprotective+activities+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm061047j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061047j%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3Dde%2BLos%2BR%25C3%25ADos%26aufirst%3DC.%26aulast%3DGuglietta%26aufirst%3DA.%26aulast%3DTerencio%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNovel%2520multipotent%2520tacrine-dihydropyridine%2520hybrids%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520neuroprotective%2520activities%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7607%26epage%3D7610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistolozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gálvez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span> </span><span class="NLM_article-title">Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">ChemMedChem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1990</span><span class="NLM_x">–</span> <span class="NLM_lpage">1997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1990-1997&author=M.+Bartoliniauthor=M.+Pistolozziauthor=V.+Andrisanoauthor=J.+Egeaauthor=M.+G.+L%C3%B3pezauthor=I.+Iriepaauthor=I.+Moraledaauthor=E.+G%C3%A1lvezauthor=J.+Marco-Contellesauthor=A.+Samadi&title=Chemical+and+pharmacological+studies+on+enantiomerically+pure+p-methoxytacripyrines%2C+promising+multi-target-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPistolozzi%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DG%25C3%25A1lvez%26aufirst%3DE.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26atitle%3DChemical%2520and%2520pharmacological%2520studies%2520on%2520enantiomerically%2520pure%2520p-methoxytacripyrines%252C%2520promising%2520multi-target-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChemMedChem.%26date%3D2011%26volume%3D6%26spage%3D1990%26epage%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">A small molecule targeting the multifactorial nature of Alzheimer’s disease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3689-3692&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=S.+Capsoniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=E.+Margottiauthor=A.+Cattaneoauthor=M.+Recanatiniauthor=C.+Melchiorre&title=A+small+molecule+targeting+the+multifactorial+nature+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMargotti%26aufirst%3DE.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DA%2520small%2520molecule%2520targeting%2520the%2520multifactorial%2520nature%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2007%26volume%3D46%26spage%3D3689%26epage%3D3692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Lecoutey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hédou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Since, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaisier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malzert Fréon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mignani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cresteil, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span> </span><span class="NLM_article-title">Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer’s disease treatment</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">E3825</span><span class="NLM_x">–</span> <span class="NLM_lpage">E3830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E3825-E3830&author=C.+Lecouteyauthor=D.+H%C3%A9douauthor=T.+Freretauthor=P.+Giannoniauthor=F.+Gavenauthor=M.+Sinceauthor=V.+Bouetauthor=C.+Ballandonneauthor=S.+Corvaisierauthor=A.+Malzert+Fr%C3%A9onauthor=S.+Mignaniauthor=T.+Cresteilauthor=M.+Boulouardauthor=S.+Claeysenauthor=C.+Rochaisauthor=P.+Dallemagne&title=Design+of+donecopride%2C+a+dual+serotonin+subtype+4+receptor+agonist%2Facetylcholinesterase+inhibitor+with+potential+interest+for+Alzheimer%E2%80%99s+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DH%25C3%25A9dou%26aufirst%3DD.%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3DSince%26aufirst%3DM.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCorvaisier%26aufirst%3DS.%26aulast%3DMalzert%2BFr%25C3%25A9on%26aufirst%3DA.%26aulast%3DMignani%26aufirst%3DS.%26aulast%3DCresteil%26aufirst%3DT.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DDallemagne%26aufirst%3DP.%26atitle%3DDesign%2520of%2520donecopride%252C%2520a%2520dual%2520serotonin%2520subtype%25204%2520receptor%2520agonist%252Facetylcholinesterase%2520inhibitor%2520with%2520potential%2520interest%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3DE3825%26epage%3DE3830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Eglen, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonhaus, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R. D.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of two novel and potent 5-HT<sub>4</sub> receptor agonists, RS67333 and RS67506, in vitro and in vivo</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">1387</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1111%2Fj.1476-5381.1995.tb16628.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=8564196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaK2MXns1Wgsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1995&pages=1387-1392&author=R.+M.+Eglenauthor=D.+W.+Bonhausauthor=L.+G.+Johnsonauthor=E.+Leungauthor=R.+D.+Clark&title=Pharmacological+characterization+of+two+novel+and+potent+5-HT4+receptor+agonists%2C+RS67333+and+RS67506%2C+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo</span></div><div class="casAuthors">Eglen, R. M.; Bonhaus, D. W.; Johnson, L. G.; Leung, E.; Clark, R. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1387-92</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">The pharmacol. of two novel 5-HT4 receptor agonists, RS 67333 (1-(4-amino-5-chloro-2-methoxy phenyl)-3-[1(n-butyl)-4-piperidinyl]-1-propanone HCl) and RS 67506 (1-(4-amino-5-chloro-2-methoxy-phenyl)-3-[1-(2-Me sulfonylamino)ethyl-4-piperidinyl]-1-propanone HCl) have been assessed in vitro and in vivo.  RS 67333 and RS 67506 exhibited affinities (pKi = 8.7 and 8.8, resp.) for the 5-HT4 binding sites, labeled with [3H]-GR 113808, in guinea-pig striatum.  The Hill coeffs. from these displacement curves were not significantly different from unity.  The compds. exhibited lower affinities (<6.0) at several other receptors including 5-HT1A, 5-HT1D, 5-HT2A, 5-HT2C, dopamine D1, D2 and muscarinic M1-M3 receptors.  However, RS 67333 and RS 67506 did exhibit affinities for the σ1 (pKi = 8.9 and 7.9, resp.) and σ2 (pKi = 8.0 and 7.3, resp.) binding sites.  At the 5-HT4 receptor mediating relaxation of the carbachol-precontracted esophagus, RS 67333 and RS 67506 acted as potent (pEC50 8.4 and 8.6, resp.) with respect to 5-HT.  Relaxant responses to RS 67333 or RS 67506 were surmountably antagonized by GR 113808 (10 nM), with apparent affinities (pKB) of 9.1 and 9.0, resp.  RS 67333 and RS 67506 induced dose-dependent increases in heart rate of the anesthetized micropig (ED50 4.9 and 5.4 μg kg-1, i.v.), with maximal increases of 35 and 47 beats min-1, resp.  RS 67333 and RS 67506, therefore, acted as potent, partial 5-HT4 receptor agonists in vitro and in vivo.  These compds., by virtue of their high potency and selectivity, may have some utility in elucidating the physiol. role of 5-HT4 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzNOdCScURALVg90H21EOLACvtfcHk0li7bVBGtsFAAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXns1Wgsrg%253D&md5=c35823f3865d177e00933fd35a779137</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb16628.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb16628.x%26sid%3Dliteratum%253Aachs%26aulast%3DEglen%26aufirst%3DR.%2BM.%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26aulast%3DJohnson%26aufirst%3DL.%2BG.%26aulast%3DLeung%26aufirst%3DE.%26aulast%3DClark%26aufirst%3DR.%2BD.%26atitle%3DPharmacological%2520characterization%2520of%2520two%2520novel%2520and%2520potent%25205-HT4%2520receptor%2520agonists%252C%2520RS67333%2520and%2520RS67506%252C%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D115%26spage%3D1387%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Lecoutey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt-Gueulle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaisier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepailleur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span> </span><span class="NLM_article-title">Synthesis of dual AChE/5-HT<sub>4</sub> receptor multi-target directed ligands</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=627-634&author=C.+Lecouteyauthor=C.+Rochaisauthor=D.+Genestauthor=S.+Butt-Gueulleauthor=C.+Ballandonneauthor=S.+Corvaisierauthor=F.+Dulinauthor=A.+Lepailleurauthor=J.+Sopkova-de+Oliveira+Santosauthor=P.+Dallemagne&title=Synthesis+of+dual+AChE%2F5-HT4+receptor+multi-target+directed+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DGenest%26aufirst%3DD.%26aulast%3DButt-Gueulle%26aufirst%3DS.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCorvaisier%26aufirst%3DS.%26aulast%3DDulin%26aufirst%3DF.%26aulast%3DLepailleur%26aufirst%3DA.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DDallemagne%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520dual%2520AChE%252F5-HT4%2520receptor%2520multi-target%2520directed%2520ligands%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D627%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Grossman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunc, K. T.</span><span> </span><span class="NLM_article-title">Development of a radioligand binding assay for 5HT<sub>4</sub> receptors in guinea pig and rat brain</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1111%2Fj.1476-5381.1993.tb13617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=8358562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFahsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1993&pages=618-624&author=C.+J.+Grossmanauthor=G.+J.+Kilpatrickauthor=K.+T.+Bunc&title=Development+of+a+radioligand+binding+assay+for+5HT4+receptors+in+guinea+pig+and+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a radioligand binding assay for 5-HT4 receptors in guinea pig and rat brain</span></div><div class="casAuthors">Grossman, C. J.; Kilpatrick, G. J.; Bunce, K. T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">618-24</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The 5-HT4 receptor antagonist, GR 113808, was radiolabeled to a high specific activity with tritium.  Characterization of specific [3H]GR 113808 binding in homogenates of guinea pig striatum and hippocampus revealed a single site of high affinity (Kd values 0.20 and 0.13 nM resp.).  [3H]GR 113808 binding was reversible and displayed rapid kinetics such that assocn. and dissocn. were complete within 3 min.  Specific [3H]GR 113808 binding was potently and stereoselectively inhibited by agonists and antagonists acting at the 5-HT4 receptor but not by compds. selective for other 5-HT receptors or other neurotransmitter receptors.  Autoradiog. anal. revealed a discrete localization in both guinea pig and rat brain with high concns. of binding in brain areas such as the striatum, substantia nigra and olfactory tubercle.  [3H]GR 113808 binding to homogenates of guinea pig striatum meets the criteria for labeling of the 5-HT4 receptor and, as such, represents the first characterization of this receptor in a radioligand binding assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1U7Xw7D_scrVg90H21EOLACvtfcHk0li7bVBGtsFAAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFahsLo%253D&md5=e56f6af24f3c2284620f86142af11e45</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1993.tb13617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1993.tb13617.x%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DC.%2BJ.%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26aulast%3DBunc%26aufirst%3DK.%2BT.%26atitle%3DDevelopment%2520of%2520a%2520radioligand%2520binding%2520assay%2520for%25205HT4%2520receptors%2520in%2520guinea%2520pig%2520and%2520rat%2520brain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D109%26spage%3D618%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Cheung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burshteyn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Height, J. J.</span><span> </span><span class="NLM_article-title">Structures of human acetylcholinesterase in complex with pharmacologically important ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10282</span><span class="NLM_x">–</span> <span class="NLM_lpage">10286</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300871x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10282-10286&author=J.+Cheungauthor=M.+J.+Rudolphauthor=F.+Burshteynauthor=M.+S.+Cassidyauthor=E.+N.+Garyauthor=J.+Loveauthor=M.+C.+Franklinauthor=J.+J.+Height&title=Structures+of+human+acetylcholinesterase+in+complex+with+pharmacologically+important+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands</span></div><div class="casAuthors">Cheung, Jonah; Rudolph, Michael J.; Burshteyn, Fiana; Cassidy, Michael S.; Gary, Ebony N.; Love, James; Franklin, Matthew C.; Height, Jude J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10282-10286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human acetylcholinesterase (AChE) is a significant target for therapeutic drugs.  Here we present high resoln. crystal structures of human AChE, alone and in complexes with drug ligands; donepezil, an Alzheimer's disease drug, binds differently to human AChE than it does to Torpedo AChE.  These crystals of human AChE provide a more accurate platform for further drug development than previously available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdjhYPmZBMf7Vg90H21EOLACvtfcHk0li7bVBGtsFAAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN&md5=c27461e0288f42ac96af354cbefd387e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm300871x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300871x%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DM.%2BJ.%26aulast%3DBurshteyn%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DM.%2BS.%26aulast%3DGary%26aufirst%3DE.%2BN.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DHeight%26aufirst%3DJ.%2BJ.%26atitle%3DStructures%2520of%2520human%2520acetylcholinesterase%2520in%2520complex%2520with%2520pharmacologically%2520important%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10282%26epage%3D10286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Dubost, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt-Gueulle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova-de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charnay, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cailly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabis, F.</span><span> </span><span class="NLM_article-title">Synthesis and structure-affinity relationships of selective high-affinity 5-HT<sub>4</sub> receptor antagonists: application to the design of new potential single photon emission computed tomography (SPECT) tracers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9693</span><span class="NLM_x">–</span> <span class="NLM_lpage">9707</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300943r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9693-9707&author=E.+Dubostauthor=N.+Dumasauthor=C.+Fosseyauthor=R.+Magnelliauthor=S.+Butt-Gueulleauthor=C.+Ballandonneauthor=D.+Caignardauthor=F.+Dulinauthor=J.+Sopkova-de+Oliveira+Santosauthor=P.+Milletauthor=Y.+Charnayauthor=S.+Raultauthor=T.+Caillyauthor=F.+Fabis&title=Synthesis+and+structure-affinity+relationships+of+selective+high-affinity+5-HT4+receptor+antagonists%3A+application+to+the+design+of+new+potential+single+photon+emission+computed+tomography+%28SPECT%29+tracers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm300943r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300943r%26sid%3Dliteratum%253Aachs%26aulast%3DDubost%26aufirst%3DE.%26aulast%3DDumas%26aufirst%3DN.%26aulast%3DFossey%26aufirst%3DC.%26aulast%3DMagnelli%26aufirst%3DR.%26aulast%3DButt-Gueulle%26aufirst%3DS.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCaignard%26aufirst%3DD.%26aulast%3DDulin%26aufirst%3DF.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DMillet%26aufirst%3DP.%26aulast%3DCharnay%26aufirst%3DY.%26aulast%3DRault%26aufirst%3DS.%26aulast%3DCailly%26aufirst%3DT.%26aulast%3DFabis%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520structure-affinity%2520relationships%2520of%2520selective%2520high-affinity%25205-HT4%2520receptor%2520antagonists%253A%2520application%2520to%2520the%2520design%2520of%2520new%2520potential%2520single%2520photon%2520emission%2520computed%2520tomography%2520%2528SPECT%2529%2520tracers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9693%26epage%3D9707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1258</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1126%2Fscience.1150577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=17962520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1258-1265&author=V.+Cherezovauthor=D.+M.+Rosenbaumauthor=M.+A.+Hansonauthor=S.+G.+Rasmussenauthor=F.+S.+Thianauthor=T.+S.+Kobilkaauthor=H.+J.+Choiauthor=P.+Kuhnauthor=W.+I.+Weisauthor=B.+K.+Kobilkaauthor=R.+C.+Stevens&title=High-resolution+crystal+structure+of+an+engineered+human+beta2-adrenergic+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein-Coupled Receptor</span></div><div class="casAuthors">Cherezov, Vadim; Rosenbaum, Daniel M.; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Kuhn, Peter; Weis, William I.; Kobilka, Brian K.; Stevens, Raymond C.; Takeda, S.; Kadowaki, S.; Haga, T.; Takaesu, H.; Mitaku, S.; Fredriksson, R.; Lagerstrom, M. C.; Lundin, L. G.; Schioth, H. B.; Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J.; Lefkowitz, R. J.; Shenoy, S. K.; Rosenbaum, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">5854</span>),
    <span class="NLM_cas:pages">1258-1265</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Second extracellular loop, which in the β2-adrenergic receptor contains an unusual pair of disulfide bonds and an extra helix.  This loop and the absence Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors constitute the largest family of eukaryotic signal transduction proteins that communicate across the membrane.  We report the crystal structure of a human β2-adrenergic receptor-T4 lysozyme fusion protein bound to the partial inverse agonist carazolol at 2.4 angstrom resoln.  The structure provides a high-resoln. view of a human G protein-coupled receptor bound to a diffusible ligand.  Ligand-binding site accessibility is enabled by the second extracellular loop, which is held out of the binding cavity by a pair of closely spaced disulfide bridges and a short helical segment within the loop.  Cholesterol, a necessary component for crystn., mediates an intriguing parallel assocn. of receptor mols. in the crystal lattice.  Although the location of carazolol in the β2-adrenergic receptor is very similar to that of retinal in rhodopsin, structural differences in the ligand-binding site and other regions highlight the challenges in using rhodopsin as a template model for this large receptor family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC-8wZ2k2GHLVg90H21EOLACvtfcHk0ljLmdtoJRZwZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I&md5=12c5bacb8464a4b243fe9341192b5b3b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1126%2Fscience.1150577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1150577%26sid%3Dliteratum%253Aachs%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DHigh-resolution%2520crystal%2520structure%2520of%2520an%2520engineered%2520human%2520beta2-adrenergic%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1258%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Vickery, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beattie, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulido-Rios, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, P. P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A. M.</span><span> </span><span class="NLM_article-title">A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT<sub>4</sub> receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1038%2Fsj.bjp.0707154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=17293885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFCqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2007&pages=782-791&author=R.+G.+Vickeryauthor=N.+Maiauthor=E.+Kaufmanauthor=D.+T.+Beattieauthor=T.+Pulido-Riosauthor=M.+O%E2%80%99Keefeauthor=P.+P.+A.+Humphreyauthor=J.+A.+M.+Smith&title=A+comparison+of+the+pharmacological+properties+of+guinea-pig+and+human+recombinant+5-HT4+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors</span></div><div class="casAuthors">Vickery, R. G.; Mai, N.; Kaufman, E.; Beattie, D. T.; Pulido-Rios, T.; O'Keefe, M.; Humphrey, P. P. A.; Smith, J. A. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">782-791</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">5-HT4 receptor agonists are used therapeutically to treat disorders of reduced gastrointestinal motility.  Since such compds. are evaluated in guinea-pigs, we cloned, expressed and pharmacol. characterized the guinea-pig 5-HT4 and human 5-HT4(b) splice variant, which share 95% homol.  The functional properties of guinea-pig 5-HT4(b) receptors were compared with native receptors in guinea-pig colon.  Membrane radioligand binding and whole cell cAMP accumulation assays were used to det. the affinities, potencies and intrinsic activities (IA).  Contraction of the guinea-pig distal colon longitudinal muscle myenteric plexus prepn. (LMMP) was monitored to evaluate functional activity.  PKi values for guinea-pig and human recombinant receptors, and guinea-pig striatum 5-HT4 receptors, were in agreement, as were the potency and IA values for guinea-pig and human 5-HT4 receptors expressed at a similar d. (∼0.2 pmol mg-1 protein).  Tegaserod was a potent (pEC50 = 8.4 and 8.7, resp.), full agonist at both guinea-pig and human 5-HT4 receptors.  In contrast, in the LMMP prepn., tegaserod was a potent, partial agonist (pEC50 = 8.2; IA = 66%).  Close agreement between the pharmacol. properties of guinea-pig and human 5-HT4 receptors support the use of guinea-pig model systems for the identification of 5-HT4 receptor therapeutics.  However, the mechanisms underlying the different agonist properties of tegaserod in recombinant and isolated tissue prepns., and the extent to which these impact the clin. efficacy of tegaserod as a prokinetic agent, remain to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq03Zcp7vtSSrVg90H21EOLACvtfcHk0ljLmdtoJRZwZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFCqtLk%253D&md5=e0e8293735f8a2faa4085374bc4e9ff9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707154%26sid%3Dliteratum%253Aachs%26aulast%3DVickery%26aufirst%3DR.%2BG.%26aulast%3DMai%26aufirst%3DN.%26aulast%3DKaufman%26aufirst%3DE.%26aulast%3DBeattie%26aufirst%3DD.%2BT.%26aulast%3DPulido-Rios%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DM.%26aulast%3DHumphrey%26aufirst%3DP.%2BP.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%2BM.%26atitle%3DA%2520comparison%2520of%2520the%2520pharmacological%2520properties%2520of%2520guinea-pig%2520and%2520human%2520recombinant%25205-HT4%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D150%26spage%3D782%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawant-Basak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waizumi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papanikolaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutzman-Engwall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubitski, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span> </span><span class="NLM_article-title">Identification of multiple 5-HT<sub>4</sub> partial agonist clinical candidates for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9240</span><span class="NLM_x">–</span> <span class="NLM_lpage">9254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300953p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9240-9254&author=M.+A.+Brodneyauthor=D.+E.+Johnsonauthor=A.+Sawant-Basakauthor=K.+J.+Coffmanauthor=E.+M.+Drummondauthor=E.+L.+Hudsonauthor=K.+E.+Fisherauthor=H.+Noguchiauthor=N.+Waizumiauthor=L.+L.+McDowellauthor=A.+Papanikolaouauthor=B.+A.+Pettersenauthor=A.+W.+Schmidtauthor=E.+Tsengauthor=K.+Stutzman-Engwallauthor=D.+M.+Rubitskiauthor=M.+A.+Vanase-Frawleyauthor=S.+Grimwood&title=Identification+of+multiple+5-HT4+partial+agonist+clinical+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm300953p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300953p%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DSawant-Basak%26aufirst%3DA.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DDrummond%26aufirst%3DE.%2BM.%26aulast%3DHudson%26aufirst%3DE.%2BL.%26aulast%3DFisher%26aufirst%3DK.%2BE.%26aulast%3DNoguchi%26aufirst%3DH.%26aulast%3DWaizumi%26aufirst%3DN.%26aulast%3DMcDowell%26aufirst%3DL.%2BL.%26aulast%3DPapanikolaou%26aufirst%3DA.%26aulast%3DPettersen%26aufirst%3DB.%2BA.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DStutzman-Engwall%26aufirst%3DK.%26aulast%3DRubitski%26aufirst%3DD.%2BM.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DGrimwood%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520multiple%25205-HT4%2520partial%2520agonist%2520clinical%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9240%26epage%3D9254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.2174%2F1568007043482615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=14965243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=39-51&author=J.+Bockaertauthor=S.+Claeysenauthor=V.+Companauthor=A.+Dumuis&title=5-HT4+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptors</span></div><div class="casAuthors">Bockaert, J.; Claeysen, S.; Compan, V.; Dumuis, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-51</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin 4 receptors (5-HT4Rs) were discovered 15 yr ago.  They are coded by a very complex gene (700Kb, 38 exons) which generates 8 C-terminal variants (a, b, c, d, e, f, g, and n).  Their sequences differ after position L358.  Another variant is characterized by a 14 residue insertion within the extracellular loop 2.  Highly selective potent 5-HT4 receptor antagonists and partial agonists which cross the blood-brain barrier have been synthesized, but a specific full agonist for brain studies is still missing.  Based on physiol. and behavioral expts., 5-HT4Rs may be targets to treat cognitive deficits, abdominal pain, and feeding disorders.  One 5-HT4R-directed drug (SL65.0155) is already in phase II to treat patients suffering from memory deficits or dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemFXFD0xNLrVg90H21EOLACvtfcHk0lhJdZE2LS6NWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D&md5=b9139c95c9d832dd89b51d45fc3bde96</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.2174%2F1568007043482615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482615%26sid%3Dliteratum%253Aachs%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT4%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D39%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, J. H.</span><span> </span><span class="NLM_article-title">Very fast empirical prediction and rationalization of protein pKa values</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=704-721&author=H.+Liauthor=A.+D.+Robertsonauthor=J.+H.+Jensen&title=Very+fast+empirical+prediction+and+rationalization+of+protein+pKa+values"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DVery%2520fast%2520empirical%2520prediction%2520and%2520rationalization%2520of%2520protein%2520pKa%2520values%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2005%26volume%3D61%26spage%3D704%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Vagedes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Åqvist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marelius, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, E.-W.</span><span> </span><span class="NLM_article-title">The deacylation step of acetylcholinesterase: computer simulation studies</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">12254</span><span class="NLM_x">–</span> <span class="NLM_lpage">12262</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0004581" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=12254-12262&author=P.+Vagedesauthor=B.+Rabensteinauthor=J.+%C3%85qvistauthor=J.+Mareliusauthor=E.-W.+Knapp&title=The+deacylation+step+of+acetylcholinesterase%3A+computer+simulation+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fja0004581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0004581%26sid%3Dliteratum%253Aachs%26aulast%3DVagedes%26aufirst%3DP.%26aulast%3DRabenstein%26aufirst%3DB.%26aulast%3D%25C3%2585qvist%26aufirst%3DJ.%26aulast%3DMarelius%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DE.-W.%26atitle%3DThe%2520deacylation%2520step%2520of%2520acetylcholinesterase%253A%2520computer%2520simulation%2520studies%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D12254%26epage%3D12262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Fragkouli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papatheodoropoulos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamatakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stylianopoulou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsilibary, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzinia, A. K.</span><span> </span><span class="NLM_article-title">Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over-expressing MMP9</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1111%2Fj.1471-4159.2011.07637.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=22192143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVKlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2012&pages=239-251&author=A.+Fragkouliauthor=C.+Papatheodoropoulosauthor=S.+Georgopoulosauthor=A.+Stamatakisauthor=F.+Stylianopoulouauthor=E.+C.+Tsilibaryauthor=A.+K.+Tzinia&title=Enhanced+neuronal+plasticity+and+elevated+endogenous+sAPP%CE%B1+levels+in+mice+over-expressing+MMP9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over-expressing MMP9</span></div><div class="casAuthors">Fragkouli, Apostolia; Papatheodoropoulos, Costas; Georgopoulos, Spiros; Stamatakis, Antonios; Stylianopoulou, Fotini; Tsilibary, Effie C.; Tzinia, Athina K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">239-251</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Evidence accumulating during the past few years points to a significant role of matrix metalloproteinase 9 (MMP9) enzymic activity in synaptic plasticity and cognitive processes.  We have previously demonstrated that MMP9 is involved in receptor-mediated α-secretase-like cleavage of APP in vitro, resulting in increased secretion of sAPPα, the sol. N-terminal product of the non-amyloidogenic pathway known to be involved in neuronal plasticity and memory formation.  To study the in vivo role of MMP9, we have generated transgenic mice over-expressing MMP9 in the brain.  Herein, we demonstrate that MMP9 transgenic animals display enhanced performance in the non-spatial novel object recognition and the spatial water-maze task and that their enhanced performance was accompanied by increased dendritic spine d. in the hippocampus and cortex following behavioral testing.  Consistent with the above observations, the electrophysiol. anal. revealed prolonged maintenance of long-term synaptic potentiation in hippocampal slices from MMP9 transgenic mice.  Moreover, elevated sAPPα levels in the hippocampus and cortex of MPP9 transgenic animals were also obsd.  Overall, our results extend previous findings on the physiol. role of MMP9 in neuronal plasticity and furthermore reveal that, APP may be one of the physiol. proteolytic targets of MMP9 in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDc4s1RZXTSrVg90H21EOLACvtfcHk0lhJdZE2LS6NWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVKlt7w%253D&md5=8aa95ff635c5b6342dba852c419d5238</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07637.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07637.x%26sid%3Dliteratum%253Aachs%26aulast%3DFragkouli%26aufirst%3DA.%26aulast%3DPapatheodoropoulos%26aufirst%3DC.%26aulast%3DGeorgopoulos%26aufirst%3DS.%26aulast%3DStamatakis%26aufirst%3DA.%26aulast%3DStylianopoulou%26aufirst%3DF.%26aulast%3DTsilibary%26aufirst%3DE.%2BC.%26aulast%3DTzinia%26aufirst%3DA.%2BK.%26atitle%3DEnhanced%2520neuronal%2520plasticity%2520and%2520elevated%2520endogenous%2520sAPP%25CE%25B1%2520levels%2520in%2520mice%2520over-expressing%2520MMP9%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D121%26spage%3D239%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Giannoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bundel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baranger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti-Gauthier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valjent, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span> </span><span class="NLM_article-title">Early administration of RS 67333, a specific 5-HT<sub>4</sub> receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Front. Aging Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.3389%2Ffnagi.2013.00096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=24399967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslamsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=96&author=P.+Giannoniauthor=F.+Gavenauthor=D.+de+Bundelauthor=K.+Barangerauthor=E.+Marchetti-Gauthierauthor=F.+S.+Romanauthor=E.+Valjentauthor=P.+Marinauthor=J.+Bockaertauthor=S.+Riveraauthor=S.+Claeysen&title=Early+administration+of+RS+67333%2C+a+specific+5-HT4+receptor+agonist%2C+prevents+amyloidogenesis+and+behavioral+deficits+in+the+5XFAD+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Early administration of RS67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease</span></div><div class="casAuthors">Giannoni, Patrizia; Gaven, Florence; Bundel, Dimitride; Baranger, Kevin; Marchetti-Gauthier, Evelyne; Roman, Francois S.; Valjent, Emmanuel; Marin, Philippe; Bockaert, Joeel; Rivera, Santiago; Claeysen, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Aging Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Dec.</span>),
    <span class="NLM_cas:pages">96/1-96/12</span>CODEN:
                <span class="NLM_cas:coden">FANRC5</span>;
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Amyloid β (Aβ) accumulation is considered the main culprit in the pathogenesis of Alzheimer's disease (AD).  Recent studies suggest that decreasing Aβ prodn. at very early stages of AD could be a promising strategy to slow down disease progression.  Serotonin 5-HT4 receptor activation stimulates α-cleavage of the amyloid precursor protein (APP), leading to the release of the sol. and neurotrophic sAPPα fragment and thus precluding Aβ formation.  Using the 5XFAD mouse model of AD that shows accelerated Aβ deposition, we investigated the effect of chronic treatments (treatment onset at different ages and different durations) with the 5-HT4 receptor agonist RS 67333 during the asymptomatic phase of the disease.  Chronic administration of RS 67333 decreased concomitantly the no. of amyloid plaques and the level of Aβ species.  Redn. of Aβ levels was accompanied by a striking decrease in hippocampal astrogliosis and microgliosis.  RS 67333 also transiently increased sAPPα concn. in the cerebrospinal fiuid and brain.  Moreover, a specific 5-HT4 receptor antagonist (RS 39604) prevented the RS 67333-mediated redn. of the amyloid pathol.  Finally, the novel object recognition test deficits of 5XFAD mice were reversed by chronic treatment with RS 67333.  Collectively, these results strongly highlight this 5-HT4 receptor agonist as a promising disease modifying-agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIgv-fla4yPLVg90H21EOLACvtfcHk0lgsyseyJ8Rk6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslamsbzJ&md5=3370afc60266e72919e21e8df93f17b4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2013.00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2013.00096%26sid%3Dliteratum%253Aachs%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3Dde%2BBundel%26aufirst%3DD.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DMarchetti-Gauthier%26aufirst%3DE.%26aulast%3DRoman%26aufirst%3DF.%2BS.%26aulast%3DValjent%26aufirst%3DE.%26aulast%3DMarin%26aufirst%3DP.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DClaeysen%26aufirst%3DS.%26atitle%3DEarly%2520administration%2520of%2520RS%252067333%252C%2520a%2520specific%25205-HT4%2520receptor%2520agonist%252C%2520prevents%2520amyloidogenesis%2520and%2520behavioral%2520deficits%2520in%2520the%25205XFAD%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2013%26volume%3D5%26spage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Tesseur, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimenova, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciesielska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Maeyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuurkes, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Hooge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Chronic 5-HT<sub>4</sub> receptor activation decreases Aβ production and deposition in hAPP/PS1 mice</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1779</span><span class="NLM_x">–</span> <span class="NLM_lpage">1789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2Fj.neurobiolaging.2013.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=23474291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFOqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1779-1789&author=I.+Tesseurauthor=A.+A.+Pimenovaauthor=A.+C.+Loauthor=M.+Ciesielskaauthor=S.+F.+Lichtenthalerauthor=J.+H.+De+Maeyerauthor=J.+A.+Schuurkesauthor=R.+D%E2%80%99Hoogeauthor=B.+De+Strooper&title=Chronic+5-HT4+receptor+activation+decreases+A%CE%B2+production+and+deposition+in+hAPP%2FPS1+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice</span></div><div class="casAuthors">Tesseur, Ina; Pimenova, Anna A.; Lo, Adrian C.; Ciesielska, Marta; Lichtenthaler, Stefan F.; De Maeyer, Joris H.; Schuurkes, Jan A. J.; D'Hooge, Rudi; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1779-1789</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Lowering the prodn. and accumulation of Aβ has been explored as treatment for Alzheimer's disease (AD), because Aβ is postulated to play an important role in the pathogenesis of AD.  5-HT4 receptors are an interesting drug target in this regard, as their activation might stimulate α-secretase processing, which increases sAPPα and reduces Aβ, at least according to the central dogma in APP processing.  Here we describe a novel high-affinity 5-HT4 receptor agonist SSP-002392 that, in cultured human neuroblastoma cells, potently increases the levels of cAMP and sAPPα at 100-fold lower concns. than the effective concns. of prucalopride, a known selective 5-HT4 receptor agonist.  Chronic administration of this compd. in a hAPP/PS1 mouse model of Alzheimer's disease decreased sol. and insol. Aβ in hippocampus, but the potential mechanisms underlying these observations seem to be complex.  We found no evidence for direct α-secretase stimulation in the brain in vivo, but obsd. decreased APP and BACE-1 expression and elevated astroglia and microglia responses.  Taken together these results provide support for a potential disease-modifying aspect when stimulating central 5-HT4 receptors; however, the complexity of the phenomena warrants further research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYF9gyZ-bbm7Vg90H21EOLACvtfcHk0lgsyseyJ8Rk6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFOqsrk%253D&md5=c9d7e525100c9ef123b2c17cbd9759ba</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2013.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2013.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DTesseur%26aufirst%3DI.%26aulast%3DPimenova%26aufirst%3DA.%2BA.%26aulast%3DLo%26aufirst%3DA.%2BC.%26aulast%3DCiesielska%26aufirst%3DM.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DDe%2BMaeyer%26aufirst%3DJ.%2BH.%26aulast%3DSchuurkes%26aufirst%3DJ.%2BA.%26aulast%3DD%25E2%2580%2599Hooge%26aufirst%3DR.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DChronic%25205-HT4%2520receptor%2520activation%2520decreases%2520A%25CE%25B2%2520production%2520and%2520deposition%2520in%2520hAPP%252FPS1%2520mice%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D1779%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Clark, R. D.; Eglen, R.; Jahangir, A.; Miller, A. B.; Gardner, J. O.</span><span> </span><span class="NLM_article-title">Preparation of 1–4-aminophenyl)-ω-amino-1-alkanones as 5-HT<sub>4</sub> receptor ligands</span>.  WO 1994027965 A1, December 8,<span class="NLM_x"> </span><span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&author=R.+D.+Clark&author=R.+Eglen&author=A.+Jahangir&author=A.+B.+Miller&author=J.+O.+Gardner&title=Preparation+of+1%E2%80%934-aminophenyl%29-%CF%89-amino-1-alkanones+as+5-HT4+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BD.%26atitle%3DPreparation%2520of%25201%25E2%2580%25934-aminophenyl%2529-%25CF%2589-amino-1-alkanones%2520as%25205-HT4%2520receptor%2520ligands%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Kawakita, T.; Kuroita, T.; Murozono, T.; Hakira, H.; Haga, K.; Ito, K.; Sonda, S.; Kawahara, T.; Asano, K.</span>Benzoic acid compounds and use thereof as medicaments. US 5864039 A, January 26,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=T.+Kawakita&author=T.+Kuroita&author=T.+Murozono&author=H.+Hakira&author=K.+Haga&author=K.+Ito&author=S.+Sonda&author=T.+Kawahara&author=K.+Asano&title=Benzoic+acid+compounds+and+use+thereof+as+medicaments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKawakita%26aufirst%3DT.%26jtitle%3DBenzoic%2520acid%2520compounds%2520and%2520use%2520thereof%2520as%2520medicaments%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">A short history of SHELX</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">A64</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lgsyseyJ8Rk6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%26date%3D2008%26volume%3DA64%26spage%3D112%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span>SHELXL2014; <span class="NLM_publisher-name">University of Göttingen</span>: <span class="NLM_publisher-loc">Göttingen, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=G.+M.+Sheldrick&title=SHELXL2014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26jtitle%3DSHELXL2014%26pub%3DUniversity%2520of%2520G%25C3%25B6ttingen%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Lowry, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosebrought, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farr, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, R. J.</span><span> </span><span class="NLM_article-title">Protein measurement with the folin phenol reagent</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FS0021-9258%2819%2952451-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=14907713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=1951&pages=265-275&author=O.+H.+Lowryauthor=N.+J.+Rosebroughtauthor=A.+L.+Farrauthor=R.+J.+Randall&title=Protein+measurement+with+the+folin+phenol+reagent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Protein measurement with the Folin phenol reagent</span></div><div class="casAuthors">Lowry, Oliver H.; Rosebrough, Nira J.; Farr, A. Lewis; Randall, Rose J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-75</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">cf. C.A. 41, 1271h.  Proteins were detd. with the Folin phenol reagent after alk. Cu treatment.  The method is as sensitive as with Nessler reagent, yet requires no digestion.  It is 10-20 times more sensitive than detn. of the ultraviolet absorption at λ = 280 mμ and is more specific.  It is several fold more sensitive than the ninhydrin reaction and 100 times more sensitive than the biuret reaction.  Two major disadvantages are: the amt. of color varies with different proteins; the color is not strictly proportional to concn.  Few substances cause serious interference.  Uric acid, guanine, and xanthine react with Folin reagent.  The method is useful for following enzyme fractionation, detg. mixed tissue proteins, detn. of very small amts. of protein, or detg. highly dild. protein, or protein in colored solns. or in the presence of N-contg. material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHNRKGd34F8LVg90H21EOLACvtfcHk0lhNRECNLv5pcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XhsVyrsw%253D%253D&md5=19d36395fad7dd87661caa3d2b97640d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2952451-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252952451-6%26sid%3Dliteratum%253Aachs%26aulast%3DLowry%26aufirst%3DO.%2BH.%26aulast%3DRosebrought%26aufirst%3DN.%2BJ.%26aulast%3DFarr%26aufirst%3DA.%2BL.%26aulast%3DRandall%26aufirst%3DR.%2BJ.%26atitle%3DProtein%2520measurement%2520with%2520the%2520folin%2520phenol%2520reagent%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1951%26volume%3D193%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetyl-cholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=91-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetyl-cholinesterase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetyl-cholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D91%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallender, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szegletes, T.</span><span> </span><span class="NLM_article-title">A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate</span> <span class="citation_source-journal">Chem. Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">119–120</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FS0009-2797%2899%2900017-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10421442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaK1MXkvVKit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119%E2%80%93120&publication_year=1999&pages=85-97&author=T.+L.+Rosenberryauthor=W.+D.+Mallenderauthor=P.+J.+Thomasauthor=T.+Szegletes&title=A+steric+blockade+model+for+inhibition+of+acetylcholinesterase+by+peripheral+site+ligands+and+substrate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate</span></div><div class="casAuthors">Rosenberry, Terrone L.; Mallender, William D.; Thomas, Patrick J.; Szegletes, Tivadar</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">119-120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-97</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The active site gorge of acetylcholinesterase (AChE) contains two sites of ligand binding, an acylation site near the base of the gorge and a peripheral site at its mouth.  We recently introduced a steric blockade model which demonstrated that small peripheral site ligands like propidium can inhibit substrate hydrolysis simply by decreasing the substrate assocn. and dissocn. rate consts. without altering the equil. const. for substrate binding to the acylation site.  We now employ our nonequil. kinetic anal. to extend this model to include blockade of the dissocn. of substrate hydrolysis products by bound peripheral site ligand.  We also report here that acetylthiocholine can bind to the AChE peripheral site with an equil. dissocn. const. KS of about 1 mM.  This value was detd. from the effect of the acetylthiocholine concn. on the rate at which fasciculin assocs. with the peripheral site.  When substrate binding to the peripheral site is incorporated into our steric blockade model, hydrolysis rates at low substrate concn. appear to be accelerated while substrate inhibition of hydrolysis occurs at high substrate concn.  The model predicts that hydrolysis rates for substrates which equilibrate with the acylation site prior to the acylation step should not be inhibited by bound peripheral site ligand.  Organophosphates equilibrate with AChE prior to phosphorylating the active site serine residue, and as predicted propidium had little effect on the phosphorylation rate consts. for the fluorogenic organophosphate ethylmethyl-phosphonylcoumarin (EMPC).  The 2nd-order phosphorylation rate const. kOP/KOP was decreased 3-fold by a high concn. of propidium and the 1st-order rate const. kOP increased somewhat.  In contrast to propidium, when the neurotoxin fasciculin bound to the AChE peripheral site both a steric blockade and a conformational change in the acylation site appeared to occur.  With satg. fasciculin, kOP/KOP decreased by a factor of more than 750 and kOP decreased 300-fold.  These data suggest that new peripheral site ligands may be designed to have selective effects on AChE phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvzXlkBuOvcLVg90H21EOLACvtfcHk0lhNRECNLv5pcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvVKit7Y%253D&md5=8731b3e4e833a42870412dbcffa71c25</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2899%2900017-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252899%252900017-4%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DMallender%26aufirst%3DW.%2BD.%26aulast%3DThomas%26aufirst%3DP.%2BJ.%26aulast%3DSzegletes%26aufirst%3DT.%26atitle%3DA%2520steric%2520blockade%2520model%2520for%2520inhibition%2520of%2520acetylcholinesterase%2520by%2520peripheral%2520site%2520ligands%2520and%2520substrate%26jtitle%3DChem.%2520Biol.%2520Interact.%26date%3D1999%26volume%3D119%25E2%2580%2593120%26spage%3D85%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Cheung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burshteyn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Height, J.</span><span> </span><span class="NLM_article-title">Structures of human acetylcholinesterase in complex with pharmacologically important ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10282</span><span class="NLM_x">–</span> <span class="NLM_lpage">10286</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300871x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10282-10286&author=J.+Cheungauthor=M.+J.+Rudolphauthor=F.+Burshteynauthor=M.+S.+Cassidyauthor=E.+N.+Garyauthor=J.+Loveauthor=M.+C.+Franklinauthor=J.+Height&title=Structures+of+human+acetylcholinesterase+in+complex+with+pharmacologically+important+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands</span></div><div class="casAuthors">Cheung, Jonah; Rudolph, Michael J.; Burshteyn, Fiana; Cassidy, Michael S.; Gary, Ebony N.; Love, James; Franklin, Matthew C.; Height, Jude J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10282-10286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human acetylcholinesterase (AChE) is a significant target for therapeutic drugs.  Here we present high resoln. crystal structures of human AChE, alone and in complexes with drug ligands; donepezil, an Alzheimer's disease drug, binds differently to human AChE than it does to Torpedo AChE.  These crystals of human AChE provide a more accurate platform for further drug development than previously available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdjhYPmZBMf7Vg90H21EOLACvtfcHk0lhNRECNLv5pcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN&md5=c27461e0288f42ac96af354cbefd387e</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm300871x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300871x%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DM.%2BJ.%26aulast%3DBurshteyn%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DM.%2BS.%26aulast%3DGary%26aufirst%3DE.%2BN.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DHeight%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520human%2520acetylcholinesterase%2520in%2520complex%2520with%2520pharmacologically%2520important%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10282%26epage%3D10286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span> </span><span class="NLM_article-title">Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1016%2FS0022-2836%2895%2980037-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=7823319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1995&pages=43-53&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glen&title=Molecular+recognition+of+receptor+sites+using+a+genetic+algorithm+with+a+description+of+desolvation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of a receptor sites using a genetic algorithm with a description of desolvation</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Understanding the principles whereby macromol. biol. receptors can recognize small mol. substrates or inhibitors is the subject of a major effort.  This is of paramount importance in rational drug design where the receptor structure is known (the "docking" problem).  Current theor. approaches utilize models of the steric and electrostatic interaction of bound ligands and recently conformational flexibility has been incorporated.  The authors report results based on software using a genetic algorithm that uses an evolutionary strategy in exploring the full conformational flexibility of the ligand with partial flexibility of the protein, and which satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Results are reported on five test systems showing excellent agreement with exptl. data.  The design of the algorithm offers insight into the mol. recognition mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Xcn7nQyVRLVg90H21EOLACvtfcHk0ljA5yzbeGC-BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D&md5=bf45edafb986a73c7c1d0ac55e070f28</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2895%2980037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252895%252980037-9%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520recognition%2520of%2520receptor%2520sites%2520using%2520a%2520genetic%2520algorithm%2520with%2520a%2520description%2520of%2520desolvation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D245%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0ljA5yzbeGC-BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Morpugo, C.</span><span> </span><span class="NLM_article-title">A new design for the screening of CNS-active drugs in mice</span> <span class="citation_source-journal">Arzneim.-Forsch./Drug Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1727</span><span class="NLM_x">–</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1971&pages=1727-1734&author=C.+Morpugo&title=A+new+design+for+the+screening+of+CNS-active+drugs+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorpugo%26aufirst%3DC.%26atitle%3DA%2520new%2520design%2520for%2520the%2520screening%2520of%2520CNS-active%2520drugs%2520in%2520mice%26jtitle%3DArzneim.-Forsch.%252FDrug%2520Res.%26date%3D1971%26volume%3D11%26spage%3D1727%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiedeville, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span> </span><span class="NLM_article-title">Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT(4) receptor activation (RS67333) on object recognition in mice</span> <span class="citation_source-journal">Behav. Brain. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2012&pages=304-308&author=T.+Freretauthor=V.+Bouetauthor=A.+Quiedevilleauthor=G.+Neeauthor=P.+Dallemagneauthor=C.+Rochaisauthor=M.+Boulouard&title=Synergistic+effect+of+acetylcholinesterase+inhibition+%28donepezil%29+and+5-HT%284%29+receptor+activation+%28RS67333%29+on+object+recognition+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DQuiedeville%26aufirst%3DA.%26aulast%3DNee%26aufirst%3DG.%26aulast%3DDallemagne%26aufirst%3DP.%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DBoulouard%26aufirst%3DM.%26atitle%3DSynergistic%2520effect%2520of%2520acetylcholinesterase%2520inhibition%2520%2528donepezil%2529%2520and%25205-HT%25284%2529%2520receptor%2520activation%2520%2528RS67333%2529%2520on%2520object%2520recognition%2520in%2520mice%26jtitle%3DBehav.%2520Brain.%2520Res.%26date%3D2012%26volume%3D230%26spage%3D304%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Hooper, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, T.</span><span> </span><span class="NLM_article-title">Effect of purines analogues on spontaneous alternation in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1996&pages=250-257&author=N.+Hooperauthor=C.+Fraserauthor=T.+Stone&title=Effect+of+purines+analogues+on+spontaneous+alternation+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHooper%26aufirst%3DN.%26aulast%3DFraser%26aufirst%3DC.%26aulast%3DStone%26aufirst%3DT.%26atitle%3DEffect%2520of%2520purines%2520analogues%2520on%2520spontaneous%2520alternation%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D1996%26volume%3D123%26spage%3D250%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Porsolt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalfre, M.</span><span> </span><span class="NLM_article-title">Behavioral despair in mice: a primary screening test for antidepressants</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=596982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADyaE1cXktlKgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1977&pages=327-336&author=R.+D.+Porsoltauthor=A.+Bertinauthor=M.+Jalfre&title=Behavioral+despair+in+mice%3A+a+primary+screening+test+for+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral despair in mice:  a primary screening test for antidepressants</span></div><div class="casAuthors">Porsolt, R. D.; Bertin, A.; Jalfre, M.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-36</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">A depressed state can be induced in mice by forcing them to swim in a narrow cylinder from which they cannot escape.  After a brief period of vigorous activity the mice adopt a characteristic immobile posture which is readily identifiable.  Immobility was reduced by tricyclic antidepressants, monoamine oxidase inhibitors and atypical antidepressants, as well as by electroconvulsive shock.  Psychostimulants also reduced immobility but in contrast to antidepressants caused marked motor stimulation.  Immobility was not affected by minor or major tranquilizers.  These findings, closely parallel to those previously reported in rats, suggest that the procedure is selectively senstitive to antidepressant treatments.  The mouse procedure is, however, more rapid and less costly than that with rats and is thus more suitable for the primary screening of antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3THea0LRwE7Vg90H21EOLACvtfcHk0ljaw1at5bfCTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXktlKgsbs%253D&md5=70dd5706992ee8151a9801a2aeb42961</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorsolt%26aufirst%3DR.%2BD.%26aulast%3DBertin%26aufirst%3DA.%26aulast%3DJalfre%26aufirst%3DM.%26atitle%3DBehavioral%2520despair%2520in%2520mice%253A%2520a%2520primary%2520screening%2520test%2520for%2520antidepressants%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1977%26volume%3D229%26spage%3D327%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Aguila, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulbault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léveillé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tóth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsodi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balboni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jauzac, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allouche, S.</span><span> </span><span class="NLM_article-title"><i>In vitro</i> and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">1312</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.1038%2Fsj.bjp.0707497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=17982482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSlsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=1312-1324&author=B.+Aguilaauthor=L.+Coulbaultauthor=M.+Boulouardauthor=F.+L%C3%A9veill%C3%A9author=A.+Davisauthor=G.+T%C3%B3thauthor=A.+Borsodiauthor=G.+Balboniauthor=S.+Salvadoriauthor=P.+Jauzacauthor=S.+Allouche&title=In+vitro+and+in+vivo+pharmacological+profile+of+UFP-512%2C+a+novel+selective+delta-opioid+receptor+agonist%3B+correlations+between+desensitization+and+tolerance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo pharmacological profile of UFP-512, a novel selective δ-opioid receptor agonist; correlations between desensitization and tolerance</span></div><div class="casAuthors">Aguila, B.; Coulbault, L.; Boulouard, M.; Leveille, F.; Davis, A.; Toth, G.; Borsodi, A.; Balboni, G.; Salvadori, S.; Jauzac, P.; Allouche, S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1312-1324</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: δ-Opioid receptors (DOP receptors) could represent a novel target in the treatment of depressive disorders.  To explore this new field of interest, the development of highly selective DOP receptor agonists is essential.  UFP-512 [H-Dmt-Tic-NH-CH(CH2-COOH)-Bid], was recently shown to behave in vitro as a selective and potent DOP receptor agonist and to promote antidepressant- and anxiolytic-like effects in vivo.  Here, we have characterized the pharmacol. properties of UFP-512 and established a link between desensitization and tolerance.  Exptl. approach: Studies were performed in the human neuroblastoma SK-N-BE cells to establish (i) binding parameters for UFP-512 (ii) signaling pathways activated after acute and chronic treatment (iii) regulation (phosphorylation and trafficking) of human DOP (hDOP) receptors after sustained activation by UFP-512.  In vivo, we studied UFP-512-induced antidepressant-like effects after acute or chronic treatment in the mouse forced swimming test.  Key results: In vitro, UFP-512 was a high affinity agonist for DOP receptors.  While UFP-512 induced marked phosphorylation of DOP receptors on Ser363, we obsd. a low desensitization of the cAMP pathway, assocd. with receptor endocytosis and recycling without any redn. on extracellular signal-regulated protein kinase 1/2 activation.  In vivo, acute administration of UFP-512 produced an antidepressant-like effect, without any sign of tolerance after chronic administration.  Conclusions and implications: There was a correlation between weak desensitization, significant internalization and recycling of the human DOP receptors and lack of tolerance to UFP-512.  This suggests that this compd. would be a promising drug prototype for exploring innovative treatments for mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLmPrOFKIhBrVg90H21EOLACvtfcHk0ljaw1at5bfCTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSlsLrO&md5=5bd27e9271431f53880f037a8f8af394</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707497%26sid%3Dliteratum%253Aachs%26aulast%3DAguila%26aufirst%3DB.%26aulast%3DCoulbault%26aufirst%3DL.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DL%25C3%25A9veill%25C3%25A9%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DT%25C3%25B3th%26aufirst%3DG.%26aulast%3DBorsodi%26aufirst%3DA.%26aulast%3DBalboni%26aufirst%3DG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DJauzac%26aufirst%3DP.%26aulast%3DAllouche%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520profile%2520of%2520UFP-512%252C%2520a%2520novel%2520selective%2520delta-opioid%2520receptor%2520agonist%253B%2520correlations%2520between%2520desensitization%2520and%2520tolerance%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D1312%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duff, K.</span><span> </span><span class="NLM_article-title">A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse</span> <span class="citation_source-journal">J. Visualized Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">960</span><span class="refDoi"> DOI: 10.3791/960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;key=10.3791%2F960" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=960&author=L.+Liuauthor=K.+Duff&title=A+technique+for+serial+collection+of+cerebrospinal+fluid+from+the+cisterna+magna+in+mouse&doi=10.3791%2F960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.3791%2F960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F960%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDuff%26aufirst%3DK.%26atitle%3DA%2520technique%2520for%2520serial%2520collection%2520of%2520cerebrospinal%2520fluid%2520from%2520the%2520cisterna%2520magna%2520in%2520mouse%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2008%26volume%3D21%26spage%3D960%26doi%3D10.3791%2F960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Bourdin, J.; Desire, L.; Schweighoffer, F.</span><span> </span><span class="NLM_article-title">Methods and tools for the therapy of neurodegenerative pathologies</span>. WO2008009868, May 8,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Bourdin&author=L.+Desire&author=F.+Schweighoffer&title=Methods+and+tools+for+the+therapy+of+neurodegenerative+pathologies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBourdin%26aufirst%3DJ.%26atitle%3DMethods%2520and%2520tools%2520for%2520the%2520therapy%2520of%2520neurodegenerative%2520pathologies%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RH1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RH1','PDB','2RH1'); return false;">PDB: 2RH1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7','PDB','4EY7'); return false;">PDB: 4EY7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i58"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00115">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11615"></div></div></div></div></div><hr /></hr><p class="last">Primary binding test for Donecopride toward a broad range of receptors. ORTEP diagram of <b>17</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00115/suppl_file/jm5b00115_si_001.pdf">jm5b00115_si_001.pdf (307.36 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-7%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00115" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00115" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995dd76de81929","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
